
<html lang="en"     class="pb-page"  data-request-id="d567aae5-d8b0-4762-9078-39849f1372c5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-3;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01294;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase" /></meta><meta name="dc.Creator" content="Jianbin  Zheng" /></meta><meta name="dc.Creator" content="Sohee  Jeon" /></meta><meta name="dc.Creator" content="Weilan  Jiang" /></meta><meta name="dc.Creator" content="Lena F.  Burbulla" /></meta><meta name="dc.Creator" content="Daniel  Ysselstein" /></meta><meta name="dc.Creator" content="Kristine  Oevel" /></meta><meta name="dc.Creator" content="Dimitri  Krainc" /></meta><meta name="dc.Creator" content="Richard B.  Silverman" /></meta><meta name="dc.Description" content="Gaucher’s disease is a lysosomal disease caused by mutations in the β-glucocerebrosidase gene (GBA1 and GCase) that have been also linked to increased risk of Parkinson’s disease (PD) and Diffuse L..." /></meta><meta name="Description" content="Gaucher’s disease is a lysosomal disease caused by mutations in the β-glucocerebrosidase gene (GBA1 and GCase) that have been also linked to increased risk of Parkinson’s disease (PD) and Diffuse L..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 15, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01294" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01294" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01294" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01294" /></link>
        
    
    

<title>Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01294" /></meta><meta property="og:title" content="Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0018.jpeg" /></meta><meta property="og:description" content="Gaucher’s disease is a lysosomal disease caused by mutations in the β-glucocerebrosidase gene (GBA1 and GCase) that have been also linked to increased risk of Parkinson’s disease (PD) and Diffuse Lewy body dementia. Prior studies have suggested that mutant GCase protein undergoes misfolding and degradation, and therefore, stabilization of the mutant protein represents an important therapeutic strategy in synucleinopathies. In this work, we present a structure–activity relationship (SAR) study of quinazoline compounds that serve as inhibitors of GCase. Unexpectedly, we found that N-methylation of these inhibitors transformed them into GCase activators. A systematic SAR study further revealed that replacement of the key oxygen atom in the linker of the quinazoline derivative also contributed to the activity switch. PD patient-derived fibroblasts and dopaminergic midbrain neurons were treated with a selected compound (9q) that partially stabilized GCase and improved its activity. These results highlight a novel strategy for therapeutic development of noninhibitory GCase modulators in PD and related synucleinopathies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01294"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01294">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01294&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01294&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01294&amp;href=/doi/10.1021/acs.jmedchem.8b01294" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1218-1230</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01280" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01305" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.9b00284"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jianbin Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianbin Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, and Center for Developmental Therapeutics, Northwestern University, Evanston, Illinois 60208, United States</div><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianbin++Zheng">Jianbin Zheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sohee Jeon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sohee Jeon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sohee++Jeon">Sohee Jeon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weilan Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weilan Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weilan++Jiang">Weilan Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lena F. Burbulla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lena F. Burbulla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lena+F.++Burbulla">Lena F. Burbulla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Ysselstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Ysselstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Ysselstein">Daniel Ysselstein</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristine Oevel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristine Oevel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristine++Oevel">Kristine Oevel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dimitri Krainc</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dimitri Krainc</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#80e4ebf2e1e9eee3c0eeedaeeff2e7"><span class="__cf_email__" data-cfemail="04606f76656d6a67446a692a6b7663">[email protected]</span></a>. Phone: 312-503-3936. Fax: 312-503-3950 (D.K.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dimitri++Krainc">Dimitri Krainc</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4716-1886" title="Orcid link">http://orcid.org/0000-0002-4716-1886</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Richard B. Silverman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard B. Silverman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, and Center for Developmental Therapeutics, Northwestern University, Evanston, Illinois 60208, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#2160464c404f614249444c0f4f4e5355495644525544534f0f444554"><span class="__cf_email__" data-cfemail="45042228242b05262d20286b2b2a37312d3220363120372b6b202130">[email protected]</span></a>. Phone: 847-491-5653. Fax: 847-491-7713 (R.B.S.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+B.++Silverman">Richard B. Silverman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9034-1084" title="Orcid link">http://orcid.org/0000-0001-9034-1084</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01294&amp;href=/doi/10.1021%2Facs.jmedchem.8b01294" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1218–1230</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 15, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 August 2018</li><li><span class="item_label"><b>Published</b> online</span>15 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01294</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1218%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJianbin%2BZheng%252C%2BSohee%2BJeon%252C%2BWeilan%2BJiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D3%26contentID%3Dacs.jmedchem.8b01294%26title%3DConversion%2Bof%2BQuinazoline%2BModulators%2Bfrom%2BInhibitors%2Bto%2BActivators%2Bof%2B%25CE%25B2-Glucocerebrosidase%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1230%26publicationDate%3DFebruary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01294"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2204</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01294" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jianbin&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Sohee&quot;,&quot;last_name&quot;:&quot;Jeon&quot;},{&quot;first_name&quot;:&quot;Weilan&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Lena&quot;,&quot;last_name&quot;:&quot;F. Burbulla&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Ysselstein&quot;},{&quot;first_name&quot;:&quot;Kristine&quot;,&quot;last_name&quot;:&quot;Oevel&quot;},{&quot;first_name&quot;:&quot;Dimitri&quot;,&quot;last_name&quot;:&quot;Krainc&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;B. Silverman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1218-1230&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01294&quot;},&quot;abstract&quot;:&quot;Gaucher’s disease is a lysosomal disease caused by mutations in the β-glucocerebrosidase gene (GBA1 and GCase) that have been also linked to increased risk of Parkinson’s disease (PD) and Diffuse Lewy body dementia. Prior studies have suggested that mutant GCase protein undergoes misfolding and degradation, and therefore, stabilization of the mutant protein represents an important therapeutic strategy in synucleinopathies. In this work, we present a structure–activity relationship (SAR) study of quinazoline compounds that serve as inhibitors of GCase. Unexpectedly, we found that N-methylation of these inhibitors transformed them into GCase activators. A systematic SAR study further revealed that replacement of the key oxygen atom in the linker of the quinazoline derivative also contributed to the activity switch. PD patient-derived fibroblasts and dopaminergic midbrain neurons were treated with a selected compound (9q) that partially stabilized GCase and improved its activity. These results highlight a novel &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01294&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01294" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01294&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01294" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01294&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01294" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01294&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01294&amp;href=/doi/10.1021/acs.jmedchem.8b01294" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01294" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01294" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01294%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DZheng%26date%3D2019%26atitle%3DConversion%2Bof%2BQuinazoline%2BModulators%2Bfrom%2BInhibitors%2Bto%2BActivators%2Bof%2B%25CE%25B2-Glucocerebrosidase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D3%26spage%3D1218%26epage%3D1230%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291466" title="Theoretical and computational chemistry">Theoretical and computational chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/jmcmar.2019.62.issue-3/20190214/jmcmar.2019.62.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Gaucher’s disease is a lysosomal disease caused by mutations in the β-glucocerebrosidase gene (<i>GBA1</i> and GCase) that have been also linked to increased risk of Parkinson’s disease (PD) and Diffuse Lewy body dementia. Prior studies have suggested that mutant GCase protein undergoes misfolding and degradation, and therefore, stabilization of the mutant protein represents an important therapeutic strategy in synucleinopathies. In this work, we present a structure–activity relationship (SAR) study of quinazoline compounds that serve as inhibitors of GCase. Unexpectedly, we found that N-methylation of these inhibitors transformed them into GCase activators. A systematic SAR study further revealed that replacement of the key oxygen atom in the linker of the quinazoline derivative also contributed to the activity switch. PD patient-derived fibroblasts and dopaminergic midbrain neurons were treated with a selected compound (<b>9q</b>) that partially stabilized GCase and improved its activity. These results highlight a novel strategy for therapeutic development of noninhibitory GCase modulators in PD and related synucleinopathies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gaucher’s disease (GD), an autosomal recessive lysosomal storage disorder, is caused by mutations of the <i>GBA1</i> gene encoding the lysosomal enzyme β-glucocerebrosidase (GCase). Mutations in <i>GBA1</i> were also found as a major risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> Most of these mutations, including the prevalent N370S mutation, are still functional, although with low residual GCase activity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Loss of function of GCase leads to accumulation of glucosylceramide (GluCer),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> which also promotes the formation and stabilization of α-synuclein oligomers.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Enhancement of GCase activity is thought to be a potential therapeutic strategy for GCase-associated synucleinopathies, including PD.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a></div><div class="NLM_p">Several different scaffolds of non-iminosugar GCase inhibitors have been reported as GCase pharmacological chaperones (PCs) since 2007<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16">(12−16)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). We found that a noninhibitory GCase PC NCGC00188758 (<b>2</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> can enhance GCase activity specifically within the lysosomal compartment, reduce GluCer and hexosylsphingosine substrates, and subsequently enhance the clearance of pathological α-synuclein.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> These findings suggested that reduction of GluCer may provide benefit in PD and strengthen the notion that GCase is a valuable target for the treatment of synucleinopathies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of GCase inhibitors and activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In our previous work,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we discovered a series of quinazoline inhibitors with nanomolar potency (see representative compounds <b>3</b> and <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Here, we unexpectedly found that N-methylation of some of the quinazoline analogues transformed quinazoline inhibitors into activators. We describe a broader structure–activity relationship (SAR) study of quinazoline derivatives to better understand the pharmacophoric requirements for this unusual activity switch as a result of such a minor structural change and to design novel noninhibitory modulators.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of target compounds for SAR exploration is similar to our previous synthesis route<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and is detailed in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the intermediate 4-chloro-2-(pyridin-3-yl)quinazoline was prepared from 2-amino-benzonitrile and nicotinoyl chloride according to a published synthesis route.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The reaction of 4-chloro-2-(pyridin-3-yl)quinazoline and appropriate amines in the presence of potassium carbonate as a base afforded <b>5a–5j</b> and <b>7a–7e</b>. Compounds <b>6a–6j</b>, <b>8a–8h</b>, and <b>9a–9v</b> were obtained either by deprotonation and N-methylation of the corresponding secondary amines (<b>5a–5j</b> and <b>7a–7e</b>), or by alkylation of 4-chloro-2-(pyridin-3-yl)quinazoline with appropriate secondary amines under basic conditions.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Methyl Quinazoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) sulfolane (ii) PCl<sub>5</sub>; 46%; (b) R<sup>1</sup>NH<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF; 34–73%; (c) (i) NaH, DMF (ii) R<sup>2</sup>I; (d) R<sup>1</sup>R<sup>2</sup>NH, K<sub>2</sub>CO<sub>3</sub>, DMF; 33–96%; (e) RH, K<sub>2</sub>CO<sub>3</sub>, DMF; 26–89%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11a–11i</b> with Modifications at the 2-Position of the Quinazoline Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-methyl-2-phenoxyethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF, 80%; (b) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O; 40–82%; (c) <i>N</i>-methyl-2-phenoxyethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF, 73%.</p></p></figure><div class="NLM_p last">Additional analogues, having modifications at position 2 of the quinazoline ring, were synthesized by reaction of <i>N</i>-methyl-2-phenoxyethanamine with 2,4-dichloroquinazoline, followed by Suzuki coupling with appropriate boronic acids to afford <b>11b–11i</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Compound <b>11a</b> was synthesized by reaction of commercially available 4-chloro-2-(pyridin-2-yl)quinazoline and <i>N</i>-methyl-2-phenoxyethanamine. The structure and purity of all of the prepared compounds were confirmed by spectroscopic and analytical techniques.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because of our unexpected observation that N-methylation of inhibitor <b>5a</b> to <b>6a</b> (R<sup>2</sup> = CH<sub>3</sub>) transformed its activity into an activator (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), we explored a broader SAR of quinazoline derivatives in an attempt to uncover the pharmacophoric basis for this finding and to identify novel noninhibitory modulators. First, we examined a series of moderate to potent quinazoline inhibitors that we previously reported<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to see if they could also be switched to activators by N-methylation (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, we were able to switch the moderately active inhibitors (<b>5a–5f</b>) to activators (<b>6a–6f</b>) by N-methylation, suggesting that these inhibitors and activators may share an allosteric binding site. According to our recent findings, the N–H forms a H-bond with Ser345 in the allosteric site;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> this interaction may be important for attaining an inhibitory conformation, and N-methylation disrupted the H-bond and may change that conformation to one that promotes activation.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. GCase enzyme activity switch by N-methylation of quinazoline derivatives. (A) Example of the change in activity by N-methylation; (B) plot demonstrating the change in activity from inhibition (<b>5a</b>) to activation (<b>6a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Enzyme Activity of Quinazoline Derivatives without and with the <i>N</i>-Methyl Substituent<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0010.gif" alt="" id="GRAPHIC-d7e527-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Experiments were performed in triplicate, and the mean ± SD is shown.</p></div></div><div></div></div><div class="NLM_p">However, for the most potent inhibitors (<b>5g–5j</b>), N-methylation only produced weak inhibitory or inactive compounds (<b>6g–6j</b>). As we noted in our inhibitor SAR study,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the most potent inhibitors (<b>5h–5j</b>), having fused substituents (R groups), have additional hydrophobic interactions (and π–π stacking with Phe347) with loop 2 residues of GCase, which stabilizes the GCase dimer form. The removal of this presumed NH H-bond interaction with Ser345 is apparently not sufficient to completely change the conformation and/or break dimer formation so that these compounds retain partial inhibitory activity, and are not activators. Therefore, substituents of the secondary amines of inhibitors might also affect an activity switch.</div><div class="NLM_p">To further explore the SAR, a methylene group in the phenylpropyl substituent of <b>5a</b> was modified to an oxygen atom to give ether <b>7a</b>, which was a moderate activator even without N-methylation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Compared to <b>7a</b>, the compounds with a longer substituent (<b>7b</b> and <b>7c</b>) or with a methyl group at the α- or β-position of <b>7a</b> (<b>7d</b> and <b>7e</b>) retained their inhibitory activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This finding suggests that the oxygen atom in <b>7a</b> may be involved in an intramolecular H-bond interaction with the NH group to avoid the intermolecular H-bond with Ser345, but an appropriate distance between the oxygen atom and quinazoline ring with no steric hindrance was required for proper H-bonding and to achieve this activation. Installation of an <i>N</i>-methyl group on the secondary amine of <b>7a</b> afforded <b>8a</b>, having the greatest maximum activation (<i>E</i><sub>max</sub> 761%) with an AC<sub>50</sub> value (3.55 μM) similar to that of <b>7a</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Likewise, N-methylation of <b>7b–7e</b> switched these inhibitors to moderate activators <b>8b–8e</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Activation of <b>8f–8h</b> was decreased with a longer substituent or with increased steric hindrance of the carbon substituents (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), suggesting a small hydrophobic pocket for the alkyl groups.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Modification of the N-substituent by oxygen replacement (<b>7a</b>) and N-methylation (<b>8a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and Inhibition or Activation Activity of Quinazoline Derivatives Having an Oxygen Isostere and Methylation in the N-Substituent<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0012.gif" alt="" id="GRAPHIC-d7e650-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0013.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Experiments were performed in triplicate, and the mean ± SD is shown.</p></div></div><div></div></div><div class="NLM_p">To further explore the conformation required for the activation activity, some conformationally restricted substituents were introduced in the modulators (<b>9a–9k</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As we expected, these compounds, without a free NH group, displayed activation activity (except for <b>9g</b> and <b>9h</b>). Interestingly, the chiral center of the steroisomers (<b>9b</b> and <b>9c</b>) did not have a striking effect on the activity. We had previously demonstrated the important role of an aromatic ring in the N-substituents of our quinazoline inhibitors;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> here, we also observed the key interaction of the aromatic ring in the activators. For example, compared to <b>9j</b>, compound <b>9k</b> with a fused phenyl ring gave a 5-fold lower AC<sub>50</sub> value.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure and Activation Activity of Quinazoline Derivatives with Conformationally Restricted Substituents and Fused Aromatic Ring Substituents<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0014.gif" alt="" id="GRAPHIC-d7e698-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0015.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Experiments were performed in triplicate, and the mean ± SD is shown.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Inhibitor.</p></div></div><div></div></div><div class="NLM_p">To pursue potent activators with greater maximum activation, we further designed and synthesized derivatives <b>9l–9v</b> having a conformationally restricted chain or a fused ring (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Most of the compounds showed similar activation activity as <b>8a</b>, except for <b>9n</b>, <b>9u</b>, and <b>9v</b>. Similar to <b>9b</b> and <b>9c</b>, compound <b>9q</b> has slightly better binding potency than its enantiomer (<b>9r</b>).</div><div class="NLM_p">Finally, we examined the aromatic ring effect at position 2 of the quinazoline ring (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). As we found in our SAR of quinazoline inhibitors, the 3-pyridinyl ring could be replaced by other aromatic rings, such as phenyl and 3-thienyl groups, without losing activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Unlike the inhibitors, the activator series modulators were not tolerant of modification of the 3-pyridinyl ring, except for <b>11b</b>, <b>11c</b>, and <b>11h</b>, which were comparable or enhanced in activity relative to <b>8a</b>. It should be noted that compound binding to the GCase allosteric site may not induce either inhibitory or activation activity because the readout of compound activity was based on the enzyme activity. A binding affinity-based or competitive-binding assay may be developed for accurate evaluation of the compounds without inhibitory or activation activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure and Activation Activity of <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)quinazolin-4-amine Derivatives Containing Aromatic Rings (<b>11a–11g</b>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0016.gif" alt="" id="GRAPHIC-d7e783-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0017.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Experiments were performed in triplicate, and the mean ± SD is shown.</p></div></div><div></div></div><div class="NLM_p">To verify compound activity in cells, the most active compounds underwent preliminary screening in healthy control fibroblast cell assays. Compound <b>9q</b>, showing the most promising effect, was further tested in healthy control and compound heterozygous N370S/84GG <i>GBA1</i> mutant fibroblasts derived from a GD patient. Compound treatment increased the post-ER form (resistant to Endo H digestion) of wild-type GCase protein levels and improved enzyme activity at a concentration of 15 μM in control fibroblasts, while control compound isofagomine (IFG) did not change post-ER GCase levels and enzyme activity at a concentration of 25 μM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Similarly, we observed an increase of GCase protein levels and improved enzyme activity upon <b>9q</b> treatment in N370S/84GG <i>GBA1</i> mutant fibroblasts (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activator <b>9q</b> increases GCase protein levels in (A) healthy control fibroblasts and (B) compound heterozygous <i>GBA1</i> mutant fibroblasts (N370S/84GG) derived from a GD patient. Cell lysates from fibroblasts treated with vehicle (DMSO), <b>9q</b> (5, 15 μM), or IFG were analyzed by immunoblotting after no digestion (top), Endo H digestion (middle), and PNGase F digestion (bottom); <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. GCase enzyme activity in cell lysates and in the lysosome of <b>9q</b>-treated cells. GCase activity was measured in lysates from (A) healthy control fibroblasts and (B) compound heterozygous <i>GBA1</i> mutant fibroblasts (N370S/84GG). Lysosomal GCase was measured using a live-cell assay in (C) healthy control, (D) homozygous N370S, and (E) homozygous L444P mutant fibroblasts after 3 day treatment with <b>9q</b> (5, 15 μM), 5 μM IFG, or vehicle (DMSO). The data are presented as the mean ± SEM, <i>n</i> = 3–4; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs vehicle treatments; one-way ANOVA was followed by the Tukey’s multiple comparisons post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm that the increase of GCase activity observed in fibroblast lysates occurred because of an increase in lysosomal GCase, we measured GCase activity in live cells. Fibroblasts from a healthy control and fibroblasts containing a homozygous N370S or L444P <i>GBA1</i> mutation were treated with <b>9q</b> and IFG and assayed for lysosomal GCase activity. Lysosomal specificity was achieved by calculating only the bafilomycin-sensitive hydrolysis of the substrate. We found that treatment with <b>9q</b> led to a significant, dose-dependent, increase in lysosomal GCase activity in healthy control and <i>GBA1</i> mutant fibroblasts with a 55 and 85% increase in the 15 μM treated N370S and L444P fibroblast, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C–E). In contrast, treatment with IFG showed little or no effect on GCase activity.</div><div class="NLM_p">Similar effects were observed in induced pluripotent stem cell (iPSC)-derived healthy control neurons and heterozygous N370S <i>GBA1</i> mutant dopaminergic neurons from a PD patient (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf" class="ext-link">Supporting Information</a> Figure for the characterization of iPSCs and differentiated neurons) treated with increasing concentrations of <b>9q</b> for 10 days and digested with Endo H or PNGase. <b>9q</b> increased GCase protein levels and enzyme activity in both wild-type and mutant neurons (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), suggesting the potential application of these GCase modulators in PD patients with/without <i>GBA1</i> mutations.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activator <b>9q</b> increases GCase protein levels and enzyme activity in (A) wild-type control and (B) patient-derived heterozygous N370S <i>GBA1</i> mutant dopaminergic neurons at day 70 of differentiation. Cell lysates from neurons treated with vehicle (DMSO) or <b>9q</b> (5, 15 μM) for 10 consecutive days were analyzed by immunoblotting after no digestion (top), Endo H digestion (middle), and PNGase F digestion (bottom); <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. GCase enzyme activity in protein lysates of (A) wild-type control and (B) patient-derived heterozygous N370S <i>GBA1</i> mutant dopaminergic neurons after 10 days consecutive treatment with vehicle (DMSO) or <b>9q</b> (day 70 of differentiation). The data are presented as the mean ± SEM, <i>n</i> = 4–7; *<i>p</i> < 0.05, **<i>p</i> < 0,01 versus vehicle treatments; one-way ANOVA was followed by the Tukey’s multiple comparisons post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Our SAR study revealed a remarkable finding that previously reported quinazoline inhibitors could be transformed to activators of GCase by N-methylation. Treatment of wild-type and <i>GBA1</i> mutant fibroblasts, as well as dopaminergic neurons with modulator <b>9q</b>, led to increased GCase protein levels and lysosomal enzyme activity, suggesting that further development of these compounds as GCase allosteric activators is warranted. It will be important to analyze the GCase-compound complex by crystallography to elucidate the mechanism of enzyme activation for future drug design.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Materials, and Methods</h4><div class="NLM_p last">Commercially available reagents and solvents were used without further purification. All reactions were monitored by thin-layer chromatography (TLC) using 0.25 mm SiliCycle extra hard 250 μM TLC plates (60 F254). Purification of reaction products was carried out by flash chromatography using an Agilent 971-FP flash purification system with SiliCycle silica gel columns. The yields are not optimized. The purity of all compounds was >95% as analyzed with an Agilent 1260 Infinity HPLC system. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained using a Bruker AVANCE III 500 MHz system (500 MHz for <sup>1</sup>H NMR and 125 MHz for <sup>13</sup>C NMR) or Agilent DD MR-400 system (400 MHz for <sup>1</sup>H NMR and 100 MHz for <sup>13</sup>C NMR) spectrometer. Chemical shifts are reported relative to chloroform (δ = 7.26 for <sup>1</sup>H NMR and δ = 77.16 for <sup>13</sup>C NMR spectra) or dimethyl sulfoxide (DMSO) (δ = 2.50 for <sup>1</sup>H and δ = 39.52 for <sup>13</sup>C NMR spectra). Data are reported as br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Mass spectra were obtained using a Bruker AmaZon SL system. High-resolution mass spectra (HRMS) were performed using an Agilent 6210A LC-time of flight (TOF) instrument with a dual spray electrospray ionization (ESI) source with a high resolution TOF mass analyzer and collecting in a 2 GHz detector mode coupled with an Agilent 1200 HPLC.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure for Compounds <b>5a–5j</b>, <b>7a–7e</b>, <b>9a–9v</b>, and <b>11a</b></h4><div class="NLM_p last">A mixture of 4-chloro-2-(pyridin-3-yl)quinazoline<a onclick="showRef(event, 'ref19 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref22">(19,22)</a> (72 mg, 0.3 mmol), amine (0.3 mmol), and potassium carbonate (69 mg, 0.3 mmol) in dimethylformamide (DMF, 2 mL) was stirred at room temperature or 60 °C overnight. Water (20 mL) was added, and the formed solid was filtered, washed with water, and dried in vacuo to give the products, which were usually pure (>95% purity). Those products without sufficient purity were further purified by flash chromatography.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure for Compounds <b>6a–6j</b> and <b>8a–8h</b></h4><div class="NLM_p last">To a solution of <b>5a–5j</b> in dry DMF was added NaH (60% in mineral oil) under an argon atmosphere at room temperature, and the mixture was stirred for 15 min. Iodomethane or an appropriate halogenated alkane was added dropwise to the mixture, and the mixture was allowed to stir at room temperature overnight. Water was added, and the formed solid was filtered, washed with water, and dried in vacuo to give the desired product.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Preparation of 2-Chloro-<i>N</i>-methyl-<i>N</i>-(2-phenoxyethyl)quinazolin-4-amine (<b>10</b>)</h4><div class="NLM_p">A mixture of 2,4-dichloroquinazoline (1.99 g, 10 mmol), <i>N</i>-methyl-2-phenoxyethanamine (1.51 g, 10 mmol), and potassium carbonate (1.38 g, 10 mmol) in DMF (20 mL) were stirred at room temperature overnight. Water (120 mL) was added, and the formed solid was filtered, washed with water, and dried to give <b>10</b> as a white solid (2.5 g, 80%).</div><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.10 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.71–7.65 (m, 1H), 7.37 (ddd, <i>J</i> = 8.4, 7.0, 1.3 Hz, 1H), 7.30–7.25 (m, 2H), 6.97–6.91 (m, 3H), 4.38 (t, <i>J</i> = 5.5 Hz, 2H), 4.18 (t, <i>J</i> = 5.4 Hz, 2H), 3.61 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.7, 158.3, 156.1, 153.6, 133.0, 129.6, 127.8, 125.7, 124.8, 121.1, 114.4, 65.5, 52.6, 42.2. MS (ESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd, 314.11; found, 314.49.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure for Compounds <b>11b–11h</b></h4><div class="NLM_p last">A mixture of 2-chloro-<i>N</i>-methyl-<i>N</i>-(2-phenoxyethyl)quinazolin-4-amine (<b>10</b>, 126 mg, 0.4 mmol), boronic acid (0.5 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (50 mg, 0.05 mmol), potassium carbonate (276 mg, 2.0 mmol) in dioxane (10 mL), and water (1.5 mL) was heated at 100 °C under an argon atmosphere for 16 h. Water (5 mL) was added, and the mixture was extracted with EtOAc (25 mL × 3). The combined organic phase was washed with brine (15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, evaporated, and purified by flash chromatography to give the product.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Analytical Data of the Novel Quinazoline Derivatives (<b>6a–6j</b>, <b>7a–7e</b>, <b>8a–8h</b>, <b>9a–9v</b>, and <b>11a–11h</b>)</h4><div id="sec5_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> <i>N</i>-Methyl-<i>N</i>-(3-phenylpropyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>6a</b>)</h5><div class="NLM_p last">Yellow solid (yield: 72%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.69 (s, 1H), 8.70 (dt, <i>J</i> = 7.9, 1.7 Hz, 1H), 8.66 (d, <i>J</i> = 4.4 Hz, 1H), 7.92–7.84 (m, 2H), 7.71–7.63 (m, 1H), 7.37 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.31–7.25 (m, 3H), 7.21–7.16 (m, 3H), 3.86–3.80 (m, 2H), 3.41 (s, 3H), 2.74 (t, <i>J</i> = 7.5 Hz, 2H), 2.25–2.16 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.3, 157.3, 152.9, 150.6, 150.2, 141.2, 135.5, 134.3, 132.1, 128.7, 128.5, 128.4, 126.1, 125.2, 124.4, 123.1, 115.0, 52.7, 40.0, 33.3, 28.8. HRMS (ESI): calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 355.1917; found, 355.1928.</div></div><div id="sec5_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> <i>N</i>-Methyl-<i>N</i>-phenethyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6b</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 81%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.74 (s, 1H), 8.80–8.56 (m, 2H), 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (d, <i>J</i> = 8.3 Hz, 1H), 7.70–7.62 (m, 1H), 7.41–7.30 (m, 2H), 7.30–7.16 (m, 5H), 4.07–3.97 (m, 2H), 3.39 (s, 3H), 3.17–3.07 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.0, 157.4, 152.9, 150.6, 150.1, 138.9, 135.6, 134.5, 132.2, 128.8, 128.7, 128.7, 126.5, 125.3, 124.5, 123.2, 115.0, 54.9, 40.7, 33.6. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 341.1761; found, 341.1770.</div></div><div id="sec5_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>N</i>-Methyl-<i>N</i>-(4-phenylbutyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>6c</b>)</h5><div class="NLM_p last">Pale-yellow oil (yield: 67%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.72 (s, 1H), 8.75 (d, <i>J</i> = 7.9 Hz, 1H), 8.68 (s, 1H), 7.94 (d, <i>J</i> = 7.7 Hz, 1H), 7.91 (d, <i>J</i> = 8.3 Hz, 1H), 7.71–7.66 (m, 1H), 7.42–7.33 (m, 2H), 7.28–7.23 (t, <i>J</i> = 7.6 Hz, 2H), 7.19–7.12 (m, 3H), 3.85–3.79 (m, 2H), 3.39 (s, 3H), 2.68 (t, <i>J</i> = 7.6 Hz, 2H), 1.93–1.84 (m, 2H), 1.78–1.70 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.3, 157.4, 152.9, 150.5, 150.1, 141.9, 135.6, 134.4, 132.2, 128.7, 128.3, 125.9, 125.3, 124.4, 123.3, 115.1, 53.1, 40.0, 35.6, 28.7, 26.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 369.2074; found, 369.2080.</div></div><div id="sec5_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>N</i>-Cyclopentyl-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6d</b>)</h5><div class="NLM_p last">Yellow solid (yield: 76%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.65 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 7.98 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 1H), 7.68 (t, <i>J</i> = 7.1 Hz, 1H), 7.44–7.31 (m, 2H), 5.04–4.92 (m, 1H), 3.25 (s, 3H), 2.15–2.02 (m, 2H), 1.86–1.60 (m, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.4, 157.4, 152.9, 150.5, 150.2, 135.6, 134.4, 132.1, 128.6, 125.4, 124.4, 123.1, 115.5, 61.6, 34.4, 28.8, 24.6. HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 305.1761; found, 305.1762.</div></div><div id="sec5_1_6_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>N</i>-Cyclohexyl-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6e</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 59%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.72 (s, 1H), 8.79 (d, <i>J</i> = 7.8 Hz, 1H), 8.67 (d, <i>J</i> = 3.8 Hz, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 2H), 7.70 (t, <i>J</i> = 7.6 Hz, 1H), 7.43–7.33 (m, 2H), 4.58–4.46 (m, 1H), 3.28 (s, 3H), 2.01 (d, <i>J</i> = 11.5 Hz, 2H), 1.92 (d, <i>J</i> = 13.2 Hz, 2H), 1.79–1.63 (m, 3H), 1.53–1.41 (m, 2H), 1.26–1.15 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.8, 157.3, 153.0, 150.7, 150.3, 135.7, 134.4, 132.2, 128.7, 125.5, 124.4, 123.2, 115.4, 59.9, 34.3, 30.1, 26.0, 25.8. HRMS (ESI): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 319.1917; found, 319.1921.</div></div><div id="sec5_1_6_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>N</i>-Cycloheptyl-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6f</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 72%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 8.77 (d, <i>J</i> = 7.9 Hz, 1H), 8.65 (d, <i>J</i> = 3.5 Hz, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 1H), 7.73–7.60 (m, 1H), 7.44–7.31 (m, 2H), 4.77–4.65 (m, 1H), 3.27 (s, 3H), 2.13–2.02 (m, 2H), 1.93–1.74 (m, 4H), 1.74–1.52 (m, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.4, 157.4, 153.0, 150.5, 150.2, 135.6, 134.5, 132.0, 128.6, 125.4, 124.2, 123.1, 115.3, 61.2, 34.5, 32.2, 27.7, 25.5. HRMS (ESI): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 333.2074; found, 333.2082.</div></div><div id="sec5_1_6_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>-Cyclooctyl-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6g</b>)</h5><div class="NLM_p last">Yellow solid (yield: 86%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (d, <i>J</i> = 1.6 Hz, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.65 (dd, <i>J</i> = 4.7, 1.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 8.3 Hz, 1H), 7.72–7.63 (m, 1H), 7.41–7.31 (m, 2H), 4.99–4.87 (m, 1H), 3.27 (s, 3H), 2.02–1.87 (m, 4H), 1.87–1.77 (m, 2H), 1.77–1.52 (m, 8H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 157.4, 153.0, 150.5, 150.2, 135.6, 134.5, 132.0, 128.6, 125.5, 124.2, 123.1, 115.3, 59.5, 34.7, 31.6, 29.7, 26.4, 25.2. HRMS (ESI): calcd for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 347.2230; found, 347.2238.</div></div><div id="sec5_1_6_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>N</i>-(2,3-Dihydro-1<i>H</i>-inden-2-yl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>6h</b>)</h5><div class="NLM_p last">Yellow solid (yield: 60%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.74 (d, <i>J</i> = 1.5 Hz, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.68 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 8.04 (d, <i>J</i> = 7.9 Hz, 1H), 7.96 (d, <i>J</i> = 8.3 Hz, 1H), 7.78–7.69 (m, 1H), 7.45–7.41 (m, 1H), 7.39 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.29 (dd, <i>J</i> = 5.2, 3.4 Hz, 2H), 7.25–7.20 (m, 2H), 5.66–5.58 (m, 1H), 3.47 (dd, <i>J</i> = 16.4, 8.6 Hz, 2H), 3.35–3.26 (m, 5H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.7, 157.5, 153.1, 150.8, 150.4, 141.3, 135.7, 134.3, 132.5, 129.0, 126.9, 125.5, 124.8, 124.7, 123.3, 115.7, 60.2, 36.4, 35.6. HRMS (ESI): calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 353.1761; found, 353.1772.</div></div><div id="sec5_1_6_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (<i>S</i>)-<i>N</i>-Methyl-2-(pyridin-3-yl)-<i>N</i>-(1,2,3,4-tetrahydronaphthalen-2-yl)quinazolin-4-amine (<b>6i</b>)</h5><div class="NLM_p last">Pale-yellow oil (yield: 63%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.70 (s, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.65 (s, 1H), 7.97 (d, <i>J</i> = 7.7 Hz, 1H), 7.93 (d, <i>J</i> = 7.7 Hz, 1H), 7.77–7.63 (m, 1H), 7.45–7.30 (m, 2H), 7.16–7.10 (m, 4H), 5.07–4.90 (m, 1H), 3.34 (s, 3H), 3.21 (d, <i>J</i> = 8.4 Hz, 2H), 3.12–2.91 (m, 2H), 2.29–2.17 (m, 1H), 2.11 (qd, <i>J</i> = 11.9, 5.9 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.1, 157.3, 153.0, 150.6, 150.2, 135.6, 135.6, 135.2, 134.3, 132.3, 129.4, 128.8, 126.1, 126.0, 125.3, 124.6, 123.2, 115.4, 56.5, 34.2, 32.0, 29.5, 27.1. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 367.1917; found, 367.1932.</div></div><div id="sec5_1_6_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>R</i>)-<i>N</i>-Methyl-2-(pyridin-3-yl)-<i>N</i>-(1,2,3,4-tetrahydronaphthalen-2-yl)quinazolin-4-amine (<b>6j</b>)</h5><div class="NLM_p last">Pale-yellow oil (yield: 69%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.70 (s, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.65 (s, 1H), 7.97 (d, <i>J</i> = 7.7 Hz, 1H), 7.93 (d, <i>J</i> = 7.7 Hz, 1H), 7.77–7.63 (m, 1H), 7.45–7.30 (m, 2H), 7.16–7.10 (m, 4H), 5.07–4.90 (m, 1H), 3.34 (s, 3H), 3.21 (d, <i>J</i> = 8.4 Hz, 2H), 3.12–2.91 (m, 2H), 2.29–2.17 (m, 1H), 2.11 (qd, <i>J</i> = 11.9, 5.9 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.1, 157.3, 153.0, 150.6, 150.2, 135.6, 135.6, 135.2, 134.3, 132.3, 129.4, 128.8, 126.1, 126.0, 125.3, 124.6, 123.2, 115.4, 56.5, 34.2, 32.0, 29.5, 27.1. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 367.1917; found, 367.1927.</div></div><div id="sec5_1_6_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i>-(2-Phenoxyethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>7a</b>)</h5><div class="NLM_p last">Off-white solid (yield: 67%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.75 (d, <i>J</i> = 1.6 Hz, 1H), 8.81 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.70 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 7.93 (d, <i>J</i> = 8.2 Hz, 1H), 7.79–7.73 (m, 2H), 7.50–7.46 (m, 1H), 7.42 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.34–7.28 (m, 2H), 7.01–6.95 (m, 3H), 6.28–6.17 (m, 1H), 4.39–4.29 (m, 2H), 4.28–4.23 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.7, 158.6, 150.8, 150.4, 150.3, 135.7, 134.4, 132.9, 129.7, 129.0, 126.0, 123.3, 121.3, 120.8, 114.6, 114.0, 66.4, 40.8. HRMS (ESI): calcd for C<sub>21</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 343.1553; found, 343.1564.</div></div><div id="sec5_1_6_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8a</b>)</h5><div class="NLM_p last">Off-white solid (yield: 96%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.69 (s, 1H), 8.75 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.67 (d, <i>J</i> = 3.5 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 8.4 Hz, 1H), 7.71 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.44–7.34 (m, 2H), 7.28–7.24 (m, 2H), 6.96–6.87 (m, 3H), 4.45 (t, <i>J</i> = 5.4 Hz, 2H), 4.28 (t, <i>J</i> = 5.4 Hz, 2H), 3.63 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.1, 158.5, 157.2, 153.0, 150.7, 150.1, 135.5, 134.2, 132.3, 129.5, 128.8, 125.5, 124.6, 123.2, 121.1, 115.1, 114.5, 65.9, 52.5, 41.9. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1722.</div></div><div id="sec5_1_6_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i>-(2-(Benzyloxy)ethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>7b</b>)</h5><div class="NLM_p last">Pale-yellow solid (51%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.72 (s, 1H), 8.77 (d, <i>J</i> = 7.9 Hz, 1H), 8.68 (s, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 1H), 7.78–7.71 (m, 1H), 7.68 (d, <i>J</i> = 8.1 Hz, 1H), 7.46–7.41 (m, 1H), 7.41–7.37 (m, 1H), 7.36–7.30 (m, 4H), 6.27–6.16 (m, 1H), 4.59 (s, 2H), 4.01 (q, <i>J</i> = 5.2 Hz, 2H), 3.84–3.80 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.6, 158.5, 150.6, 150.2, 150.1, 137.8, 135.6, 132.7, 128.8, 128.5, 127.9, 127.8, 125.8, 123.2, 120.7, 113.9, 73.3, 68.4, 41.0. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1721.</div></div><div id="sec5_1_6_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i>-(2-(Benzyloxy)ethyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>8b</b>)</h5><div class="NLM_p last">Pale-yellow oil (87%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.63 (s, 1H), 8.68 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.61 (d, <i>J</i> = 3.7 Hz, 1H), 8.07 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.85 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.63 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.34–7.28 (m, 2H), 7.24–7.16 (m, 5H), 4.50 (s, 2H), 4.01 (t, <i>J</i> = 5.5 Hz, 2H), 3.88 (t, <i>J</i> = 5.5 Hz, 2H), 3.46 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 157.2, 152.9, 150.6, 150.1, 138.0, 135.5, 134.3, 132.2, 128.7, 128.4, 127.7, 127.5, 125.6, 124.5, 123.1, 115.1, 73.3, 68.1, 53.1, 41.2. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 371.1866; found, 371.1880.</div></div><div id="sec5_1_6_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i>-(3-Phenoxypropyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>7c</b>)</h5><div class="NLM_p last">Off-white solid (yield: 73%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.75 (s, 1H), 8.79 (d, <i>J</i> = 7.9 Hz, 1H), 8.66 (d, <i>J</i> = 3.4 Hz, 1H), 7.89 (d, <i>J</i> = 8.4 Hz, 1H), 7.77–7.63 (m, 2H), 7.47–7.39 (m, 1H), 7.37 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 7.32–7.25 (m, 2H), 6.99–6.90 (m, 3H), 6.50 (s, 1H), 4.18 (t, <i>J</i> = 5.6 Hz, 2H), 4.02–3.95 (m, 2H), 2.28 (p, <i>J</i> = 5.9 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.7, 158.6, 158.5, 150.6, 150.2, 150.2, 135.6, 134.5, 132.7, 129.6, 128.8, 125.8, 123.1, 121.1, 120.6, 114.4, 113.9, 66.8, 39.7, 28.5. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1723.</div></div><div id="sec5_1_6_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>N</i>-Methyl-<i>N</i>-(3-phenoxypropyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8c</b>)</h5><div class="NLM_p last">Yellow solid (77%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.72 (s, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.66 (d, <i>J</i> = 3.7 Hz, 1H), 8.06 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.91 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.70 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.42–7.33 (m, 2H), 7.29–7.24 (m, 2H), 6.93 (t, <i>J</i> = 7.3 Hz, 1H), 6.88 (d, <i>J</i> = 7.8 Hz, 2H), 4.10 (t, <i>J</i> = 5.8 Hz, 2H), 4.07–4.02 (m, 2H), 3.48 (s, 3H), 2.40–2.32 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 158.7, 157.3, 152.9, 150.6, 150.1, 135.6, 134.3, 132.2, 129.5, 128.8, 125.4, 124.5, 123.1, 120.8, 115.1, 114.4, 65.2, 50.5, 40.5, 27.2. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 371.1866; found, 371.1879.</div></div><div id="sec5_1_6_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-(2-Phenoxypropyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>7d</b>)</h5><div class="NLM_p last">Off-white solid (yield: 34%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.76 (s, 1H), 8.79 (d, <i>J</i> = 7.9 Hz, 1H), 8.71 (s, 1H), 7.92 (d, <i>J</i> = 7.9 Hz, 1H), 7.75 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.50–7.36 (m, 2H), 7.31–7.26 (m, 2H), 7.02–6.91 (m, 3H), 6.35–6.20 (m, 1H), 4.87–4.75 (m, 1H), 4.31 (ddd, <i>J</i> = 13.9, 6.8, 3.5 Hz, 1H), 3.85 (ddd, <i>J</i> = 13.9, 7.5, 4.7 Hz, 1H), 1.44 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.6, 158.5, 157.6, 150.7, 150.3, 150.2, 135.6, 134.3, 132.8, 129.7, 128.9, 126.0, 123.2, 121.4, 120.6, 116.2, 113.8, 72.8, 46.1, 17.6. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1720.</div></div><div id="sec5_1_6_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxypropyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8d</b>)</h5><div class="NLM_p last">Off-white solid (yield: 67%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.67 (s, 1H), 8.74 (dt, <i>J</i> = 7.9, 1.7 Hz, 1H), 8.67 (d, <i>J</i> = 3.8 Hz, 1H), 8.04 (d, <i>J</i> = 8.3 Hz, 1H), 7.91 (d, <i>J</i> = 8.2 Hz, 1H), 7.73–7.65 (m, 1H), 7.38 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.37–7.32 (m, 1H), 7.21–7.13 (m, 2H), 6.91–6.79 (m, 3H), 5.06–4.97 (m, 1H), 4.36 (dd, <i>J</i> = 14.1, 3.2 Hz, 1H), 3.90 (dd, <i>J</i> = 14.1, 8.1 Hz, 1H), 3.59 (s, 3H), 1.42 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.0, 157.8, 157.1, 153.0, 150.6, 150.0, 135.6, 134.3, 132.3, 129.5, 128.6, 125.6, 124.5, 123.2, 121.0, 115.7, 115.0, 72.9, 58.4, 42.9, 18.1. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 371.1866; found, 371.1879.</div></div><div id="sec5_1_6_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>N</i>-(1-Phenoxypropan-2-yl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>7e</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 60%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.01 (s, 1H), 9.08 (d, <i>J</i> = 7.9 Hz, 1H), 8.96 (s, 1H), 8.21 (d, <i>J</i> = 8.2 Hz, 1H), 8.09–7.96 (m, 2H), 7.76–7.65 (m, 2H), 7.58–7.50 (m, 3H), 7.26–7.21 (m, 2H), 6.44 (d, <i>J</i> = 7.1 Hz, 1H), 5.39–5.29 (m, 1H), 4.51 (dd, <i>J</i> = 9.4, 4.3 Hz, 1H), 4.46 (dd, <i>J</i> = 9.3, 3.7 Hz, 1H), 1.84 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 159.0, 158.6, 158.4, 150.5, 150.1, 150.0, 135.8, 134.3, 132.9, 129.6, 128.7, 126.0, 123.3, 121.3, 120.7, 114.6, 113.8, 70.3, 46.2, 17.5. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1726.</div></div><div id="sec5_1_6_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-Methyl-<i>N</i>-(1-phenoxypropan-2-yl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8e</b>)</h5><div class="NLM_p last">Pale-yellow oil (yield: 78%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (s, 1H), 8.76 (d, <i>J</i> = 7.9 Hz, 1H), 8.67 (s, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.73–7.66 (m, 1H), 7.43–7.32 (m, 2H), 7.22 (dd, <i>J</i> = 8.6, 7.5 Hz, 2H), 6.91 (t, <i>J</i> = 7.4 Hz, 1H), 6.84 (d, <i>J</i> = 7.8 Hz, 2H), 5.27–5.16 (m, 1H), 4.28 (dd, <i>J</i> = 9.8, 7.6 Hz, 1H), 4.16 (dd, <i>J</i> = 9.9, 5.1 Hz, 1H), 3.34 (s, 3H), 1.51 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.5, 158.4, 157.3, 153.0, 150.6, 150.2, 135.6, 134.3, 132.3, 129.5, 128.7, 125.4, 124.6, 123.2, 121.1, 115.4, 114.6, 69.2, 54.4, 33.9, 14.3. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 371.1866; found, 371.1882.</div></div><div id="sec5_1_6_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-Ethyl-<i>N</i>-(2-phenoxyethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8f</b>)</h5><div class="NLM_p last">Off-white solid (yield: 68%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.69 (d, <i>J</i> = 1.5 Hz, 1H), 8.74 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.67 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.74–7.67 (m, 1H), 7.43–7.34 (m, 2H), 7.26–7.22 (m, 2H), 6.95–6.87 (m, 3H), 4.42 (t, <i>J</i> = 5.6 Hz, 2H), 4.21 (t, <i>J</i> = 5.6 Hz, 2H), 3.94 (q, <i>J</i> = 7.1 Hz, 2H), 1.53 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 162.8, 158.5, 157.2, 152.9, 150.7, 150.1, 135.5, 134.2, 132.3, 129.5, 129.0, 124.9, 124.8, 123.2, 121.0, 115.2, 114.5, 65.7, 49.7, 47.7, 13.7. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 371.1866; found, 371.1882.</div></div><div id="sec5_1_6_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(2-Phenoxyethyl)-<i>N</i>-propyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>8g</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 49%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.68 (d, <i>J</i> = 1.7 Hz, 1H), 8.74 (dt, <i>J</i> = 7.9, 1.7 Hz, 1H), 8.66 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.3 Hz, 1H), 7.74–7.66 (m, 1H), 7.43–7.35 (m, 2H), 7.27–7.21 (m, 2H), 6.95–6.87 (m, 3H), 4.41 (t, <i>J</i> = 5.6 Hz, 2H), 4.22 (t, <i>J</i> = 5.6 Hz, 2H), 3.84–3.78 (m, 2H), 2.02–1.93 (m, 2H), 1.02 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 162.9, 158.5, 157.2, 152.9, 150.7, 150.1, 135.5, 134.2, 132.3, 129.5, 129.0, 124.9, 124.7, 123.2, 121.0, 115.2, 114.5, 65.7, 54.8, 50.4, 21.6, 11.3. HRMS (ESI): calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 385.2023; found, 385.2039.</div></div><div id="sec5_1_6_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(Cyclopropylmethyl)-<i>N</i>-(2-phenoxyethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>8h</b>)</h5><div class="NLM_p last">Off-white solid (33%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.70 (d, <i>J</i> = 1.5 Hz, 1H), 8.75 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.67 (dd, <i>J</i> = 4.7, 1.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.78–7.65 (m, 1H), 7.45–7.34 (m, 2H), 7.23 (t, <i>J</i> = 15.9 Hz, 2H), 6.92 (t, <i>J</i> = 7.3 Hz, 1H), 6.88 (d, <i>J</i> = 8.0 Hz, 2H), 4.43 (t, <i>J</i> = 5.6 Hz, 2H), 4.34 (t, <i>J</i> = 5.6 Hz, 2H), 3.79 (d, <i>J</i> = 6.3 Hz, 2H), 1.36–1.26 (m, 1H), 0.70–0.63 (m, 2H), 0.38–0.32 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.3, 158.5, 157.2, 152.9, 150.7, 150.1, 135.6, 134.2, 132.3, 129.5, 129.0, 125.1, 124.9, 123.2, 121.0, 115.3, 114.5, 65.9, 57.2, 49.6, 10.1, 4.0. HRMS (ESI): calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 397.2023; found, 397.2043.</div></div><div id="sec5_1_6_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-(3-Phenoxypyrrolidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9a</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 31%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (d, <i>J</i> = 1.5 Hz, 1H), 8.76 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.65 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 8.17 (d, <i>J</i> = 8.3 Hz, 1H), 7.91 (dd, <i>J</i> = 8.3, 0.7 Hz, 1H), 7.72–7.67 (m, 1H), 7.41–7.35 (m, 2H), 7.33–7.28 (m, 2H), 6.98 (t, <i>J</i> = 7.4 Hz, 1H), 6.93 (d, <i>J</i> = 7.9 Hz, 2H), 5.09–5.13 (m, 1H), 4.39–4.27 (m, 2H), 4.27–4.14 (m, 2H), 2.54–2.40 (m, 1H), 2.33–2.17 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 160.0, 157.8, 156.9, 152.5, 150.6, 150.2, 135.5, 134.3, 132.2, 129.7, 128.6, 125.1, 124.6, 123.0, 121.4, 115.6, 115.3, 75.1, 55.9, 48.8, 31.4. HRMS (ESI): calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 369.1710; found, 369.1727.</div></div><div id="sec5_1_6_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>S</i>)-4-(3-Phenoxypiperidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9b</b>)</h5><div class="NLM_p last">Yellow oil (yield: 79%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (d, <i>J</i> = 1.4 Hz, 1H), 8.73 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.68 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 7.94 (s, 1H), 7.70 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.42–7.33 (m, 2H), 7.30–7.25 (m, 2H), 6.98–6.92 (m, 3H), 4.64–4.55 (m, 1H), 4.36 (dd, <i>J</i> = 13.1, 3.2 Hz, 1H), 4.04–3.95 (m, 1H), 3.76–3.61 (m, 2H), 2.24–2.16 (m, 1H), 2.13–2.04 (m, 1H), 1.97–1.88 (m, 1H), 1.84–1.73 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 165.0, 157.7, 157.2, 152.7, 150.7, 150.2, 135.6, 134.2, 132.6, 129.6, 128.9, 125.2, 125.0, 123.1, 121.3, 116.0, 115.4, 71.4, 53.4, 50.3, 30.1, 22.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 383.1866; found, 383.1881.</div></div><div id="sec5_1_6_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>R</i>)-4-(3-Phenoxypiperidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9c</b>)</h5><div class="NLM_p last">Yellow oil (yield: 63%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (d, <i>J</i> = 1.4 Hz, 1H), 8.73 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.68 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 7.94 (s, 1H), 7.70 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.42–7.33 (m, 2H), 7.30–7.25 (m, 2H), 6.98–6.92 (m, 3H), 4.64–4.55 (m, 1H), 4.36 (dd, <i>J</i> = 13.1, 3.2 Hz, 1H), 4.04–3.95 (m, 1H), 3.76–3.61 (m, 2H), 2.24–2.16 (m, 1H), 2.13–2.04 (m, 1H), 1.97–1.88 (m, 1H), 1.84–1.73 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 165.0, 157.7, 157.2, 152.7, 150.7, 150.2, 135.6, 134.2, 132.6, 129.6, 128.9, 125.2, 125.0, 123.1, 121.3, 116.0, 115.4, 71.4, 53.4, 50.3, 30.1, 22.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 383.1866; found, 383.1883.</div></div><div id="sec5_1_6_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 4-(2-Benzylpiperidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9d</b>)</h5><div class="NLM_p last">Yellow solid (yield: 42%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.72 (s, 1H), 8.76 (d, <i>J</i> = 7.9 Hz, 1H), 8.69 (d, <i>J</i> = 4.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (d, <i>J</i> = 8.3 Hz, 1H), 7.70 (d, <i>J</i> = 7.0 Hz, 1H), 7.40 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 7.36 (d, <i>J</i> = 7.1 Hz, 1H), 7.22–7.15 (m, 4H), 7.12 (d, <i>J</i> = 6.4 Hz, 1H), 5.00–5.06 (m, 1H), 4.30 (d, <i>J</i> = 13.2 Hz, 1H), 3.68–3.55 (m, 1H), 3.26 (dd, <i>J</i> = 13.5, 6.6 Hz, 1H), 3.09 (dd, <i>J</i> = 13.5, 8.8 Hz, 1H), 2.01–1.67 (m, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 165.2, 157.7, 152.9, 150.7, 150.4, 139.0, 135.7, 134.5, 132.4, 129.2, 128.8, 128.5, 126.4, 125.1, 124.7, 123.2, 115.6, 58.0, 45.4, 35.8, 27.3, 25.9, 19.5. HRMS (ESI): calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 381.2074; found, 381.2084.</div></div><div id="sec5_1_6_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-(3-Benzylpiperidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9e</b>)</h5><div class="NLM_p last">Off-white solid (yield: 46%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.70 (s, 1H), 8.68 (d, <i>J</i> = 7.6 Hz, 2H), 7.92 (d, <i>J</i> = 8.2 Hz, 1H), 7.71–7.59 (m, 2H), 7.44–7.36 (m, 1H), 7.36–7.29 (m, 2H), 7.27–7.23 (m, 2H), 7.21 (d, <i>J</i> = 7.1 Hz, 2H), 4.43 (dd, <i>J</i> = 30.6, 13.0 Hz, 2H), 3.30–3.14 (m, 1H), 2.91 (dd, <i>J</i> = 13.0, 10.7 Hz, 1H), 2.69 (dd, <i>J</i> = 13.5, 6.5 Hz, 1H), 2.60 (dd, <i>J</i> = 13.5, 8.1 Hz, 1H), 2.24–2.08 (m, 1H), 2.06–1.95 (m, 1H), 1.95–1.84 (m, 1H), 1.84–1.67 (m, 1H), 1.48–1.30 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.6, 157.6, 152.7, 150.7, 150.3, 139.8, 135.7, 132.5, 129.1, 128.8, 128.6, 126.3, 125.1, 125.0, 123.3, 115.5, 55.6, 50.6, 40.7, 38.6, 31.7, 25.7. HRMS (ESI): calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 381.2074; found, 381.2089.</div></div><div id="sec5_1_6_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 4-(3-Phenylpiperidin-1-yl)-2-(pyridin-3-yl)quinazoline (<b>9f</b>)</h5><div class="NLM_p last">Yellow solid (yield: 34%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.68 (s, 1H), 8.73 (d, <i>J</i> = 7.9 Hz, 1H), 8.61 (d, <i>J</i> = 3.9 Hz, 1H), 7.87 (dd, <i>J</i> = 17.0, 8.3 Hz, 2H), 7.66 (s, 1H), 7.38–7.27 (m, 5H), 7.25–7.18 (m, 2H), 4.58–4.45 (m, 2H), 3.24–3.13 (m, 2H), 3.08–2.98 (m, 1H), 2.12 (d, <i>J</i> = 12.3 Hz, 1H), 1.96–1.73 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 165.0, 157.7, 152.8, 150.8, 150.3, 143.5, 135.7, 134.3, 132.6, 129.0, 128.8, 127.2, 126.9, 125.3, 125.2, 123.2, 115.8, 56.6, 50.8, 42.8, 32.2, 25.9. HRMS (ESI): calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 367.1917; found, 367.1930.</div></div><div id="sec5_1_6_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)-2-(pyridin-3-yl)quinazoline (<b>9g</b>)</h5><div class="NLM_p last">Yellow solid (yield: 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.79 (s, 1H), 8.83 (d, <i>J</i> = 7.9 Hz, 1H), 8.71 (s, 1H), 7.99 (dd, <i>J</i> = 14.1, 8.4 Hz, 2H), 7.81–7.69 (m, 1H), 7.53–7.37 (m, 2H), 7.23 (s, 4H), 5.07 (s, 2H), 4.15 (t, <i>J</i> = 5.7 Hz, 2H), 3.22 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 164.2, 157.6, 152.8, 150.8, 150.4, 135.8, 134.8, 133.9, 132.6, 129.0, 128.9, 126.9, 126.6, 126.5, 125.2, 125.0, 123.3, 115.6, 51.4, 48.2, 29.0. HRMS (ESI): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 339.1604; found, 339.1613.</div></div><div id="sec5_1_6_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 2-(2-(Pyridin-3-yl)quinazolin-4-yl)-2,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>9h</b>)</h5><div class="NLM_p last">Light-brown solid (yield: 37%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.78 (s, 1H), 8.81 (d, <i>J</i> = 7.9 Hz, 1H), 8.69 (d, <i>J</i> = 3.7 Hz, 1H), 8.21 (s, 1H), 8.04 (d, <i>J</i> = 8.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 1H), 7.74 (t, <i>J</i> = 7.6 Hz, 1H), 7.48 (t, <i>J</i> = 7.8 Hz, 2H), 7.41 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.17–7.11 (m, 1H), 7.11–7.05 (m, 1H), 5.14 (s, 2H), 4.27 (t, <i>J</i> = 5.5 Hz, 2H), 3.29–3.17 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.6, 157.5, 152.8, 150.7, 150.2, 135.9, 135.7, 134.2, 132.6, 132.2, 128.9, 125.5, 125.2, 125.0, 123.2, 121.7, 119.7, 117.4, 115.6, 110.8, 107.8, 47.7, 47.0, 23.4. HRMS (ESI): calcd for C<sub>24</sub>H<sub>20</sub>N<sub>5</sub> [M + H]<sup>+</sup>, 378.1713; found, 378.1727.</div></div><div id="sec5_1_6_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-(2-(Pyridin-3-yl)quinazolin-4-yl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole (<b>9i</b>)</h5><div class="NLM_p last">Yellow solid (yield: 62%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.75 (s, 1H), 8.79 (d, <i>J</i> = 7.9 Hz, 1H), 8.68 (d, <i>J</i> = 3.7 Hz, 1H), 8.38 (s, 1H), 8.02–7.91 (m, 2H), 7.73 (t, <i>J</i> = 7.6 Hz, 1H), 7.54 (d, <i>J</i> = 7.6 Hz, 1H), 7.48–7.42 (m, 1H), 7.39 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 7.35 (d, <i>J</i> = 7.9 Hz, 1H), 7.21–7.10 (m, 2H), 4.99 (s, 2H), 4.14 (t, <i>J</i> = 5.3 Hz, 2H), 3.18 (d, <i>J</i> = 4.7 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.5, 157.4, 152.6, 150.7, 150.1, 136.3, 135.7, 134.1, 132.7, 130.9, 129.0, 127.0, 125.4, 124.6, 123.2, 121.8, 119.7, 118.0, 115.5, 111.0, 108.9, 49.8, 46.8, 22.0. HRMS (ESI): calcd for C<sub>24</sub>H<sub>20</sub>N<sub>5</sub> [M + H]<sup>+</sup>, 378.1713; found, 378.1728.</div></div><div id="sec5_1_6_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 4-(2-(Pyridin-3-yl)quinazolin-4-yl)-1,4-oxazepane (<b>9j</b>)</h5><div class="NLM_p last">White solid (yield: 58%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.71 (d, <i>J</i> = 1.0 Hz, 1H), 8.81–8.57 (m, 2H), 7.93 (dd, <i>J</i> = 12.0, 8.4 Hz, 2H), 7.74–7.66 (m, 1H), 7.43–7.34 (m, 2H), 4.18–4.10 (m, 4H), 4.03–3.99 (m, 2H), 3.85–3.80 (m, 2H), 2.21 (p, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.3, 157.2, 153.1, 150.6, 150.1, 135.5, 132.3, 128.9, 125.2, 124.5, 114.9, 70.2, 70.1, 53.7, 50.3, 30.7. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 307.1553; found, 307.1557.</div></div><div id="sec5_1_6_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4-(2-(Pyridin-3-yl)quinazolin-4-yl)-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]oxazepine (<b>9k</b>)</h5><div class="NLM_p last">Yellow solid (yield: 55%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.62 (s, 1H), 8.72–8.59 (m, 2H), 7.94 (t, <i>J</i> = 8.1 Hz, 2H), 7.77–7.68 (m, 1H), 7.45–7.39 (m, 1H), 7.39–7.31 (m, 2H), 7.22 (d, <i>J</i> = 7.5 Hz, 1H), 7.10 (t, <i>J</i> = 7.2 Hz, 1H), 7.02 (d, <i>J</i> = 7.9 Hz, 1H), 4.97 (s, 2H), 4.48–4.39 (m, 2H), 4.35–4.26 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.4, 159.3, 157.4, 152.8, 150.7, 150.2, 135.6, 132.6, 129.9, 129.0, 128.9, 128.7, 125.2, 125.1, 123.1, 120.5, 115.2, 70.9, 54.5, 54.0. HRMS (ESI): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 355.1553; found, 355.1565.</div></div><div id="sec5_1_6_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-Methyl-<i>N</i>-(naphthalen-2-ylmethyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>9l</b>)</h5><div class="NLM_p last">Off-white solid (yield: 52%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.77 (s, 1H), 8.83 (d, <i>J</i> = 7.8 Hz, 1H), 8.69 (d, <i>J</i> = 3.5 Hz, 1H), 7.99 (d, <i>J</i> = 8.6 Hz, 2H), 7.95–7.78 (m, 4H), 7.78–7.67 (m, 1H), 7.58–7.44 (m, 3H), 7.41 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 7.37–7.28 (m, 1H), 5.23 (s, 2H), 3.45 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 164.0, 157.5, 152.9, 150.8, 150.3, 135.8, 134.9, 134.3, 133.6, 133.0, 132.6, 129.0, 128.9, 127.9, 126.6, 126.1, 125.9, 125.3, 125.2, 125.1, 123.3, 115.1, 57.4, 39.7. HRMS (ESI): calcd for C<sub>25</sub>H<sub>21</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 377.1761; found, 377.1775.</div></div><div id="sec5_1_6_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-(Benzo[<i>c</i>][1,2,5]thiadiazol-5-ylmethyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9m</b>)</h5><div class="NLM_p last">Pale yellow solid (yield: 65%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.70 (d, <i>J</i> = 1.6 Hz, 1H), 8.77 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.67 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.07–8.02 (m, 2H), 8.00 (t, <i>J</i> = 8.1 Hz, 2H), 7.79–7.70 (m, 1H), 7.64 (dd, <i>J</i> = 9.1, 1.4 Hz, 1H), 7.43–7.32 (m, 2H), 5.24 (s, 2H), 3.49 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.9, 157.5, 155.2, 154.6, 153.1, 150.9, 150.3, 139.7, 135.7, 134.1, 132.8, 129.5, 129.2, 125.2, 125.0, 123.3, 122.2, 119.2, 115.1, 56.8, 40.3. HRMS (ESI): calcd for C<sub>21</sub>H<sub>17</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, 385.1230; found, 385.1245.</div></div><div id="sec5_1_6_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-Methyl-<i>N</i>-((2-methylisoindolin-5-yl)methyl)-2-(pyridin-3-yl)quinazolin-4-amine (<b>9n</b>)</h5><div class="NLM_p last">Light-brown solid (yield: 61%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.73 (d, <i>J</i> = 1.5 Hz, 1H), 8.79 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 8.68 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 7.99–7.91 (m, 2H), 7.77–7.68 (m, 1H), 7.39 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.36–7.29 (m, 1H), 7.28–7.21 (m, 4H), 5.05 (s, 2H), 3.97 (d, <i>J</i> = 6.7 Hz, 4H), 3.38 (s, 3H), 2.64 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.9, 157.6, 153.0, 150.8, 150.3, 136.2, 135.7, 134.3, 132.5, 128.9, 126.1, 125.2, 125.0, 123.2, 122.8, 121.1, 115.1, 60.9, 60.8, 57.1, 42.4, 39.6. HRMS (ESI): calcd for C<sub>24</sub>H<sub>24</sub>N<sub>5</sub> [M + H]<sup>+</sup>, 382.2026; found, 382.2040.</div></div><div id="sec5_1_6_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-(Benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9o</b>)</h5><div class="NLM_p last">Yellow solid (yield: 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.74 (s, 1H), 8.80 (d, <i>J</i> = 8.0 Hz, 1H), 8.68 (d, <i>J</i> = 3.3 Hz, 1H), 7.97 (d, <i>J</i> = 8.8 Hz, 2H), 7.76–7.66 (m, 1H), 7.40 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 7.37–7.32 (m, 1H), 6.89 (d, <i>J</i> = 9.4 Hz, 2H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 5.97 (s, 2H), 4.98 (s, 2H), 3.37 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.8, 157.5, 152.9, 150.8, 150.3, 148.4, 147.2, 135.8, 132.5, 131.2, 128.9, 125.2, 125.0, 123.3, 120.7, 115.1, 108.6, 107.8, 101.2, 56.7, 39.6. HRMS (ESI): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 371.1503; found, 371.1518.</div></div><div id="sec5_1_6_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> <i>N</i>-((2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9p</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 36%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.73 (s, 1H), 8.79 (d, <i>J</i> = 7.9 Hz, 1H), 8.67 (d, <i>J</i> = 4.6 Hz, 1H), 7.95 (t, <i>J</i> = 8.0 Hz, 2H), 7.74–7.66 (m, 1H), 7.39 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 7.36–7.30 (m, 1H), 6.94 (s, 1H), 6.89 (s, 2H), 4.95 (s, 2H), 4.27 (s, 4H), 3.37 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.8, 157.5, 153.0, 150.8, 150.3, 144.0, 143.1, 135.7, 134.3, 132.5, 130.6, 128.9, 125.2, 124.9, 123.2, 120.3, 117.7, 116.1, 115.1, 64.5, 64.4, 56.5, 39.5. HRMS (ESI): calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 385.1659; found, 385.1683.</div></div><div id="sec5_1_6_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (<i>S</i>)-<i>N</i>-((2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-2-yl)methyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9q</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 85%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.65 (s, 1H), 8.72 (d, <i>J</i> = 7.9 Hz, 1H), 8.69–8.64 (m, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.76–7.68 (m, 1H), 7.43–7.34 (m, 2H), 6.90–6.78 (m, 4H), 4.84–4.76 (m, 1H), 4.40–4.27 (m, 2H), 4.17–4.08 (m, 2H), 3.66 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.0, 157.1, 153.1, 150.8, 150.0, 143.1, 142.6, 135.5, 134.1, 132.5, 128.9, 125.5, 124.7, 123.2, 121.8, 121.5, 117.4, 117.2, 115.0, 71.8, 66.0, 53.0, 43.1. HRMS (ESI): calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 385.1659; found, 385.1657.</div></div><div id="sec5_1_6_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> (<i>R</i>)-<i>N</i>-((2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-2-yl)methyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9r</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 89%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.65 (s, 1H), 8.72 (d, <i>J</i> = 7.9 Hz, 1H), 8.69–8.64 (m, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.76–7.68 (m, 1H), 7.43–7.34 (m, 2H), 6.90–6.78 (m, 4H), 4.84–4.76 (m, 1H), 4.40–4.27 (m, 2H), 4.17–4.08 (m, 2H), 3.66 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.0, 157.1, 153.1, 150.8, 150.0, 143.1, 142.6, 135.5, 134.1, 132.5, 128.9, 125.5, 124.7, 123.2, 121.8, 121.5, 117.4, 117.2, 115.0, 71.8, 66.0, 53.0, 43.1. HRMS (ESI): calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 385.1659; found, 385.1653.</div></div><div id="sec5_1_6_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-Methyl-2-(pyridin-3-yl)-<i>N</i>-(quinoxalin-2-ylmethyl)quinazolin-4-amine (<b>9s</b>)</h5><div class="NLM_p last">Yellow solid (yield: 47%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.65 (s, 1H), 9.02 (s, 1H), 8.70 (d, <i>J</i> = 7.7 Hz, 1H), 8.65 (d, <i>J</i> = 2.4 Hz, 1H), 8.14 (d, <i>J</i> = 8.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.1 Hz, 2H), 7.99 (d, <i>J</i> = 8.3 Hz, 1H), 7.83–7.72 (m, 3H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.35 (dd, <i>J</i> = 7.2, 5.0 Hz, 1H), 5.41 (s, 2H), 3.63 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.5, 157.4, 153.2, 153.1, 150.8, 150.1, 144.7, 142.1, 135.7, 134.0, 132.8, 130.4, 129.9, 129.4, 129.2, 129.1, 125.3, 125.2, 123.3, 115.0, 57.0, 41.4. HRMS (ESI): calcd for C<sub>23</sub>H<sub>19</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 379.1666; found, 379.1682.</div></div><div id="sec5_1_6_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> <i>N</i>-(Benzo[<i>d</i>]thiazol-2-ylmethyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9t</b>)</h5><div class="NLM_p last">Yellow solid (yield: 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.80 (s, 1H), 8.84 (d, <i>J</i> = 8.0 Hz, 1H), 8.69 (d, <i>J</i> = 3.6 Hz, 1H), 8.13 (d, <i>J</i> = 8.3 Hz, 1H), 8.02 (dd, <i>J</i> = 16.6, 8.2 Hz, 2H), 7.81 (d, <i>J</i> = 7.9 Hz, 1H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 7.48 (d, <i>J</i> = 7.3 Hz, 1H), 7.46–7.34 (m, 3H), 5.44 (s, 2H), 3.58 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 168.5, 163.2, 157.2, 153.1, 152.8, 150.9, 150.4, 135.9, 135.8, 133.8, 132.9, 129.1, 126.2, 125.4, 125.3, 125.3, 123.3, 123.0, 121.9, 115.0, 54.8, 40.8. HRMS (ESI): calcd for C<sub>22</sub>H<sub>18</sub>N<sub>5</sub>S [M + H]<sup>+</sup>, 384.1277; found, 384.1293.</div></div><div id="sec5_1_6_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> <i>N</i>-((1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)methyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9u</b>)</h5><div class="NLM_p last">Yellow solid (yield: 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.61 (s, 1H), 8.66 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 8.61–8.48 (m, 1H), 8.03 (d, <i>J</i> = 8.3 Hz, 1H), 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 7.79–7.68 (m, 1H), 7.57 (br s, 2H), 7.46–7.33 (m, 1H), 7.26–7.20 (m, 3H), 5.27 (s, 2H), 3.47 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 163.4, 156.9, 152.9, 151.1, 150.7, 149.5, 135.5, 133.7, 133.2, 128.9, 125.6, 125.5, 123.4, 122.8, 114.9, 50.5, 40.7. HRMS (ESI): calcd for C<sub>22</sub>H<sub>19</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 367.1666; found, 367.1683.</div></div><div id="sec5_1_6_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> <i>N</i>-(Benzo[<i>d</i>]oxazol-2-ylmethyl)-<i>N</i>-methyl-2-(pyridin-3-yl)quinazolin-4-amine (<b>9v</b>)</h5><div class="NLM_p last">Off-white solid (yield: 35%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.66 (d, <i>J</i> = 1.5 Hz, 1H), 8.73 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.65 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.21 (d, <i>J</i> = 7.9 Hz, 1H), 7.99 (d, <i>J</i> = 8.3 Hz, 1H), 7.82–7.75 (m, 1H), 7.75–7.70 (m, 1H), 7.59–7.51 (m, 1H), 7.50–7.44 (m, 1H), 7.38–7.30 (m, 3H), 5.25 (s, 2H), 3.71 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.5, 163.1, 157.2, 153.0, 150.9, 150.7, 150.1, 141.1, 135.9, 134.0, 132.9, 129.1, 125.4, 125.3, 125.3, 124.7, 123.3, 120.2, 115.1, 110.8, 50.4, 41.7. HRMS (ESI): calcd for C<sub>22</sub>H<sub>18</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 368.1506; found, 368.1518.</div></div><div id="sec5_1_6_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(pyridin-2-yl)quinazolin-4-amine (<b>11a</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 73%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.85 (d, <i>J</i> = 4.7 Hz, 1H), 8.48 (d, <i>J</i> = 7.9 Hz, 1H), 8.16 (d, <i>J</i> = 8.4 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.71 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 1H), 7.40 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.37–7.32 (m, 1H), 7.27–7.24 (m, 2H), 6.97–6.87 (m, 3H), 4.44 (t, <i>J</i> = 5.6 Hz, 2H), 4.28 (t, <i>J</i> = 5.6 Hz, 2H), 3.61 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.5, 158.5, 157.9, 156.0, 153.2, 150.0, 136.6, 132.2, 129.8, 129.5, 125.2, 124.9, 124.2, 123.6, 121.1, 115.3, 114.5, 65.8, 52.4, 41.7. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1724.</div></div><div id="sec5_1_6_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(pyridin-4-yl)quinazolin-4-amine (<b>11b</b>)</h5><div class="NLM_p last">White solid (yield: 56%). <sup>1</sup>H NMR (500 MHz): δ 9.69 (s, 1H), 8.75 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 8.67 (d, <i>J</i> = 4.0 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 8.4 Hz, 1H), 7.73–7.68 (m, 1H), 7.41–7.35 (m, 2H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 6.95–6.87 (m, 3H), 4.45 (t, <i>J</i> = 5.4 Hz, 2H), 4.28 (t, <i>J</i> = 5.4 Hz, 2H), 3.68 (s, 3H), 3.63 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 158.5, 157.0, 152.9, 150.2, 146.2, 132.4, 129.6, 129.0, 125.5, 125.0, 122.2, 121.1, 115.3, 114.5, 65.8, 52.5, 41.7. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 357.1710; found, 357.1721.</div></div><div id="sec5_1_6_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine (<b>11c</b>)</h5><div class="NLM_p last">White solid (yield: 61%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.73 (s, 2H), 9.27 (s, 1H), 8.15 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.3 Hz, 1H), 7.76–7.70 (m, 1H), 7.45–7.40 (m, 1H), 7.29–7.24 (m, 2H), 6.93 (t, <i>J</i> = 7.4 Hz, 1H), 6.89 (d, <i>J</i> = 7.9 Hz, 2H), 4.44 (t, <i>J</i> = 5.3 Hz, 2H), 4.28 (t, <i>J</i> = 5.3 Hz, 2H), 3.64 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 162.0, 158.2, 157.4, 155.7, 154.0, 151.8, 131.5, 130.8, 128.5, 127.8, 124.6, 124.0, 120.1, 114.2, 113.4, 64.8, 51.5, 40.9. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 358.1662; found, 358.1673.</div></div><div id="sec5_1_6_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-phenylquinazolin-4-amine (<b>11d</b>)</h5><div class="NLM_p last">White solid (yield: 82%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.54–8.47 (m, 2H), 8.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.48–7.43 (m, 3H), 7.36 (ddd, <i>J</i> = 8.3, 6.9, 1.2 Hz, 1H), 7.28–7.24 (m, 2H), 6.97–6.89 (m, 3H), 4.45 (t, <i>J</i> = 5.6 Hz, 2H), 4.27 (t, <i>J</i> = 5.6 Hz, 2H), 3.60 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 159.0, 158.6, 132.1, 130.0, 129.5, 128.4, 128.3, 125.4, 124.2, 121.0, 114.5, 65.9, 52.4, 41.8. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 356.1744; found, 356.1771.</div></div><div id="sec5_1_6_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(thiophen-3-yl)quinazolin-4-amine (<b>11e</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 71%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.26 (s, 1H), 8.08 (d, <i>J</i> = 8.4 Hz, 1H), 7.94 (dd, <i>J</i> = 5.0, 0.9 Hz, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.69–7.63 (m, 1H), 7.37–7.30 (m, 2H), 7.26 (dd, <i>J</i> = 8.6, 7.5 Hz, 2H), 6.96–6.90 (m, 3H), 4.43 (t, <i>J</i> = 5.6 Hz, 2H), 4.23 (t, <i>J</i> = 5.6 Hz, 2H), 3.58 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 158.6, 156.4, 153.1, 142.8, 132.1, 129.5, 128.5, 127.8, 127.2, 125.4, 124.0, 121.0, 114.8, 114.6, 65.9, 52.4, 41.7. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 362.1322; found, 362.1336.</div></div><div id="sec5_1_6_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> <i>N</i>-Methyl-<i>N</i>-(2-phenoxyethyl)-2-(thiophen-2-yl)quinazolin-4-amine (<b>11f</b>)</h5><div class="NLM_p last">Pale-yellow solid (yield: 45%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 8.00 (s, 1H), 7.86 (s, 1H), 7.66 (t, <i>J</i> = 7.4 Hz, 1H), 7.41 (d, <i>J</i> = 4.8 Hz, 1H), 7.36–7.29 (m, 1H), 7.28–7.24 (m, 2H), 7.14–7.11 (m, 1H), 6.95–6.89 (m, 3H), 4.46 (t, <i>J</i> = 5.5 Hz, 2H), 4.22 (t, <i>J</i> = 5.5 Hz, 2H), 3.60 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 162.8, 158.6, 155.9, 153.0, 145.0, 132.3, 129.5, 128.8, 128.3, 128.0, 125.5, 124.0, 121.0, 114.8, 114.5, 65.9, 52.6, 41.9. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 362.1322; found, 362.1336.</div></div><div id="sec5_1_6_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 2-(Furan-2-yl)-<i>N</i>-methyl-<i>N</i>-(2-phenoxyethyl)quinazolin-4-amine (<b>11g</b>)</h5><div class="NLM_p last">Yellow oil (yield: 40%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.06 (dd, <i>J</i> = 8.5, 0.9 Hz, 1H), 7.95 (dd, <i>J</i> = 8.4, 0.8 Hz, 1H), 7.67 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.61 (dd, <i>J</i> = 1.6, 0.8 Hz, 1H), 7.34 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.29–7.22 (m, 3H), 6.96–6.90 (m, 3H), 6.53 (dd, <i>J</i> = 3.3, 1.7 Hz, 1H), 4.42 (t, <i>J</i> = 5.6 Hz, 2H), 4.20 (t, <i>J</i> = 5.6 Hz, 2H), 3.56 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.2, 158.5, 153.2, 152.8, 152.5, 144.5, 132.3, 129.5, 128.7, 125.4, 124.2, 121.0, 115.0, 114.5, 112.7, 111.7, 65.7, 52.4, 41.7. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 346.1550; found, 346.1559.</div></div><div id="sec5_1_6_53" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 2-(Furan-3-yl)-<i>N</i>-methyl-<i>N</i>-(2-phenoxyethyl)quinazolin-4-amine (<b>11h</b>)</h5><div class="NLM_p last">Yellow solid (yield: 63%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.21 (s, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.85 (d, <i>J</i> = 8.3 Hz, 1H), 7.69–7.63 (m, 1H), 7.47 (t, <i>J</i> = 1.7 Hz, 1H), 7.35–7.29 (m, 1H), 7.29–7.24 (m, 2H), 7.11 (d, <i>J</i> = 1.5 Hz, 1H), 6.96–6.92 (m, 1H), 6.91 (d, <i>J</i> = 7.9 Hz, 2H), 4.41 (t, <i>J</i> = 5.6 Hz, 2H), 4.19 (t, <i>J</i> = 5.6 Hz, 2H), 3.55 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 163.1, 158.6, 155.7, 153.0, 144.5, 143.4, 132.1, 129.5, 128.3, 127.9, 125.4, 123.9, 121.0, 114.9, 114.5, 109.9, 65.8, 52.3, 41.6. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 346.1550; found, 346.1561.</div></div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Enzyme Activity Assay</h4><div class="NLM_p">4-Methylumbelliferyl β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside (4MU-β-Glc) and buffer components were purchased from Sigma-Aldrich (St. Louis, MO). Residual injection solutions of the recombinant wild-type GCase enzyme velaglucerase alfa (Vpriv, Shire Human Genetic Therapies, Inc.) in clinics were collected for the activity assays. The GCase activity assay buffer was composed of 50 mM citric acid, 176 mM K<sub>2</sub>HPO<sub>4</sub>, and 0.01% Tween-20 at pH 5.9. A solution of 1 M sodium hydroxide and 1 M glycine was used as the stop solution.</div><div class="NLM_p last">The compounds in DMSO solution (0.5 μL/well) were transferred to a black 96-well plate (the final titration was 48 nM to 100 μM, a 12-point dilution series). The enzyme solution (33.5 μL, 7.5 nM final concentration) was transferred to the wells. After 5 min of incubation at room temperature, the enzyme reaction was initiated by the addition of a blue substrate (4MU-β-Glc) (33 μL/well). The final concentration of the blue substrate was 1.5 mM. The blue substrate reaction was terminated by the addition of 33 μL/well stop solution (1 M NaOH and 1 M glycine mixture, pH 10) after 30 min of incubation at 37 °C. The fluorescence was then measured in a Biotek Synergy H1 multimode plate reader with λ<sub>ex</sub> = 365 nm and λ<sub>em</sub> = 440 nm.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Cell Culture and Compound Treatment</h4><div class="NLM_p last">The GBA N370S/84GG fibroblast cell line was obtained from Coriell, GM00372, cultured in DMEM medium (Life Tech) including 1% v/v <span class="smallcaps smallerCapital">l</span>-glutamine 200 mM (Life Tech), 1% v/v pen strep (Life Tech), 10% FBS (Life Tech) at 37 °C, and 5% CO<sub>2</sub> and treated with different compounds at indicated concentrations. The same volume of DMSO (0.1% v/v) was used as a control. After a 3 day treatment for fibroblasts or a 10 day treatment for dopaminergic neurons, cells were washed with PBS twice followed by 1% Triton X-100 lysis buffer to lyse cells. Protein concentrations were measured with a BCA kit (Thermo), and the GCase activity was determined at pH 5.5.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Measurement of Lysosomal GCase Activity</h4><div class="NLM_p last">Fibroblasts were plated into a 96-well plate and cultured and treated with compounds as described above. After 3 days of treatment, the medium was replaced with media containing 5-(pentafluorobenzoylamino)fluorescein di-β-<span class="smallcaps smallerCapital">d</span>-glucopyranodside (PFB-FDGlu) or media containing PFB-FDGlu with 400 μM bafilomycin. Cells were incubated for 1 h to allow for loading of the substrate into the lysosome. After loading, substrate hydrolysis was monitored by measuring fluorescence unquenching every 20 min at 485 nm excitation and 525 nm emission.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Human iPSC Culture and Neural Differentiation</h4><div class="NLM_p">Human iPSC lines were generated from skin fibroblasts through retroviral expression or using Sendai virus based delivery of key reprogramming vectors including four Yamanaka factors (Oct, Sox2, Klf4, and c-Myc).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Heterozygous N370S <i>GBA1</i> mutant fibroblasts were reprogrammed into iPSC through Northwestern University Stem Cell Core Facility and characterized in this study (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf" class="ext-link">Supporting Information</a> figure).</div><div class="NLM_p">The iPSC line from one separate healthy control subject was previously described and characterized.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Healthy control and <i>GBA1</i> mutant iPSC lines were characterized for expression of pluripotent markers by immunocytochemistry (NANOG, OCT4, SSEA4, and TRA1-81). Karyotype analysis was performed by Cell Line Genetics using standard protocols for high-resolution G-banding. iPSC were cultured in mTeSR media (Stem Cell Technologies) and passaged every 5–7 days on matrigel (Corning) coated plates. All lines were routinely tested for mycoplasma contamination.</div><div class="NLM_p last">Differentiation of iPSCs into midbrain dopaminergic neurons was done according to published protocols,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> passaged and maintained as described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> At d25 to d30, neural blocks were passed by accutase treatment onto PDL/laminin-coated culture dishes. Neutralization growth factors were withdrawn at d40, and neurons were maintained in Neurobasal media (Life Technologies) containing Neurocult SM1 (Stemcell technologies). Immunocytochemistry demonstrated the neuralization efficiency in neurons derived from iPSC lines using neural (β-III-tubulin) and midbrain (TH, FOXA2, LMX1a) specific markers.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Sequencing Analysis</h4><div class="NLM_p last">DNA samples were extracted from cell pellets using Mini prep kits (Qiagen). Eluted gDNA was used as a template for PCR amplification using Phusion Master Mix (NEB). The PCR product was purified using the PCR Purification Kit (Qiagen) and sent for sequencing through Northwestern University Seq Core or University of Chicago Seq Core.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Deglycosylation of Proteins/Molecular Shift Assay<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></h4><div class="NLM_p last">To study the subcellular localization and transport of the various GCase mutants (ER and post-ER localization), EndoH and PNGaseF digestions were performed. For both reactions, 20 μg of protein was used, and the experimental procedure was performed according to the manufacturer’s handbook (New England Biolabs). A positive digestion resulted in a shift in molecular size after the protein was subjected to SDS/PAGE. Anti-hGCase (From Johannes Aerts, Leiden University, Leiden, The Netherlands) was used to detect the different forms of GCase.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Western Blots</h4><div class="NLM_p last">Proteins were denatured in 20% SDS sample buffer at 100 °C for 10 min; 10% Tris-glycine (Life Tech) was used for gels; a Trans-Blot Turbo PVDF kit (Bio-Rad) was used for membrane transfer. GCase antibody (Sigma-Aldrich) and GAPDH primary antibodies (EMD Millipore) were incubated with the membranes overnight, and then the incubated membranes were treated with the secondary antibody (IRDye 680RD goat anti-rabbit IgG (H + L) or IRDye 800CW Goat anti-mouse IgG (H + L), LI-COR) for 30 min. An Odyssey CLx Imaging System (LI-COR) was used to scan the membranes and analyze the imaging.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01294" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01294" class="ext-link">10.1021/acs.jmedchem.8b01294</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Characterization of iPSC lines and differentiated dopaminergic neurons. <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>6a</b>, <b>8a</b>, <b>9l</b>, <b>9o</b>, <b>9q</b>, <b>9s</b>, <b>11a</b>, and <b>11b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf">jm8b01294_si_001.pdf (1.85 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_002.csv">jm8b01294_si_002.csv (4.63 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01294" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dimitri Krainc</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4716-1886" title="Orcid link">http://orcid.org/0000-0002-4716-1886</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f99d928b9890979ab99794d7968b9e"><span class="__cf_email__" data-cfemail="a6c2cdd4c7cfc8c5e6c8cb88c9d4c1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard B. Silverman</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry of Life Processes Institute, Center for Molecular
Innovation and Drug Discovery, and Center for Developmental Therapeutics, Northwestern University, Evanston, Illinois 60208, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9034-1084" title="Orcid link">http://orcid.org/0000-0001-9034-1084</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4607212b272806252e232b68282934322e3123353223342868232233"><span class="__cf_email__" data-cfemail="cf8ea8a2aea18faca7aaa2e1a1a0bdbba7b8aabcbbaabda1e1aaabba">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianbin Zheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry of Life Processes Institute, Center for Molecular
Innovation and Drug Discovery, and Center for Developmental Therapeutics, Northwestern University, Evanston, Illinois 60208, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sohee Jeon</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weilan Jiang</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lena F. Burbulla</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Ysselstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristine Oevel</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Northwestern University Feinberg
School of Medicine, Chicago, Illinois 60611, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH R01NS076054, R01NS096240, WildKat and Buckeye Research LLC (to D.K.) and The Michael J. Fox Foundation for Parkinson’s Research (to J.Z.). This work made use of the IMSERC at Northwestern University, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205); the State of Illinois and International Institute for Nanotechnology (IIN). We would like to thank H. Goudarzi and S. Shafaie in IMSERC at Northwestern University for their assistance with HRMS experiments. We thank the Northwestern Stem Cell Core Facility for the generation of iPSC lines from the <i>GBA1</i> mutation carrier.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">GD</td><td class="NLM_def"><p class="first last">Gaucher’s disease</p></td></tr><tr><td class="NLM_term">GCase</td><td class="NLM_def"><p class="first last">β-glucocerebrosidase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">pharmacological chaperone</p></td></tr><tr><td class="NLM_term">IFG</td><td class="NLM_def"><p class="first last">isofagomine</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">DLB</td><td class="NLM_def"><p class="first last">dementia with Lewy bodies</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aharon-Peretz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershoni-Baruch, R.</span></span> <span> </span><span class="NLM_article-title">Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1056/nejmoa033277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1056%2Fnejmoa033277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=15525722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1Wksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=1972-1977&author=J.+Aharon-Peretzauthor=H.+Rosenbaumauthor=R.+Gershoni-Baruch&title=Mutations+in+the+glucocerebrosidase+gene+and+Parkinson%E2%80%99s+disease+in+Ashkenazi+Jews&doi=10.1056%2Fnejmoa033277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews</span></div><div class="casAuthors">Aharon-Peretz, Judith; Rosenbaum, Hanna; Gershoni-Baruch, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1972-1977</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND A clin. assocn. has been reported between type 1 Gaucher's disease, which is caused by a glucocerebrosidase deficiency owing to mutations in the glucocerebrosidase gene (GBA), and parkinsonism.  We examd. whether mutations in the GBA gene are relevant to idiopathic Parkinson's disease.  METHODS A clinic-based case series of 99 Ashkenazi patients with idiopathic Parkinson's disease, 74 Ashkenazi patients with Alzheimer's disease, and 1543 healthy Ashkenazi Jews who underwent testing to identify heterozygosity for certain recessive diseases were screened for the six GBA mutations (N370S, L444P, 84GG, IVS+1, V394L, and R496H) that are most common among Ashkenazi Jews.  RESULTS Thirty-one patients with Parkinson's disease (31.3 %; 95 % confidence interval, 22.2 to 40.4 %) had one or two mutant GBA alleles: 23 were heterozygous for N370S, 4 were heterozygous for 84GG, 3 were homozygous for N370S, and 1 was heterozygous for R496H.  Among the 74 patients with Alzheimer's disease, 3 were identified as carriers of Gaucher's disease (4.1 %; 95 % confidence interval, 0.0 to 8.5 %): 2 were heterozygous for N370S, and 1 was heterozygous for 84GG: Ninety-five carriers of Gaucher's disease were identified among the 1543 control subjects (6.2 %; 95 % confidence interval, 5.0 to 7.4 %): 92 were heterozygous for N370S, and 3 were heterozygous for 84GG.  Patients with Parkinson's disease had significantly greater odds of being carriers of Gaucher's disease than did patients with Alzheimer's disease (odds ratio, 10.8; 95 % confidence interval, 3.0 to 46.6; P<0.001) or control subjects (odds ratio, 7.0; 95 % confidence interval, 4.2 to 11.4; P<0.001).  Among the patients with Parkinson's disease, patients who were carriers of Gaucher's disease were younger than those who were not carriers (mean [±SD] age at onset, 60.0+14.2 years vs. 64.2+11.7 years; P=0.04).  CONCLUSIONS Our results suggest that heterozygosity for a GBA mutation may predispose Ashkenazi Jews to Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7EVcsaW69ybVg90H21EOLACvtfcHk0lhs7L8JRfW1mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1Wksbc%253D&md5=c2b26fc09659ef614ee7b7cdb17af86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa033277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa033277%26sid%3Dliteratum%253Aachs%26aulast%3DAharon-Peretz%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DH.%26aulast%3DGershoni-Baruch%26aufirst%3DR.%26atitle%3DMutations%2520in%2520the%2520glucocerebrosidase%2520gene%2520and%2520Parkinson%25E2%2580%2599s%2520disease%2520in%2520Ashkenazi%2520Jews%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D1972%26epage%3D1977%26doi%3D10.1056%2Fnejmoa033277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalls, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasly, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharon-Peretz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Shira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dürr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eblan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan-Or, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershoni-Baruch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giladi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Chen, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayebi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiano, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittstock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfsberg, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabetian, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S. G.</span></span> <span> </span><span class="NLM_article-title">Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1651</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1056/nejmoa0901281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1056%2Fnejmoa0901281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=19846850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1651-1661&author=E.+Sidranskyauthor=M.+A.+Nallsauthor=J.+O.+Aaslyauthor=J.+Aharon-Peretzauthor=G.+Annesiauthor=E.+R.+Barbosaauthor=A.+Bar-Shiraauthor=D.+Bergauthor=J.+Brasauthor=A.+Briceauthor=C.-M.+Chenauthor=L.+N.+Clarkauthor=C.+Condroyerauthor=E.+V.+De+Marcoauthor=A.+D%C3%BCrrauthor=M.+J.+Eblanauthor=S.+Fahnauthor=M.+J.+Farrerauthor=H.-C.+Fungauthor=Z.+Gan-Orauthor=T.+Gasserauthor=R.+Gershoni-Baruchauthor=N.+Giladiauthor=A.+Griffithauthor=T.+Gurevichauthor=C.+Januarioauthor=P.+Kroppauthor=A.+E.+Langauthor=G.-J.+Lee-Chenauthor=S.+Lesageauthor=K.+Marderauthor=I.+F.+Mataauthor=A.+Mirelmanauthor=J.+Mitsuiauthor=I.+Mizutaauthor=G.+Nicolettiauthor=C.+Oliveiraauthor=R.+Ottmanauthor=A.+Orr-Urtregerauthor=L.+V.+Pereiraauthor=A.+Quattroneauthor=E.+Rogaevaauthor=A.+Rolfsauthor=H.+Rosenbaumauthor=R.+Rozenbergauthor=A.+Samiiauthor=T.+Samaddarauthor=C.+Schulteauthor=M.+Sharmaauthor=A.+Singletonauthor=M.+Spitzauthor=E.-K.+Tanauthor=N.+Tayebiauthor=T.+Todaauthor=A.+R.+Troianoauthor=S.+Tsujiauthor=M.+Wittstockauthor=T.+G.+Wolfsbergauthor=Y.-R.+Wuauthor=C.+P.+Zabetianauthor=Y.+Zhaoauthor=S.+G.+Ziegler&title=Multicenter+analysis+of+glucocerebrosidase+mutations+in+Parkinson%E2%80%99s+disease&doi=10.1056%2Fnejmoa0901281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease</span></div><div class="casAuthors">Sidransky, E.; Nalls, M. A.; Aasly, J. O.; Aharon-Peretz, J.; Annesi, G.; Barbosa, E. R.; Bar-Shira, A.; Berg, D.; Bras, J.; Brice, A.; Chen, C.-M.; Clark, L. N.; Condroyer, C.; De Marco, E. V.; Duerr, A.; Eblan, M. J.; Fahn, S.; Farrer, M. J.; Fung, H.-C.; Gan-Or, Z.; Gasser, T.; Gershoni-Baruch, R.; Giladi, N.; Griffith, A.; Gurevich, T.; Januario, C.; Kropp, P.; Lang, A. E.; Lee-Chen, G.-J.; Lesage, S.; Marder, K.; Mata, I. F.; Mirelman, A.; Mitsui, J.; Mizuta, I.; Nicoletti, G.; Oliveira, C.; Ottman, R.; Orr-Urtreger, A.; Pereira, L. V.; Quattrone, A.; Rogaeva, E.; Rolfs, A.; Rosenbaum, H.; Rozenberg, R.; Samii, A.; Samaddar, T.; Schulte, C.; Sharma, M.; Singleton, A.; Spitz, M.; Tan, E.-K.; Tayebi, N.; Toda, T.; Troiano, A. R.; Tsuji, S.; Wittstock, M.; Wolfsberg, T. G.; Wu, Y.-R.; Zabetian, C. P.; Zhao, Y.; Ziegler, S. G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1651-1661</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Recent studies indicate an increased frequency of mutations in the gene encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among patients with Parkinson's disease.  We aimed to ascertain the frequency of GBA mutations in an ethnically diverse group of patients with Parkinson's disease.  METHODS Sixteen centers participated in our international, collaborative study: five from the Americas, six from Europe, two from Israel, and three from Asia.  Each center genotyped a std. DNA panel to permit comparison of the genotyping results across centers.  Genotypes and phenotypic data from a total of 5691 patients with Parkinson's disease (780 Ashkenazi Jews) and 4898 controls (387 Ashkenazi Jews) were analyzed, with multivariate logistic-regression models and the Mantel-Haenszel procedure used to est. odds ratios across centers.  RESULTS All 16 centers could detect two GBA mutations, L444P and N370S.  Among Ashkenazi Jewish subjects, either mutation was found in 15% of patients and 3% of controls, and among non-Ashkenazi Jewish subjects, either mutation was found in 3% of patients and less than 1% of controls.  GBA was fully sequenced for 1883 non-Ashkenazi Jewish patients, and mutations were identified in 7%, showing that limited mutation screening can miss half the mutant alleles.  The odds ratio for any GBA mutation in patients vs. controls was 5.43 across centers.  As compared with patients who did not carry a GBA mutation, those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were more likely to have atypical clin. manifestations.  CONCLUSIONS Data collected from 16 centers demonstrate that there is a strong assocn. between GBA mutations and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq63Clf93zPLrVg90H21EOLACvtfcHk0lj7xuWugjVM5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgs77P&md5=5a309403069e28e93240b11b9a110c2e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa0901281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa0901281%26sid%3Dliteratum%253Aachs%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DAasly%26aufirst%3DJ.%2BO.%26aulast%3DAharon-Peretz%26aufirst%3DJ.%26aulast%3DAnnesi%26aufirst%3DG.%26aulast%3DBarbosa%26aufirst%3DE.%2BR.%26aulast%3DBar-Shira%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DBras%26aufirst%3DJ.%26aulast%3DBrice%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.-M.%26aulast%3DClark%26aufirst%3DL.%2BN.%26aulast%3DCondroyer%26aufirst%3DC.%26aulast%3DDe%2BMarco%26aufirst%3DE.%2BV.%26aulast%3DD%25C3%25BCrr%26aufirst%3DA.%26aulast%3DEblan%26aufirst%3DM.%2BJ.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DFung%26aufirst%3DH.-C.%26aulast%3DGan-Or%26aufirst%3DZ.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DGershoni-Baruch%26aufirst%3DR.%26aulast%3DGiladi%26aufirst%3DN.%26aulast%3DGriffith%26aufirst%3DA.%26aulast%3DGurevich%26aufirst%3DT.%26aulast%3DJanuario%26aufirst%3DC.%26aulast%3DKropp%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DLee-Chen%26aufirst%3DG.-J.%26aulast%3DLesage%26aufirst%3DS.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DMirelman%26aufirst%3DA.%26aulast%3DMitsui%26aufirst%3DJ.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DNicoletti%26aufirst%3DG.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DOttman%26aufirst%3DR.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DPereira%26aufirst%3DL.%2BV.%26aulast%3DQuattrone%26aufirst%3DA.%26aulast%3DRogaeva%26aufirst%3DE.%26aulast%3DRolfs%26aufirst%3DA.%26aulast%3DRosenbaum%26aufirst%3DH.%26aulast%3DRozenberg%26aufirst%3DR.%26aulast%3DSamii%26aufirst%3DA.%26aulast%3DSamaddar%26aufirst%3DT.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DSpitz%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DE.-K.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DT.%26aulast%3DTroiano%26aufirst%3DA.%2BR.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DWittstock%26aufirst%3DM.%26aulast%3DWolfsberg%26aufirst%3DT.%2BG.%26aulast%3DWu%26aufirst%3DY.-R.%26aulast%3DZabetian%26aufirst%3DC.%2BP.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZiegler%26aufirst%3DS.%2BG.%26atitle%3DMulticenter%2520analysis%2520of%2520glucocerebrosidase%2520mutations%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1651%26epage%3D1661%26doi%3D10.1056%2Fnejmoa0901281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, A. H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olanow, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenamyre, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span> <span> </span><span class="NLM_article-title">Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(14)61010-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2FS0140-6736%2814%2961010-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=24954676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVanu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2014&pages=545-555&author=A.+H.+V.+Schapiraauthor=C.+W.+Olanowauthor=J.+T.+Greenamyreauthor=E.+Bezard&title=Slowing+of+neurodegeneration+in+Parkinson%E2%80%99s+disease+and+Huntington%E2%80%99s+disease%3A+future+therapeutic+perspectives&doi=10.1016%2Fs0140-6736%2814%2961010-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives</span></div><div class="casAuthors">Schapira, Anthony H. V.; Olanow, C. Warren; Greenamyre, J. Timothy; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">9942</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease and Huntington's disease.  These advances have been informed by both direct anal. of the post-mortem brain and by study of the biol. consequences of the genetic causes of these diseases.  Some of the pathways that have been implicated so far include mitochondrial dysfunction, oxidative stress, kinase pathways, calcium dysregulation, inflammation, protein handling, and prion-like processes.  Intriguingly, these pathways seem to be important in the pathogenesis of both diseases and have led to the identification of mol. targets for candidate interventions designed to slow or reverse their course.  We review some recent advances that underlie putative therapies for neuroprotection in Parkinson's disease and Huntington's disease, and potential targets that might be exploited in the future.  Although we will need to overcome important hurdles, esp. in terms of clin. trial design, we propose several target pathways that merit further study.  In Parkinson's disease, these targets include agents that might improve mitochondrial function or increase degrdn. of defective mitochondria, kinase inhibitors, calcium channel blockers, and approaches that interfere with the misfolding, templating, and transmission of α-synuclein.  In Huntington's disease, strategies might also be directed at mitochondrial bioenergetics and turnover, the prevention of protein dysregulation, disruption of the interaction between huntingtin and p53 or huntingtin-interacting protein 1 to reduce apoptosis, and interference with expression of mutant huntingtin at both the nucleic acid and protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD0xsb-NEEXLVg90H21EOLACvtfcHk0liS244NSY-rRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVanu7jL&md5=06278a44eed0250df403002eecc7b51e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2814%2961010-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252814%252961010-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DSlowing%2520of%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520Huntington%25E2%2580%2599s%2520disease%253A%2520future%2520therapeutic%2520perspectives%26jtitle%3DLancet%26date%3D2014%26volume%3D384%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fs0140-6736%2814%2961010-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, G.</span></span> <span> </span><span class="NLM_article-title">The link between the GBA gene and parkinsonism</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70190-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fs1474-4422%2812%2970190-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=23079555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCqtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=986-998&author=E.+Sidranskyauthor=G.+Lopez&title=The+link+between+the+GBA+gene+and+parkinsonism&doi=10.1016%2Fs1474-4422%2812%2970190-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The link between the GBA gene and parkinsonism</span></div><div class="casAuthors">Sidransky, Ellen; Lopez, Grisel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">986-998</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Mutations in the glucocerebrosidase (GBA) gene, which encodes the lysosomal enzyme that is deficient in Gaucher's disease, are important and common risk factors for Parkinson's disease and related disorders.  This assocn. was first recognized in the clinic, where parkinsonism was noted, albeit rarely, in patients with Gaucher's disease and more frequently in relatives who were obligate carriers.  Subsequently, findings from large studies showed that patients with Parkinson's disease and assocd. Lewy body disorders had an increased frequency of GBA mutations when compared with control individuals.  Patients with GBA-assocd. parkinsonism exhibit varying parkinsonian phenotypes but tend to have an earlier age of onset and more assocd. cognitive changes than patients with parkinsonism without GBA mutations.  Hypotheses proposed to explain this assocn. include a gain-of-function due to mutations in glucocerebrosidase that promotes α-synuclein aggregation; substrate accumulation due to enzymic loss-of-function, which affects α-synuclein processing and clearance; and a bidirectional feedback loop.  Identification of the pathol. mechanisms underlying GBA-assocd. parkinsonism will improve our understanding of the genetics, pathophysiol., and treatment for both rare and common neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHlv_PqOQd-bVg90H21EOLACvtfcHk0liS244NSY-rRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCqtbnJ&md5=522c2d24e1e4f8e826a211991fe35df8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2812%2970190-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252812%252970190-4%26sid%3Dliteratum%253Aachs%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DG.%26atitle%3DThe%2520link%2520between%2520the%2520GBA%2520gene%2520and%2520parkinsonism%26jtitle%3DLancet%2520Neurol.%26date%3D2012%26volume%3D11%26spage%3D986%26epage%3D998%26doi%3D10.1016%2Fs1474-4422%2812%2970190-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M. J.</span></span> <span> </span><span class="NLM_article-title">Genetics and genomics of Parkinson’s disease</span>. <i>Genome Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/gm566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1186%2Fgm566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=25061481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=M.+K.+Linauthor=M.+J.+Farrer&title=Genetics+and+genomics+of+Parkinson%E2%80%99s+disease&doi=10.1186%2Fgm566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and genomics of Parkinson's disease</span></div><div class="casAuthors">Lin Michelle K; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Genome medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn">1756-994X</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is a progressively debilitating neurodegenerative syndrome.  Although best described as a movement disorder, the condition has prominent autonomic, cognitive, psychiatric, sensory and sleep components.  Striatal dopaminergic innervation and nigral neurons are progressively lost, with associated Lewy pathology readily apparent on autopsy.  Nevertheless, knowledge of the molecular events leading to this pathophysiology is limited.  Current therapies offer symptomatic benefit but they fail to slow progression and patients continue to deteriorate.  Recent discoveries in sporadic, Mendelian and more complex forms of parkinsonism provide novel insight into disease etiology; 28 genes, including those encoding alpha-synuclein (SNCA), leucine-rich repeat kinase 2 (LRRK2) and microtubule-associated protein tau (MAPT), have been linked and/or associated with PD.  A consensus regarding the affected biological pathways and molecular processes has also started to emerge.  In early-onset and more a typical PD, deficits in mitophagy pathways and lysosomal function appear to be prominent.  By contrast, in more typical late-onset PD, chronic, albeit subtle, dysfunction in synaptic transmission, early endosomal trafficking and receptor recycling, as well as chaperone-mediated autophagy, provide a unifying synthesis of the molecular pathways involved.  Disease-modification (neuroprotection) is no longer such an elusive goal given the unparalleled opportunity for diagnosis, translational neuroscience and therapeutic development provided by genetic discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZ98nLXyY0xUNoizSOkG_FfW6udTcc2eYr3wBPEVxX07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D&md5=2812917436574ba10ba7170d48bf4eb4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fgm566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgm566%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DGenetics%2520and%2520genomics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DGenome%2520Med.%26date%3D2014%26volume%3D6%26spage%3D48%26doi%3D10.1186%2Fgm566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawkar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Nonlinear partial differential equations and applications: Chemical chaperones increase the cellular activity of N370S β-glucosidase: A therapeutic strategy for Gaucher disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">15428</span>– <span class="NLM_lpage">15433</span>, <span class="refDoi"> DOI: 10.1073/pnas.192582899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.192582899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15428-15433&author=A.+R.+Sawkarauthor=W.-C.+Chengauthor=E.+Beutlerauthor=C.-H.+Wongauthor=W.+E.+Balchauthor=J.+W.+Kelly&title=Nonlinear+partial+differential+equations+and+applications%3A+Chemical+chaperones+increase+the+cellular+activity+of+N370S+%CE%B2-glucosidase%3A+A+therapeutic+strategy+for+Gaucher+disease&doi=10.1073%2Fpnas.192582899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192582899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192582899%26sid%3Dliteratum%253Aachs%26aulast%3DSawkar%26aufirst%3DA.%2BR.%26aulast%3DCheng%26aufirst%3DW.-C.%26aulast%3DBeutler%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNonlinear%2520partial%2520differential%2520equations%2520and%2520applications%253A%2520Chemical%2520chaperones%2520increase%2520the%2520cellular%2520activity%2520of%2520N370S%2520%25CE%25B2-glucosidase%253A%2520A%2520therapeutic%2520strategy%2520for%2520Gaucher%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D15428%26epage%3D15433%26doi%3D10.1073%2Fpnas.192582899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, G. A.</span></span> <span> </span><span class="NLM_article-title">Phenotype, diagnosis, and treatment of Gaucher’s disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(08)61522-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fs0140-6736%2808%2961522-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=19094956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2ku7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=1263-1271&author=G.+A.+Grabowski&title=Phenotype%2C+diagnosis%2C+and+treatment+of+Gaucher%E2%80%99s+disease&doi=10.1016%2Fs0140-6736%2808%2961522-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotype, diagnosis, and treatment of Gaucher's disease</span></div><div class="casAuthors">Grabowski, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9645</span>),
    <span class="NLM_cas:pages">1263-1271</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Gaucher's disease continues to be a model for applications of mol. medicine to clin. delineation, diagnosis, and treatment.  Analyses of several thousand affected individuals have broadened the range of the pan-ethnic disease variants, provided initial genotype and phenotype correlations, and established the effectiveness of enzyme therapy.  Large nos. of affected individuals worldwide have provided insight into the effect of disease variation related to ethnic origin, prognosis, and outcome.  The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacol. chaperone strategies.  Such innovations could provide interventions that are effective for neuronopathic variants and, potentially, could be more cost effective than other treatments.  These developments are novel, clin. important, advancements for patients with other lysosomal storage diseases and genetic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UO6xuFQQO7Vg90H21EOLACvtfcHk0ljBZoTk2fiwIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2ku7nP&md5=78f8052baf74c448ecff494b66b4d06d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2808%2961522-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252808%252961522-6%26sid%3Dliteratum%253Aachs%26aulast%3DGrabowski%26aufirst%3DG.%2BA.%26atitle%3DPhenotype%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520Gaucher%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D1263%26epage%3D1271%26doi%3D10.1016%2Fs0140-6736%2808%2961522-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, D.</span></span> <span> </span><span class="NLM_article-title">Gaucher disease and its treatment options</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1177/1060028013500469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1177%2F1060028013500469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2013&pages=1182-1193&author=L.+L.+Bennettauthor=D.+Mohan&title=Gaucher+disease+and+its+treatment+options&doi=10.1177%2F1060028013500469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1177%2F1060028013500469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028013500469%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DL.%2BL.%26aulast%3DMohan%26aufirst%3DD.%26atitle%3DGaucher%2520disease%2520and%2520its%2520treatment%2520options%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2013%26volume%3D47%26spage%3D1182%26epage%3D1193%26doi%3D10.1177%2F1060028013500469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.cell.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=21700325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=37-52&author=J.+R.+Mazzulliauthor=Y.-H.+Xuauthor=Y.+Sunauthor=A.+L.+Knightauthor=P.+J.+McLeanauthor=G.+A.+Caldwellauthor=E.+Sidranskyauthor=G.+A.+Grabowskiauthor=D.+Krainc&title=Gaucher+disease+glucocerebrosidase+and+%CE%B1-synuclein+form+a+bidirectional+pathogenic+loop+in+synucleinopathies&doi=10.1016%2Fj.cell.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies</span></div><div class="casAuthors">Mazzulli, Joseph R.; Xu, You-Hai; Sun, Ying; Knight, Adam L.; McLean, Pamela J.; Caldwell, Guy A.; Sidransky, Ellen; Grabowski, Gregory A.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Parkinson's disease (PD), an adult neurodegenerative disorder, has been clin. linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known.  Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degrdn., causes accumulation of α-synuclein (α-syn), and results in neurotoxicity through aggregation-dependent mechanisms.  Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified α-syn by stabilizing sol. oligomeric intermediates.  We further demonstrate that α-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies.  These findings suggest that the bidirectional effect of α-syn and GCase forms a pos. feedback loop that may lead to a self-propagating disease.  Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2Uua6ozAKLVg90H21EOLACvtfcHk0ljBZoTk2fiwIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslCksrk%253D&md5=03172d302518c8ca4f788a6207a37291</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DXu%26aufirst%3DY.-H.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DKnight%26aufirst%3DA.%2BL.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DGrabowski%26aufirst%3DG.%2BA.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DGaucher%2520disease%2520glucocerebrosidase%2520and%2520%25CE%25B1-synuclein%2520form%2520a%2520bidirectional%2520pathogenic%2520loop%2520in%2520synucleinopathies%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.cell.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sardi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamsett, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treleaven, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shihabuddin, L. S.</span></span> <span> </span><span class="NLM_article-title">Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3537</span>– <span class="NLM_lpage">3542</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220464110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.1220464110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=23297226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3537-3542&author=S.+P.+Sardiauthor=J.+Clarkeauthor=C.+Vielauthor=M.+Chanauthor=T.+J.+Tamsettauthor=C.+M.+Treleavenauthor=J.+Buauthor=L.+Sweetauthor=M.+A.+Passiniauthor=J.+C.+Dodgeauthor=W.+H.+Yuauthor=R.+L.+Sidmanauthor=S.+H.+Chengauthor=L.+S.+Shihabuddin&title=Augmenting+CNS+glucocerebrosidase+activity+as+a+therapeutic+strategy+for+parkinsonism+and+other+Gaucher-related+synucleinopathies&doi=10.1073%2Fpnas.1220464110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies</span></div><div class="casAuthors">Sardi, S. Pablo; Clarke, Jennifer; Viel, Catherine; Chan, Monyrath; Tamsett, Thomas J.; Treleaven, Christopher M.; Bu, Jie; Sweet, Lindsay; Passini, Marco A.; Dodge, James C.; Yu, W. Haung; Sidman, Richard L.; Cheng, Seng H.; Shihabuddin, Lamya S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3537-3542, S3537/1-S3537/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations of GBA1, the gene encoding glucocerebrosidase, represent a common genetic risk factor for developing the synucleinopathies Parkinson disease (PD) and dementia with Lewy bodies.  PD patients with or without GBA1 mutations also exhibit lower enzymic levels of glucocerebrosidase in the central nervous system (CNS), suggesting a possible link between the enzyme and the development of the disease.  Previously, we have shown that early treatment with glucocerebrosidase can modulate α-synuclein aggregation in a presymptomatic mouse model of Gaucher-related synucleinopathy (Gba1D409V/D409V) and ameliorate the assocd. cognitive deficit.  To probe this link further, we have now evaluated the efficacy of augmenting glucocerebrosidase activity in the CNS of symptomatic Gba1D409V/D409V mice and in a transgenic mouse model overexpressing A53T α-synuclein.  Adeno-assocd. virus-mediated expression of glucocerebrosidase in the CNS of symptomatic Gba1D409V/D409V mice completely cor. the aberrant accumulation of the toxic lipid glucosylsphingosine and reduced the levels of ubiquitin, tau, and proteinase K-resistant α-synuclein aggregates.  Importantly, hippocampal expression of glucocerebrosidase in Gba1D409V/D409V mice (starting at 4 or 12 mo of age) also reversed their cognitive impairment when examd. using a novel object recognition test.  Correspondingly, overexpression of glucocerebrosidase in the CNS of A53T α-synuclein mice reduced the levels of sol. α-synuclein, suggesting that increasing the glycosidase activity can modulate α-synuclein processing and may modulate the progression of α-synucleinopathies.  Hence, increasing glucocerebrosidase activity in the CNS represents a potential therapeutic strategy for GBA1-related and non-GBA1-assocd. synucleinopathies, including PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3A7pMjY6NM7Vg90H21EOLACvtfcHk0ljBZoTk2fiwIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyntrc%253D&md5=5735e718c200156d42b53319fbc95121</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220464110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220464110%26sid%3Dliteratum%253Aachs%26aulast%3DSardi%26aufirst%3DS.%2BP.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DViel%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DM.%26aulast%3DTamsett%26aufirst%3DT.%2BJ.%26aulast%3DTreleaven%26aufirst%3DC.%2BM.%26aulast%3DBu%26aufirst%3DJ.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DPassini%26aufirst%3DM.%2BA.%26aulast%3DDodge%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DSidman%26aufirst%3DR.%2BL.%26aulast%3DCheng%26aufirst%3DS.%2BH.%26aulast%3DShihabuddin%26aufirst%3DL.%2BS.%26atitle%3DAugmenting%2520CNS%2520glucocerebrosidase%2520activity%2520as%2520a%2520therapeutic%2520strategy%2520for%2520parkinsonism%2520and%2520other%2520Gaucher-related%2520synucleinopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D3537%26epage%3D3542%26doi%3D10.1073%2Fpnas.1220464110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Development of targeted therapies for Parkinson’s disease and related synucleinopathies</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1996</span>– <span class="NLM_lpage">2003</span>, <span class="refDoi"> DOI: 10.1194/jlr.r047381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1194%2Fjlr.r047381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1996-2003&author=E.+Sybertzauthor=D.+Krainc&title=Development+of+targeted+therapies+for+Parkinson%E2%80%99s+disease+and+related+synucleinopathies&doi=10.1194%2Fjlr.r047381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1194%2Fjlr.r047381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.r047381%26sid%3Dliteratum%253Aachs%26aulast%3DSybertz%26aufirst%3DE.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520targeted%2520therapies%2520for%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520related%2520synucleinopathies%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1996%26epage%3D2003%26doi%3D10.1194%2Fjlr.r047381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goker-Alpan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarca, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span> <span> </span><span class="NLM_article-title">Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">13192</span>– <span class="NLM_lpage">13197</span>, <span class="refDoi"> DOI: 10.1073/pnas.0705637104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.0705637104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=17670938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13192-13197&author=W.+Zhengauthor=J.+Padiaauthor=D.+J.+Urbanauthor=A.+Jadhavauthor=O.+Goker-Alpanauthor=A.+Simeonovauthor=E.+Goldinauthor=D.+Auldauthor=M.+E.+LaMarcaauthor=J.+Ingleseauthor=C.+P.+Austinauthor=E.+Sidransky&title=Three+classes+of+glucocerebrosidase+inhibitors+identified+by+quantitative+high-throughput+screening+are+chaperone+leads+for+Gaucher+disease&doi=10.1073%2Fpnas.0705637104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease</span></div><div class="casAuthors">Zheng, Wei; Padia, Janak; Urban, Daniel J.; Jadhav, Ajit; Goker-Alpan, Ozlem; Simeonov, Anton; Goldin, Ehud; Auld, Douglas; LaMarca, Mary E.; Inglese, James; Austin, Christopher P.; Sidransky, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13192-13197, S13192/1-S13192/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gaucher disease is an autosomal recessive lysosomal storage disorder caused by mutations in the glucocerebrosidase gene.  Missense mutations result in reduced enzyme activity that may be due to misfolding, raising the possibility of small-mol. chaperone correction of the defect.  Screening large compd. libraries by quant. high-throughput screening (qHTS) provides comprehensive information on the potency, efficacy, and structure-activity relationships (SAR) of active compds. directly from the primary screen, facilitating identification of leads for medicinal chem. optimization.  We used qHTS to rapidly identify three structural series of potent, selective, nonsugar glucocerebrosidase inhibitors.  The three structural classes had excellent potencies and efficacies and, importantly, high selectivity against closely related hydrolases.  Preliminary SAR data were used to select compds. with high activity in both enzyme and cell-based assays.  Compds. from two of these structural series increased N370S mutant glucocerebrosidase activity by 40 - 90% in patient cell lines and enhanced lysosomal colocalization, indicating chaperone activity.  These small mols. have potential as leads for chaperone therapy for Gaucher disease, and this paradigm promises to accelerate the development of leads for other rare genetic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQME0eO7kg7Vg90H21EOLACvtfcHk0lgXJGKQLhKrfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Gmsr0%253D&md5=78aa269b58404b3324a1099f8efd3628</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705637104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705637104%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DGoker-Alpan%26aufirst%3DO.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DAuld%26aufirst%3DD.%26aulast%3DLaMarca%26aufirst%3DM.%2BE.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DSidransky%26aufirst%3DE.%26atitle%3DThree%2520classes%2520of%2520glucocerebrosidase%2520inhibitors%2520identified%2520by%2520quantitative%2520high-throughput%2520screening%2520are%2520chaperone%2520leads%2520for%2520Gaucher%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D13192%26epage%3D13197%26doi%3D10.1073%2Fpnas.0705637104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubblefield, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aungst, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1058</span>, <span class="refDoi"> DOI: 10.1021/jm1008902</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1008902" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1033-1058&author=J.+J.+Maruganauthor=W.+Zhengauthor=O.+Motabarauthor=N.+Southallauthor=E.+Goldinauthor=W.+Westbroekauthor=B.+K.+Stubblefieldauthor=E.+Sidranskyauthor=R.+A.+Aungstauthor=W.+A.+Leaauthor=A.+Simeonovauthor=W.+Leisterauthor=C.+P.+Austin&title=Evaluation+of+quinazoline+analogues+as+glucocerebrosidase+inhibitors+with+chaperone+activity&doi=10.1021%2Fjm1008902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm1008902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008902%26sid%3Dliteratum%253Aachs%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DStubblefield%26aufirst%3DB.%2BK.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DAungst%26aufirst%3DR.%2BA.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26atitle%3DEvaluation%2520of%2520quinazoline%2520analogues%2520as%2520glucocerebrosidase%2520inhibitors%2520with%2520chaperone%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1033%26epage%3D1058%26doi%3D10.1021%2Fjm1008902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBernardi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span> <span> </span><span class="NLM_article-title">Non-iminosugar glucocerebrosidase small molecule chaperones</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1039/c1md00200g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1039%2Fc1md00200g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=56-60&author=J.+J.+Maruganauthor=W.+Huangauthor=O.+Motabarauthor=W.+Zhengauthor=J.+Xiaoauthor=S.+Patnaikauthor=N.+Southallauthor=W.+Westbroekauthor=W.+A.+Leaauthor=A.+Simeonovauthor=E.+Goldinauthor=M.+A.+DeBernardiauthor=E.+Sidransky&title=Non-iminosugar+glucocerebrosidase+small+molecule+chaperones&doi=10.1039%2Fc1md00200g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc1md00200g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00200g%26sid%3Dliteratum%253Aachs%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DDeBernardi%26aufirst%3DM.%2BA.%26aulast%3DSidransky%26aufirst%3DE.%26atitle%3DNon-iminosugar%2520glucocerebrosidase%2520small%2520molecule%2520chaperones%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D56%26epage%3D60%26doi%3D10.1039%2Fc1md00200g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tropak, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhaber, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuske, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahuran, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on β-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2662</span>, <span class="refDoi"> DOI: 10.1002/cbic.200800304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1002%2Fcbic.200800304" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2650-2662&author=M.+B.+Tropakauthor=G.+J.+Kornhaberauthor=B.+A.+Rigatauthor=G.+H.+Maegawaauthor=J.+D.+Buttnerauthor=J.+E.+Blanchardauthor=C.+Murphyauthor=S.+J.+Tuskeauthor=S.+J.+Coalesauthor=Y.+Hamuroauthor=E.+D.+Brownauthor=D.+J.+Mahuran&title=Identification+of+pharmacological+chaperones+for+Gaucher+disease+and+characterization+of+their+effects+on+%CE%B2-glucocerebrosidase+by+hydrogen%2Fdeuterium+exchange+mass+spectrometry&doi=10.1002%2Fcbic.200800304"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800304%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DBlanchard%26aufirst%3DJ.%2BE.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DTuske%26aufirst%3DS.%2BJ.%26aulast%3DCoales%26aufirst%3DS.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520pharmacological%2520chaperones%2520for%2520Gaucher%2520disease%2520and%2520characterization%2520of%2520their%2520effects%2520on%2520%25CE%25B2-glucocerebrosidase%2520by%2520hydrogen%252Fdeuterium%2520exchange%2520mass%2520spectrometry%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2650%26epage%3D2662%26doi%3D10.1002%2Fcbic.200800304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5783</span>– <span class="NLM_lpage">5789</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.08.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.bmcl.2007.08.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=17827006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSit7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5783-5789&author=W.+Huangauthor=W.+Zhengauthor=D.+J.+Urbanauthor=J.+Ingleseauthor=E.+Sidranskyauthor=C.+P.+Austinauthor=C.+J.+Thomas&title=N4-phenyl+modifications+of+N2-%282-hydroxyl%29ethyl-6-%28pyrrolidin-1-yl%29-1%2C3%2C5-triazine-2%2C4-diamines+enhance+glucocerebrosidase+inhibition+by+small+molecules+with+potential+as+chemical+chaperones+for+Gaucher+disease&doi=10.1016%2Fj.bmcl.2007.08.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease</span></div><div class="casAuthors">Huang, Wenwei; Zheng, Wei; Urban, Daniel J.; Inglese, James; Sidransky, Ellen; Austin, Christopher P.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5783-5789</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 1,3,5-triazine-2,4,6-triamines were prepd. and analyzed as inhibitors of glucocerebrosidase.  Synthesis, structure activity relationships and the selectivity of chosen analogs against related sugar hydrolases enzymes are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5lbmm0Aa1arVg90H21EOLACvtfcHk0ljKbrX2S0vDYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSit7rF&md5=d1d66009fdbc3ab7d79ace982c81ff7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.08.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DN4-phenyl%2520modifications%2520of%2520N2-%25282-hydroxyl%2529ethyl-6-%2528pyrrolidin-1-yl%2529-1%252C3%252C5-triazine-2%252C4-diamines%2520enhance%2520glucocerebrosidase%2520inhibition%2520by%2520small%2520molecules%2520with%2520potential%2520as%2520chemical%2520chaperones%2520for%2520Gaucher%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5783%26epage%3D5789%26doi%3D10.1016%2Fj.bmcl.2007.08.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velayati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5734</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1021/jm300063b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300063b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5734-5748&author=S.+Patnaikauthor=W.+Zhengauthor=J.+H.+Choiauthor=O.+Motabarauthor=N.+Southallauthor=W.+Westbroekauthor=W.+A.+Leaauthor=A.+Velayatiauthor=E.+Goldinauthor=E.+Sidranskyauthor=W.+Leisterauthor=J.+J.+Marugan&title=Discovery%2C+structure-activity+relationship%2C+and+biological+evaluation+of+noninhibitory+small+molecule+chaperones+of+glucocerebrosidase&doi=10.1021%2Fjm300063b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300063b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300063b%26sid%3Dliteratum%253Aachs%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DVelayati%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520biological%2520evaluation%2520of%2520noninhibitory%2520small%2520molecule%2520chaperones%2520of%2520glucocerebrosidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5734%26epage%3D5748%26doi%3D10.1021%2Fjm300063b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbulla, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sue, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Activation of β-glucocerebrosidase reduces pathological α-synuclein and restores lysosomal function in Parkinson's patient midbrain neurons</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7693</span>– <span class="NLM_lpage">7706</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.0628-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1523%2Fjneurosci.0628-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=27445146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=7693-7706&author=J.+R.+Mazzulliauthor=F.+Zunkeauthor=T.+Tsunemiauthor=N.+J.+Tokerauthor=S.+Jeonauthor=L.+F.+Burbullaauthor=S.+Patnaikauthor=E.+Sidranskyauthor=J.+J.+Maruganauthor=C.+M.+Sueauthor=D.+Krainc&title=Activation+of+%CE%B2-glucocerebrosidase+reduces+pathological+%CE%B1-synuclein+and+restores+lysosomal+function+in+Parkinson%27s+patient+midbrain+neurons&doi=10.1523%2Fjneurosci.0628-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of β-glucocerebrosidase reduces pathological α-synuclein and restores lysosomal function in parkinson's patient midbrain neurons</span></div><div class="casAuthors">Mazzulli, Joseph R.; Zunke, Friederike; Tsunemi, Taiji; Toker, Nicholas J.; Jeon, Sohee; Burbulla, Lena F.; Patnaik, Samarjit; Sidransky, Ellen; Marugan, Juan J.; Sue, Carolyn M.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7693-7706</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by the accumulation of α-synuclein (α-syn) within Lewy body inclusions in the nervous system.  There are currently no disease-modifying therapies capable of reducing α-syn inclusions in PD.  Recent data has indicated that loss-of-function mutations in the GBA1 gene that encodes lysosomal β-glucocerebrosidase (GCase) represent an important risk factor for PD, and can lead to α-syn accumulation.  Here we use a small-mol. modulator of GCase to det. whether GCase activation within lysosomes can reduce α-syn levels and ameliorate downstream toxicity.  Using induced pluripotent stem cell (iPSC)-derived human midbrain dopamine (DA) neurons from synucleinopathy patients with different PD-linked mutations, we find that a non-inhibitory small mol. modulator of GCase specifically enhanced activity within lysosomal compartments.  This resulted in redn. of GCase substrates and clearance of pathol. α-syn, regardless of the disease causing mutations.  Importantly, the redn. of α-syn was sufficient to reverse downstream cellular pathologies induced by α-syn, including perturbations in hydrolase maturation and lysosomal dysfunction.  These results indicate that enhancement of a single lysosomal hydrolase, GCase, can effectively reduce α-syn and provide therapeutic benefit in human midbrain neurons.  This suggests that GCase activators may prove beneficial as treatments for PD and related synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpohFsjVOGt-7Vg90H21EOLACvtfcHk0ljKbrX2S0vDYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWks7%252FM&md5=a69d50297698c71db413c0af99d07003</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.0628-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.0628-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DZunke%26aufirst%3DF.%26aulast%3DTsunemi%26aufirst%3DT.%26aulast%3DToker%26aufirst%3DN.%2BJ.%26aulast%3DJeon%26aufirst%3DS.%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DSue%26aufirst%3DC.%2BM.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DActivation%2520of%2520%25CE%25B2-glucocerebrosidase%2520reduces%2520pathological%2520%25CE%25B1-synuclein%2520and%2520restores%2520lysosomal%2520function%2520in%2520Parkinson%2527s%2520patient%2520midbrain%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26spage%3D7693%26epage%3D7706%26doi%3D10.1523%2Fjneurosci.0628-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent quinazolines as selective β-glucocerebrosidase modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8508</span>– <span class="NLM_lpage">8520</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGjtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8508-8520&author=J.+Zhengauthor=L.+Chenauthor=M.+Schwakeauthor=R.+B.+Silvermanauthor=D.+Krainc&title=Design+and+synthesis+of+potent+quinazolines+as+selective+%CE%B2-glucocerebrosidase+modulators&doi=10.1021%2Facs.jmedchem.6b00930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators</span></div><div class="casAuthors">Zheng, Jianbin; Chen, Long; Schwake, Michael; Silverman, Richard B.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8508-8520</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gaucher's disease is a common genetic disease caused by mutations in the β-glucocerebrosidase (GBA1) gene that have been also linked to increased risk of Parkinson's disease and Lewy body dementia.  Stabilization of misfolded mutant β-glucocerebrosidase (GCase) represents an important therapeutic strategy in synucleinopathies.  Here we report a novel class of GCase quinazoline inhibitors, obtained in a high throughput screening, with moderate potency against wild-type GCase.  Rational design and a SAR study of this class of compds. led to a new series of quinazoline derivs. with single-digit nanomolar potency.  These compds. were shown to selectively stabilize GCase when compared to other lysosomal enzymes and to increase N370S mutant GCase protein concn. and activity in cell assays.  To the best of our knowledge, these mols. are the most potent noniminosugar GCase modulators to date that may prove useful for future mechanistic studies and therapeutic approaches in Gaucher's and Parkinson's diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3P9w1W1rwPbVg90H21EOLACvtfcHk0lh6bDgtLJla_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGjtrbM&md5=007e764b27dc604eac179ae85cc33311</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00930%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSchwake%26aufirst%3DM.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520quinazolines%2520as%2520selective%2520%25CE%25B2-glucocerebrosidase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8508%26epage%3D8520%26doi%3D10.1021%2Facs.jmedchem.6b00930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Storz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoagland, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisardi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollywood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, G.</span></span> <span> </span><span class="NLM_article-title">Convenient and practical one-pot synthesis of 4-chloropyrimidines via a novel chloroimidate annulation</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/op1002352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op1002352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=918-924&author=T.+Storzauthor=R.+Heidauthor=J.+Zeldisauthor=S.+M.+Hoaglandauthor=V.+Rapisardiauthor=S.+Hollywoodauthor=G.+Morton&title=Convenient+and+practical+one-pot+synthesis+of+4-chloropyrimidines+via+a+novel+chloroimidate+annulation&doi=10.1021%2Fop1002352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fop1002352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1002352%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DT.%26aulast%3DHeid%26aufirst%3DR.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DHoagland%26aufirst%3DS.%2BM.%26aulast%3DRapisardi%26aufirst%3DV.%26aulast%3DHollywood%26aufirst%3DS.%26aulast%3DMorton%26aufirst%3DG.%26atitle%3DConvenient%2520and%2520practical%2520one-pot%2520synthesis%2520of%25204-chloropyrimidines%2520via%2520a%2520novel%2520chloroimidate%2520annulation%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D918%26epage%3D924%26doi%3D10.1021%2Fop1002352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ysselstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansbury, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerlj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrosek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heunisch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">β-Glucocerebrosidase modulators promote dimerization of β-glucocerebrosidase and reveal an allosteric binding site</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">5914</span>– <span class="NLM_lpage">5924</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b13003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b13003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=5914-5924&author=J.+Zhengauthor=L.+Chenauthor=O.+S.+Skinnerauthor=D.+Ysselsteinauthor=J.+Remisauthor=P.+Lansburyauthor=R.+Skerljauthor=M.+Mrosekauthor=U.+Heunischauthor=S.+Krappauthor=J.+Charrowauthor=M.+Schwakeauthor=N.+L.+Kelleherauthor=R.+B.+Silvermanauthor=D.+Krainc&title=%CE%B2-Glucocerebrosidase+modulators+promote+dimerization+of+%CE%B2-glucocerebrosidase+and+reveal+an+allosteric+binding+site&doi=10.1021%2Fjacs.7b13003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b13003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b13003%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSkinner%26aufirst%3DO.%2BS.%26aulast%3DYsselstein%26aufirst%3DD.%26aulast%3DRemis%26aufirst%3DJ.%26aulast%3DLansbury%26aufirst%3DP.%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DMrosek%26aufirst%3DM.%26aulast%3DHeunisch%26aufirst%3DU.%26aulast%3DKrapp%26aufirst%3DS.%26aulast%3DCharrow%26aufirst%3DJ.%26aulast%3DSchwake%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DN.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3D%25CE%25B2-Glucocerebrosidase%2520modulators%2520promote%2520dimerization%2520of%2520%25CE%25B2-glucocerebrosidase%2520and%2520reveal%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D5914%26epage%3D5924%26doi%3D10.1021%2Fjacs.7b13003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zunke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothaug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3791</span>– <span class="NLM_lpage">3796</span>, <span class="refDoi"> DOI: 10.1073/pnas.1514005113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.1514005113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=3791-3796&author=F.+Zunkeauthor=L.+Andresenauthor=S.+Wesselerauthor=J.+Grothauthor=P.+Arnoldauthor=M.+Rothaugauthor=J.+R.+Mazzulliauthor=D.+Kraincauthor=J.+Blanzauthor=P.+Saftigauthor=M.+Schwake&title=Characterization+of+the+complex+formed+by+%CE%B2-glucocerebrosidase+and+the+lysosomal+integral+membrane+protein+type-2&doi=10.1073%2Fpnas.1514005113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1514005113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1514005113%26sid%3Dliteratum%253Aachs%26aulast%3DZunke%26aufirst%3DF.%26aulast%3DAndresen%26aufirst%3DL.%26aulast%3DWesseler%26aufirst%3DS.%26aulast%3DGroth%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DP.%26aulast%3DRothaug%26aufirst%3DM.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchwake%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520complex%2520formed%2520by%2520%25CE%25B2-glucocerebrosidase%2520and%2520the%2520lysosomal%2520integral%2520membrane%2520protein%2520type-2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3D3791%26epage%3D3796%26doi%3D10.1073%2Fpnas.1514005113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0lg2PXwvQPpR1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seibler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziotto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simunovic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">5970</span>– <span class="NLM_lpage">5976</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4441-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1523%2Fjneurosci.4441-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=21508222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5970-5976&author=P.+Seiblerauthor=J.+Graziottoauthor=H.+Jeongauthor=F.+Simunovicauthor=C.+Kleinauthor=D.+Krainc&title=Mitochondrial+Parkin+recruitment+is+impaired+in+neurons+derived+from+mutant+PINK1+induced+pluripotent+stem+cells&doi=10.1523%2Fjneurosci.4441-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</span></div><div class="casAuthors">Seibler, Philip; Graziotto, John; Jeong, Hyun; Simunovic, Filip; Klein, Christine; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5970-5976</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Genetic Parkinson disease (PD) has been assocd. with mutations in PINK1, a gene encoding a mitochondrial kinase implicated in the regulation of mitochondrial degrdn.  While the studies so far examd. PINK1 function in non-neuronal systems or through PINK1 knockdown approaches, there is an imperative to examine the role of endogenous PINK1 in appropriate human-derived and biol. relevant cell models.  Here we report the generation of induced pluripotent stem (iPS) cells from skin fibroblasts taken from three PD patients with nonsense (c.1366C>T; p.Q456X) or missense (c.509T>G; p.V170G) mutations in the PINK1 gene.  These cells were differentiated into dopaminergic neurons that upon mitochondrial depolarization showed impaired recruitment of lentivirally expressed Parkin to mitochondria, increased mitochondrial copy no., and upregulation of PGC-1α, an important regulator of mitochondrial biogenesis.  Importantly, these alterations were cor. by lentiviral expression of wild-type PINK1 in mutant iPS cell-derived PINK1 neurons.  In conclusion, our studies suggest that fibroblasts from genetic PD can be reprogrammed and differentiated into neurons.  These neurons exhibit distinct phenotypes that should be amenable to further mechanistic studies in this relevant biol. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOdV6u6gwXKLVg90H21EOLACvtfcHk0lg2PXwvQPpR1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7Y%253D&md5=1d653ce94d4fff88dd9f6f16c0ab4382</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.4441-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.4441-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSeibler%26aufirst%3DP.%26aulast%3DGraziotto%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DSimunovic%26aufirst%3DF.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DMitochondrial%2520Parkin%2520recruitment%2520is%2520impaired%2520in%2520neurons%2520derived%2520from%2520mutant%2520PINK1%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5970%26epage%3D5976%26doi%3D10.1523%2Fjneurosci.4441-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kriks, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganat, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo-Reid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auyeung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonacci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surmeier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordower, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, L.</span></span> <span> </span><span class="NLM_article-title">Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>480</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature10648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1038%2Fnature10648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=22056989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=547-551&author=S.+Kriksauthor=J.-W.+Shimauthor=J.+Piaoauthor=Y.+M.+Ganatauthor=D.+R.+Wakemanauthor=Z.+Xieauthor=L.+Carrillo-Reidauthor=G.+Auyeungauthor=C.+Antonacciauthor=A.+Buchauthor=L.+Yangauthor=M.+F.+Bealauthor=D.+J.+Surmeierauthor=J.+H.+Kordowerauthor=V.+Tabarauthor=L.+Studer&title=Dopamine+neurons+derived+from+human+ES+cells+efficiently+engraft+in+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1038%2Fnature10648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease</span></div><div class="casAuthors">Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Wakeman, Dustin R.; Xie, Zhong; Carrillo-Reid, Luis; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Yang, Lichuan; Beal, M. Flint; Surmeier, D. James; Kordower, Jeffrey H.; Tabar, Viviane; Studer, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">480</span>
        (<span class="NLM_cas:issue">7378</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new strategy for derivation of human midbrain dopamine neurons from pluripotent cells was developed; transplantation of the neurons in mice, rats and parkinsonian monkeys show they are a promising source of cells for applications in regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowqLdlQBwForVg90H21EOLACvtfcHk0lg2PXwvQPpR1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfP&md5=99bc76fc18a87a84078260bf0bae23ad</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature10648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10648%26sid%3Dliteratum%253Aachs%26aulast%3DKriks%26aufirst%3DS.%26aulast%3DShim%26aufirst%3DJ.-W.%26aulast%3DPiao%26aufirst%3DJ.%26aulast%3DGanat%26aufirst%3DY.%2BM.%26aulast%3DWakeman%26aufirst%3DD.%2BR.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DCarrillo-Reid%26aufirst%3DL.%26aulast%3DAuyeung%26aufirst%3DG.%26aulast%3DAntonacci%26aufirst%3DC.%26aulast%3DBuch%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DKordower%26aufirst%3DJ.%2BH.%26aulast%3DTabar%26aufirst%3DV.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DDopamine%2520neurons%2520derived%2520from%2520human%2520ES%2520cells%2520efficiently%2520engraft%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D547%26epage%3D551%26doi%3D10.1038%2Fnature10648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burbulla, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampese, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermaier, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strojny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiskinis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surmeier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1126/science.aam9080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1126%2Fscience.aam9080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=28882997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=1255-1261&author=L.+F.+Burbullaauthor=P.+Songauthor=J.+R.+Mazzulliauthor=E.+Zampeseauthor=Y.+C.+Wongauthor=S.+Jeonauthor=D.+P.+Santosauthor=J.+Blanzauthor=C.+D.+Obermaierauthor=C.+Strojnyauthor=J.+N.+Savasauthor=E.+Kiskinisauthor=X.+Zhuangauthor=R.+Kr%C3%BCgerauthor=D.+J.+Surmeierauthor=D.+Krainc&title=Dopamine+oxidation+mediates+mitochondrial+and+lysosomal+dysfunction+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.aam9080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease</span></div><div class="casAuthors">Burbulla, Lena F.; Song, Pingping; Mazzulli, Joseph R.; Zampese, Enrico; Wong, Yvette C.; Jeon, Sohee; Santos, David P.; Blanz, Judith; Obermaier, Carolin D.; Strojny, Chelsee; Savas, Jeffrey N.; Kiskinis, Evangelos; Zhuang, Xiaoxi; Krueger, Rejko; Surmeier, D. James; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6357</span>),
    <span class="NLM_cas:pages">1255-1261</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurodegeneration in Parkinson's disease (PD), but how these pathways are linked in human neurons remains unclear.  Here we studied dopaminergic neurons derived from patients with idiopathic and familial PD.  We identified a time-dependent pathol. cascade beginning with mitochondrial oxidant stress leading to oxidized dopamine accumulation and ultimately resulting in reduced glucocerebrosidase enzymic activity, lysosomal dysfunction, and α-synuclein accumulation.  This toxic cascade was obsd. in human, but not in mouse, PD neurons at least in part because of species-specific differences in dopamine metab.  Increasing dopamine synthesis or α-synuclein amts. in mouse midbrain neurons recapitulated pathol. phenotypes obsd. in human neurons.  Thus, dopamine oxidn. represents an important link between mitochondrial and lysosomal dysfunction in PD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrpNz9CE9s7Vg90H21EOLACvtfcHk0liy_GyQM5zHNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWhurfK&md5=1425c696c8a838b8f0d697f6b055fe2d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aam9080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aam9080%26sid%3Dliteratum%253Aachs%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DZampese%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DJeon%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DD.%2BP.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DObermaier%26aufirst%3DC.%2BD.%26aulast%3DStrojny%26aufirst%3DC.%26aulast%3DSavas%26aufirst%3DJ.%2BN.%26aulast%3DKiskinis%26aufirst%3DE.%26aulast%3DZhuang%26aufirst%3DX.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDopamine%2520oxidation%2520mediates%2520mitochondrial%2520and%2520lysosomal%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D1255%26epage%3D1261%26doi%3D10.1126%2Fscience.aam9080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uzair S.  Ismailani</span>, <span class="hlFld-ContribAuthor ">Maxime  Munch</span>, <span class="hlFld-ContribAuthor ">Braeden A.  Mair</span>, <span class="hlFld-ContribAuthor ">Benjamin H.  Rotstein</span>. </span><span class="cited-content_cbyCitation_article-title">Interrupted aza-Wittig reactions using iminophosphoranes to synthesize
              11
              C–carbonyls. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (43)
                                     , 5266-5269. <a href="https://doi.org/10.1039/D1CC01016F" title="DOI URL">https://doi.org/10.1039/D1CC01016F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC01016F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC01016F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DInterrupted%252Baza-Wittig%252Breactions%252Busing%252Biminophosphoranes%252Bto%252Bsynthesize%252B11%252BC%2525E2%252580%252593carbonyls%26aulast%3DIsmailani%26aufirst%3DUzair%2BS.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D43%26spage%3D5266%26epage%3D5269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriele  Bonaventura</span>, <span class="hlFld-ContribAuthor ">Rosario  Iemmolo</span>, <span class="hlFld-ContribAuthor ">Giuseppe Antonino  Attaguile</span>, <span class="hlFld-ContribAuthor ">Valentina  La Cognata</span>, <span class="hlFld-ContribAuthor ">Brigida Sabrina  Pistone</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Raudino</span>, <span class="hlFld-ContribAuthor ">Velia  D’Agata</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Cantarella</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Barcellona</span>, <span class="hlFld-ContribAuthor ">Sebastiano  Cavallaro</span>. </span><span class="cited-content_cbyCitation_article-title">iPSCs: A Preclinical Drug Research Tool for Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 4596. <a href="https://doi.org/10.3390/ijms22094596" title="DOI URL">https://doi.org/10.3390/ijms22094596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22094596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22094596%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DiPSCs%25253A%252BA%252BPreclinical%252BDrug%252BResearch%252BTool%252Bfor%252BNeurological%252BDisorders%26aulast%3DBonaventura%26aufirst%3DGabriele%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Christopher J.T.  Hyland</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Steven M.  Wales</span>, <span class="hlFld-ContribAuthor ">Grace E.O.  Constable</span>, <span class="hlFld-ContribAuthor ">Wesley J.  Olivier</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-membered rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 565-614. <a href="https://doi.org/10.1016/B978-0-323-89812-6.00016-X" title="DOI URL">https://doi.org/10.1016/B978-0-323-89812-6.00016-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-89812-6.00016-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-89812-6.00016-X%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-membered%252Brings%26aulast%3DMeyer%26aufirst%3DAdam%2BG.%26date%3D2021%26spage%3D565%26epage%3D614%26pub%3DElsevier%26date%3D2021%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khang H.  Trinh</span>, <span class="hlFld-ContribAuthor ">Khang X.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Phuc H.  Pham</span>, <span class="hlFld-ContribAuthor ">Tung T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Anh N. Q.  Phan</span>, <span class="hlFld-ContribAuthor ">Nam T. S.  Phan</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen peroxide-mediated synthesis of 2,4-substituted quinazolines
              via
              one-pot three-component reactions under metal-free conditions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (50)
                                     , 29900-29909. <a href="https://doi.org/10.1039/D0RA05040G" title="DOI URL">https://doi.org/10.1039/D0RA05040G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05040G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05040G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DHydrogen%252Bperoxide-mediated%252Bsynthesis%252Bof%252B2%25252C4-substituted%252Bquinazolines%252Bvia%252Bone-pot%252Bthree-component%252Breactions%252Bunder%252Bmetal-free%252Bconditions%26aulast%3DTrinh%26aufirst%3DKhang%2BH.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D50%26spage%3D29900%26epage%3D29909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Xiao</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Hui  Nie</span>, <span class="hlFld-ContribAuthor ">Ling-Bin  Kong</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Silver-catalyzed cascade reactions of 3-cyanochromone with 1,1-enediamines: synthesis of highly functionalized 2-(pyridin-3-yl)-chromeno[2,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (15)
                                     , 2035-2039. <a href="https://doi.org/10.1039/D0QO00388C" title="DOI URL">https://doi.org/10.1039/D0QO00388C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00388C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00388C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSilver-catalyzed%252Bcascade%252Breactions%252Bof%252B3-cyanochromone%252Bwith%252B1%25252C1-enediamines%25253A%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252B2-%252528pyridin-3-yl%252529-chromeno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DXiao%26aufirst%3DQiang%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D15%26spage%3D2035%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">My Lan  Tran</span>, <span class="hlFld-ContribAuthor ">Yves  Génisson</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Ballereau</span>, <span class="hlFld-ContribAuthor ">Cécile  Dehoux</span>. </span><span class="cited-content_cbyCitation_article-title">Second-Generation Pharmacological Chaperones: Beyond Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (14)
                                     , 3145. <a href="https://doi.org/10.3390/molecules25143145" title="DOI URL">https://doi.org/10.3390/molecules25143145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25143145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25143145%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSecond-Generation%252BPharmacological%252BChaperones%25253A%252BBeyond%252BInhibitors%26aulast%3DTran%26aufirst%3DMy%2BLan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D14%26spage%3D3145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nick  Marotta</span>, <span class="hlFld-ContribAuthor ">Soojin  Kim</span>, <span class="hlFld-ContribAuthor ">Dimitri  Krainc</span>. </span><span class="cited-content_cbyCitation_article-title">Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (4)
                                     , 427-441. <a href="https://doi.org/10.1080/17460441.2020.1703671" title="DOI URL">https://doi.org/10.1080/17460441.2020.1703671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1703671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1703671%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DOrganoid%252Band%252Bpluripotent%252Bstem%252Bcells%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bmodeling%25253A%252Ban%252Bexpert%252Bview%252Bon%252Btheir%252Bvalue%252Bto%252Bdrug%252Bdiscovery%26aulast%3DMarotta%26aufirst%3DNick%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D4%26spage%3D427%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clarissa  Valdez</span>, <span class="hlFld-ContribAuthor ">Daniel  Ysselstein</span>, <span class="hlFld-ContribAuthor ">Tiffany J  Young</span>, <span class="hlFld-ContribAuthor ">Jianbin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dimitri  Krainc</span>. </span><span class="cited-content_cbyCitation_article-title">Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2020,</strong> <em>29 </em>
                                    (5)
                                     , 716-726. <a href="https://doi.org/10.1093/hmg/ddz229" title="DOI URL">https://doi.org/10.1093/hmg/ddz229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddz229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddz229%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DProgranulin%252Bmutations%252Bresult%252Bin%252Bimpaired%252Bprocessing%252Bof%252Bprosaposin%252Band%252Breduced%252Bglucocerebrosidase%252Bactivity%26aulast%3DValdez%26aufirst%3DClarissa%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D5%26spage%3D716%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Paolini Paoletti</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Gaetani</span>, <span class="hlFld-ContribAuthor ">Lucilla  Parnetti</span>. </span><span class="cited-content_cbyCitation_article-title">The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 335. <a href="https://doi.org/10.3390/biom10020335" title="DOI URL">https://doi.org/10.3390/biom10020335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10020335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10020335%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DThe%252BChallenge%252Bof%252BDisease-Modifying%252BTherapies%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%25253A%252BRole%252Bof%252BCSF%252BBiomarkers%26aulast%3DPaolini%2BPaoletti%26aufirst%3DFederico%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  McCorvie</span>, <span class="hlFld-ContribAuthor ">Wyatt W.  Yue</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided discovery of pharmacological chaperones targeting protein conformational and misfolding diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 281-308. <a href="https://doi.org/10.1016/B978-0-12-819132-3.00013-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-819132-3.00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819132-3.00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819132-3.00013-0%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-guided%252Bdiscovery%252Bof%252Bpharmacological%252Bchaperones%252Btargeting%252Bprotein%252Bconformational%252Band%252Bmisfolding%252Bdiseases%26aulast%3DMcCorvie%26aufirst%3DThomas%2BJ.%26date%3D2020%26spage%3D281%26epage%3D308%26pub%3DElsevier%26atitle%3DProtein%252BHomeostasis%252BDiseases%26date%3D2020%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Ysselstein</span>, <span class="hlFld-ContribAuthor ">Maria  Nguyen</span>, <span class="hlFld-ContribAuthor ">Tiffany J.  Young</span>, <span class="hlFld-ContribAuthor ">Alex  Severino</span>, <span class="hlFld-ContribAuthor ">Michael  Schwake</span>, <span class="hlFld-ContribAuthor ">Kalpana  Merchant</span>, <span class="hlFld-ContribAuthor ">Dimitri  Krainc</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-13413-w" title="DOI URL">https://doi.org/10.1038/s41467-019-13413-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-13413-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-13413-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DLRRK2%252Bkinase%252Bactivity%252Bregulates%252Blysosomal%252Bglucocerebrosidase%252Bin%252Bneurons%252Bderived%252Bfrom%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bpatients%26aulast%3DYsselstein%26aufirst%3DDaniel%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of GCase inhibitors and activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Methyl Quinazoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) sulfolane (ii) PCl<sub>5</sub>; 46%; (b) R<sup>1</sup>NH<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF; 34–73%; (c) (i) NaH, DMF (ii) R<sup>2</sup>I; (d) R<sup>1</sup>R<sup>2</sup>NH, K<sub>2</sub>CO<sub>3</sub>, DMF; 33–96%; (e) RH, K<sub>2</sub>CO<sub>3</sub>, DMF; 26–89%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>11a–11i</b> with Modifications at the 2-Position of the Quinazoline Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-methyl-2-phenoxyethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF, 80%; (b) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O; 40–82%; (c) <i>N</i>-methyl-2-phenoxyethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF, 73%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. GCase enzyme activity switch by N-methylation of quinazoline derivatives. (A) Example of the change in activity by N-methylation; (B) plot demonstrating the change in activity from inhibition (<b>5a</b>) to activation (<b>6a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Modification of the N-substituent by oxygen replacement (<b>7a</b>) and N-methylation (<b>8a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activator <b>9q</b> increases GCase protein levels in (A) healthy control fibroblasts and (B) compound heterozygous <i>GBA1</i> mutant fibroblasts (N370S/84GG) derived from a GD patient. Cell lysates from fibroblasts treated with vehicle (DMSO), <b>9q</b> (5, 15 μM), or IFG were analyzed by immunoblotting after no digestion (top), Endo H digestion (middle), and PNGase F digestion (bottom); <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. GCase enzyme activity in cell lysates and in the lysosome of <b>9q</b>-treated cells. GCase activity was measured in lysates from (A) healthy control fibroblasts and (B) compound heterozygous <i>GBA1</i> mutant fibroblasts (N370S/84GG). Lysosomal GCase was measured using a live-cell assay in (C) healthy control, (D) homozygous N370S, and (E) homozygous L444P mutant fibroblasts after 3 day treatment with <b>9q</b> (5, 15 μM), 5 μM IFG, or vehicle (DMSO). The data are presented as the mean ± SEM, <i>n</i> = 3–4; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs vehicle treatments; one-way ANOVA was followed by the Tukey’s multiple comparisons post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activator <b>9q</b> increases GCase protein levels and enzyme activity in (A) wild-type control and (B) patient-derived heterozygous N370S <i>GBA1</i> mutant dopaminergic neurons at day 70 of differentiation. Cell lysates from neurons treated with vehicle (DMSO) or <b>9q</b> (5, 15 μM) for 10 consecutive days were analyzed by immunoblotting after no digestion (top), Endo H digestion (middle), and PNGase F digestion (bottom); <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/medium/jm-2018-01294p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. GCase enzyme activity in protein lysates of (A) wild-type control and (B) patient-derived heterozygous N370S <i>GBA1</i> mutant dopaminergic neurons after 10 days consecutive treatment with vehicle (DMSO) or <b>9q</b> (day 70 of differentiation). The data are presented as the mean ± SEM, <i>n</i> = 4–7; *<i>p</i> < 0.05, **<i>p</i> < 0,01 versus vehicle treatments; one-way ANOVA was followed by the Tukey’s multiple comparisons post hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01294/20190211/images/large/jm-2018-01294p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01294&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aharon-Peretz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershoni-Baruch, R.</span></span> <span> </span><span class="NLM_article-title">Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1056/nejmoa033277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1056%2Fnejmoa033277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=15525722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1Wksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=1972-1977&author=J.+Aharon-Peretzauthor=H.+Rosenbaumauthor=R.+Gershoni-Baruch&title=Mutations+in+the+glucocerebrosidase+gene+and+Parkinson%E2%80%99s+disease+in+Ashkenazi+Jews&doi=10.1056%2Fnejmoa033277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews</span></div><div class="casAuthors">Aharon-Peretz, Judith; Rosenbaum, Hanna; Gershoni-Baruch, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1972-1977</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND A clin. assocn. has been reported between type 1 Gaucher's disease, which is caused by a glucocerebrosidase deficiency owing to mutations in the glucocerebrosidase gene (GBA), and parkinsonism.  We examd. whether mutations in the GBA gene are relevant to idiopathic Parkinson's disease.  METHODS A clinic-based case series of 99 Ashkenazi patients with idiopathic Parkinson's disease, 74 Ashkenazi patients with Alzheimer's disease, and 1543 healthy Ashkenazi Jews who underwent testing to identify heterozygosity for certain recessive diseases were screened for the six GBA mutations (N370S, L444P, 84GG, IVS+1, V394L, and R496H) that are most common among Ashkenazi Jews.  RESULTS Thirty-one patients with Parkinson's disease (31.3 %; 95 % confidence interval, 22.2 to 40.4 %) had one or two mutant GBA alleles: 23 were heterozygous for N370S, 4 were heterozygous for 84GG, 3 were homozygous for N370S, and 1 was heterozygous for R496H.  Among the 74 patients with Alzheimer's disease, 3 were identified as carriers of Gaucher's disease (4.1 %; 95 % confidence interval, 0.0 to 8.5 %): 2 were heterozygous for N370S, and 1 was heterozygous for 84GG: Ninety-five carriers of Gaucher's disease were identified among the 1543 control subjects (6.2 %; 95 % confidence interval, 5.0 to 7.4 %): 92 were heterozygous for N370S, and 3 were heterozygous for 84GG.  Patients with Parkinson's disease had significantly greater odds of being carriers of Gaucher's disease than did patients with Alzheimer's disease (odds ratio, 10.8; 95 % confidence interval, 3.0 to 46.6; P<0.001) or control subjects (odds ratio, 7.0; 95 % confidence interval, 4.2 to 11.4; P<0.001).  Among the patients with Parkinson's disease, patients who were carriers of Gaucher's disease were younger than those who were not carriers (mean [±SD] age at onset, 60.0+14.2 years vs. 64.2+11.7 years; P=0.04).  CONCLUSIONS Our results suggest that heterozygosity for a GBA mutation may predispose Ashkenazi Jews to Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7EVcsaW69ybVg90H21EOLACvtfcHk0lg7Z1irRXIuzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1Wksbc%253D&md5=c2b26fc09659ef614ee7b7cdb17af86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa033277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa033277%26sid%3Dliteratum%253Aachs%26aulast%3DAharon-Peretz%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DH.%26aulast%3DGershoni-Baruch%26aufirst%3DR.%26atitle%3DMutations%2520in%2520the%2520glucocerebrosidase%2520gene%2520and%2520Parkinson%25E2%2580%2599s%2520disease%2520in%2520Ashkenazi%2520Jews%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D1972%26epage%3D1977%26doi%3D10.1056%2Fnejmoa033277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalls, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasly, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharon-Peretz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Shira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dürr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eblan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan-Or, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershoni-Baruch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giladi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Chen, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr-Urtreger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayebi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiano, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittstock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfsberg, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabetian, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S. G.</span></span> <span> </span><span class="NLM_article-title">Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1651</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1056/nejmoa0901281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1056%2Fnejmoa0901281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=19846850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1651-1661&author=E.+Sidranskyauthor=M.+A.+Nallsauthor=J.+O.+Aaslyauthor=J.+Aharon-Peretzauthor=G.+Annesiauthor=E.+R.+Barbosaauthor=A.+Bar-Shiraauthor=D.+Bergauthor=J.+Brasauthor=A.+Briceauthor=C.-M.+Chenauthor=L.+N.+Clarkauthor=C.+Condroyerauthor=E.+V.+De+Marcoauthor=A.+D%C3%BCrrauthor=M.+J.+Eblanauthor=S.+Fahnauthor=M.+J.+Farrerauthor=H.-C.+Fungauthor=Z.+Gan-Orauthor=T.+Gasserauthor=R.+Gershoni-Baruchauthor=N.+Giladiauthor=A.+Griffithauthor=T.+Gurevichauthor=C.+Januarioauthor=P.+Kroppauthor=A.+E.+Langauthor=G.-J.+Lee-Chenauthor=S.+Lesageauthor=K.+Marderauthor=I.+F.+Mataauthor=A.+Mirelmanauthor=J.+Mitsuiauthor=I.+Mizutaauthor=G.+Nicolettiauthor=C.+Oliveiraauthor=R.+Ottmanauthor=A.+Orr-Urtregerauthor=L.+V.+Pereiraauthor=A.+Quattroneauthor=E.+Rogaevaauthor=A.+Rolfsauthor=H.+Rosenbaumauthor=R.+Rozenbergauthor=A.+Samiiauthor=T.+Samaddarauthor=C.+Schulteauthor=M.+Sharmaauthor=A.+Singletonauthor=M.+Spitzauthor=E.-K.+Tanauthor=N.+Tayebiauthor=T.+Todaauthor=A.+R.+Troianoauthor=S.+Tsujiauthor=M.+Wittstockauthor=T.+G.+Wolfsbergauthor=Y.-R.+Wuauthor=C.+P.+Zabetianauthor=Y.+Zhaoauthor=S.+G.+Ziegler&title=Multicenter+analysis+of+glucocerebrosidase+mutations+in+Parkinson%E2%80%99s+disease&doi=10.1056%2Fnejmoa0901281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease</span></div><div class="casAuthors">Sidransky, E.; Nalls, M. A.; Aasly, J. O.; Aharon-Peretz, J.; Annesi, G.; Barbosa, E. R.; Bar-Shira, A.; Berg, D.; Bras, J.; Brice, A.; Chen, C.-M.; Clark, L. N.; Condroyer, C.; De Marco, E. V.; Duerr, A.; Eblan, M. J.; Fahn, S.; Farrer, M. J.; Fung, H.-C.; Gan-Or, Z.; Gasser, T.; Gershoni-Baruch, R.; Giladi, N.; Griffith, A.; Gurevich, T.; Januario, C.; Kropp, P.; Lang, A. E.; Lee-Chen, G.-J.; Lesage, S.; Marder, K.; Mata, I. F.; Mirelman, A.; Mitsui, J.; Mizuta, I.; Nicoletti, G.; Oliveira, C.; Ottman, R.; Orr-Urtreger, A.; Pereira, L. V.; Quattrone, A.; Rogaeva, E.; Rolfs, A.; Rosenbaum, H.; Rozenberg, R.; Samii, A.; Samaddar, T.; Schulte, C.; Sharma, M.; Singleton, A.; Spitz, M.; Tan, E.-K.; Tayebi, N.; Toda, T.; Troiano, A. R.; Tsuji, S.; Wittstock, M.; Wolfsberg, T. G.; Wu, Y.-R.; Zabetian, C. P.; Zhao, Y.; Ziegler, S. G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1651-1661</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Recent studies indicate an increased frequency of mutations in the gene encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among patients with Parkinson's disease.  We aimed to ascertain the frequency of GBA mutations in an ethnically diverse group of patients with Parkinson's disease.  METHODS Sixteen centers participated in our international, collaborative study: five from the Americas, six from Europe, two from Israel, and three from Asia.  Each center genotyped a std. DNA panel to permit comparison of the genotyping results across centers.  Genotypes and phenotypic data from a total of 5691 patients with Parkinson's disease (780 Ashkenazi Jews) and 4898 controls (387 Ashkenazi Jews) were analyzed, with multivariate logistic-regression models and the Mantel-Haenszel procedure used to est. odds ratios across centers.  RESULTS All 16 centers could detect two GBA mutations, L444P and N370S.  Among Ashkenazi Jewish subjects, either mutation was found in 15% of patients and 3% of controls, and among non-Ashkenazi Jewish subjects, either mutation was found in 3% of patients and less than 1% of controls.  GBA was fully sequenced for 1883 non-Ashkenazi Jewish patients, and mutations were identified in 7%, showing that limited mutation screening can miss half the mutant alleles.  The odds ratio for any GBA mutation in patients vs. controls was 5.43 across centers.  As compared with patients who did not carry a GBA mutation, those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were more likely to have atypical clin. manifestations.  CONCLUSIONS Data collected from 16 centers demonstrate that there is a strong assocn. between GBA mutations and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq63Clf93zPLrVg90H21EOLACvtfcHk0lghVHvWMihtDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgs77P&md5=5a309403069e28e93240b11b9a110c2e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa0901281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa0901281%26sid%3Dliteratum%253Aachs%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DAasly%26aufirst%3DJ.%2BO.%26aulast%3DAharon-Peretz%26aufirst%3DJ.%26aulast%3DAnnesi%26aufirst%3DG.%26aulast%3DBarbosa%26aufirst%3DE.%2BR.%26aulast%3DBar-Shira%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DBras%26aufirst%3DJ.%26aulast%3DBrice%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.-M.%26aulast%3DClark%26aufirst%3DL.%2BN.%26aulast%3DCondroyer%26aufirst%3DC.%26aulast%3DDe%2BMarco%26aufirst%3DE.%2BV.%26aulast%3DD%25C3%25BCrr%26aufirst%3DA.%26aulast%3DEblan%26aufirst%3DM.%2BJ.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DFung%26aufirst%3DH.-C.%26aulast%3DGan-Or%26aufirst%3DZ.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DGershoni-Baruch%26aufirst%3DR.%26aulast%3DGiladi%26aufirst%3DN.%26aulast%3DGriffith%26aufirst%3DA.%26aulast%3DGurevich%26aufirst%3DT.%26aulast%3DJanuario%26aufirst%3DC.%26aulast%3DKropp%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DLee-Chen%26aufirst%3DG.-J.%26aulast%3DLesage%26aufirst%3DS.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DMirelman%26aufirst%3DA.%26aulast%3DMitsui%26aufirst%3DJ.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DNicoletti%26aufirst%3DG.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DOttman%26aufirst%3DR.%26aulast%3DOrr-Urtreger%26aufirst%3DA.%26aulast%3DPereira%26aufirst%3DL.%2BV.%26aulast%3DQuattrone%26aufirst%3DA.%26aulast%3DRogaeva%26aufirst%3DE.%26aulast%3DRolfs%26aufirst%3DA.%26aulast%3DRosenbaum%26aufirst%3DH.%26aulast%3DRozenberg%26aufirst%3DR.%26aulast%3DSamii%26aufirst%3DA.%26aulast%3DSamaddar%26aufirst%3DT.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DSpitz%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DE.-K.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DToda%26aufirst%3DT.%26aulast%3DTroiano%26aufirst%3DA.%2BR.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DWittstock%26aufirst%3DM.%26aulast%3DWolfsberg%26aufirst%3DT.%2BG.%26aulast%3DWu%26aufirst%3DY.-R.%26aulast%3DZabetian%26aufirst%3DC.%2BP.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZiegler%26aufirst%3DS.%2BG.%26atitle%3DMulticenter%2520analysis%2520of%2520glucocerebrosidase%2520mutations%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1651%26epage%3D1661%26doi%3D10.1056%2Fnejmoa0901281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, A. H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olanow, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenamyre, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezard, E.</span></span> <span> </span><span class="NLM_article-title">Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(14)61010-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2FS0140-6736%2814%2961010-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=24954676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVanu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2014&pages=545-555&author=A.+H.+V.+Schapiraauthor=C.+W.+Olanowauthor=J.+T.+Greenamyreauthor=E.+Bezard&title=Slowing+of+neurodegeneration+in+Parkinson%E2%80%99s+disease+and+Huntington%E2%80%99s+disease%3A+future+therapeutic+perspectives&doi=10.1016%2Fs0140-6736%2814%2961010-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives</span></div><div class="casAuthors">Schapira, Anthony H. V.; Olanow, C. Warren; Greenamyre, J. Timothy; Bezard, Erwan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">9942</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease and Huntington's disease.  These advances have been informed by both direct anal. of the post-mortem brain and by study of the biol. consequences of the genetic causes of these diseases.  Some of the pathways that have been implicated so far include mitochondrial dysfunction, oxidative stress, kinase pathways, calcium dysregulation, inflammation, protein handling, and prion-like processes.  Intriguingly, these pathways seem to be important in the pathogenesis of both diseases and have led to the identification of mol. targets for candidate interventions designed to slow or reverse their course.  We review some recent advances that underlie putative therapies for neuroprotection in Parkinson's disease and Huntington's disease, and potential targets that might be exploited in the future.  Although we will need to overcome important hurdles, esp. in terms of clin. trial design, we propose several target pathways that merit further study.  In Parkinson's disease, these targets include agents that might improve mitochondrial function or increase degrdn. of defective mitochondria, kinase inhibitors, calcium channel blockers, and approaches that interfere with the misfolding, templating, and transmission of α-synuclein.  In Huntington's disease, strategies might also be directed at mitochondrial bioenergetics and turnover, the prevention of protein dysregulation, disruption of the interaction between huntingtin and p53 or huntingtin-interacting protein 1 to reduce apoptosis, and interference with expression of mutant huntingtin at both the nucleic acid and protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD0xsb-NEEXLVg90H21EOLACvtfcHk0ljpLWZqegd0DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVanu7jL&md5=06278a44eed0250df403002eecc7b51e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2814%2961010-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252814%252961010-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26aulast%3DBezard%26aufirst%3DE.%26atitle%3DSlowing%2520of%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520Huntington%25E2%2580%2599s%2520disease%253A%2520future%2520therapeutic%2520perspectives%26jtitle%3DLancet%26date%3D2014%26volume%3D384%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fs0140-6736%2814%2961010-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, G.</span></span> <span> </span><span class="NLM_article-title">The link between the GBA gene and parkinsonism</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70190-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fs1474-4422%2812%2970190-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=23079555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCqtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=986-998&author=E.+Sidranskyauthor=G.+Lopez&title=The+link+between+the+GBA+gene+and+parkinsonism&doi=10.1016%2Fs1474-4422%2812%2970190-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The link between the GBA gene and parkinsonism</span></div><div class="casAuthors">Sidransky, Ellen; Lopez, Grisel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">986-998</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Mutations in the glucocerebrosidase (GBA) gene, which encodes the lysosomal enzyme that is deficient in Gaucher's disease, are important and common risk factors for Parkinson's disease and related disorders.  This assocn. was first recognized in the clinic, where parkinsonism was noted, albeit rarely, in patients with Gaucher's disease and more frequently in relatives who were obligate carriers.  Subsequently, findings from large studies showed that patients with Parkinson's disease and assocd. Lewy body disorders had an increased frequency of GBA mutations when compared with control individuals.  Patients with GBA-assocd. parkinsonism exhibit varying parkinsonian phenotypes but tend to have an earlier age of onset and more assocd. cognitive changes than patients with parkinsonism without GBA mutations.  Hypotheses proposed to explain this assocn. include a gain-of-function due to mutations in glucocerebrosidase that promotes α-synuclein aggregation; substrate accumulation due to enzymic loss-of-function, which affects α-synuclein processing and clearance; and a bidirectional feedback loop.  Identification of the pathol. mechanisms underlying GBA-assocd. parkinsonism will improve our understanding of the genetics, pathophysiol., and treatment for both rare and common neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHlv_PqOQd-bVg90H21EOLACvtfcHk0ljpLWZqegd0DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCqtbnJ&md5=522c2d24e1e4f8e826a211991fe35df8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2812%2970190-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252812%252970190-4%26sid%3Dliteratum%253Aachs%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DG.%26atitle%3DThe%2520link%2520between%2520the%2520GBA%2520gene%2520and%2520parkinsonism%26jtitle%3DLancet%2520Neurol.%26date%3D2012%26volume%3D11%26spage%3D986%26epage%3D998%26doi%3D10.1016%2Fs1474-4422%2812%2970190-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M. J.</span></span> <span> </span><span class="NLM_article-title">Genetics and genomics of Parkinson’s disease</span>. <i>Genome Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/gm566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1186%2Fgm566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=25061481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=M.+K.+Linauthor=M.+J.+Farrer&title=Genetics+and+genomics+of+Parkinson%E2%80%99s+disease&doi=10.1186%2Fgm566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and genomics of Parkinson's disease</span></div><div class="casAuthors">Lin Michelle K; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Genome medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn">1756-994X</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is a progressively debilitating neurodegenerative syndrome.  Although best described as a movement disorder, the condition has prominent autonomic, cognitive, psychiatric, sensory and sleep components.  Striatal dopaminergic innervation and nigral neurons are progressively lost, with associated Lewy pathology readily apparent on autopsy.  Nevertheless, knowledge of the molecular events leading to this pathophysiology is limited.  Current therapies offer symptomatic benefit but they fail to slow progression and patients continue to deteriorate.  Recent discoveries in sporadic, Mendelian and more complex forms of parkinsonism provide novel insight into disease etiology; 28 genes, including those encoding alpha-synuclein (SNCA), leucine-rich repeat kinase 2 (LRRK2) and microtubule-associated protein tau (MAPT), have been linked and/or associated with PD.  A consensus regarding the affected biological pathways and molecular processes has also started to emerge.  In early-onset and more a typical PD, deficits in mitophagy pathways and lysosomal function appear to be prominent.  By contrast, in more typical late-onset PD, chronic, albeit subtle, dysfunction in synaptic transmission, early endosomal trafficking and receptor recycling, as well as chaperone-mediated autophagy, provide a unifying synthesis of the molecular pathways involved.  Disease-modification (neuroprotection) is no longer such an elusive goal given the unparalleled opportunity for diagnosis, translational neuroscience and therapeutic development provided by genetic discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZ98nLXyY0xUNoizSOkG_FfW6udTcc2ea3pAvqa83Lv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D&md5=2812917436574ba10ba7170d48bf4eb4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fgm566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgm566%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DGenetics%2520and%2520genomics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DGenome%2520Med.%26date%3D2014%26volume%3D6%26spage%3D48%26doi%3D10.1186%2Fgm566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawkar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Nonlinear partial differential equations and applications: Chemical chaperones increase the cellular activity of N370S β-glucosidase: A therapeutic strategy for Gaucher disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">15428</span>– <span class="NLM_lpage">15433</span>, <span class="refDoi"> DOI: 10.1073/pnas.192582899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.192582899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15428-15433&author=A.+R.+Sawkarauthor=W.-C.+Chengauthor=E.+Beutlerauthor=C.-H.+Wongauthor=W.+E.+Balchauthor=J.+W.+Kelly&title=Nonlinear+partial+differential+equations+and+applications%3A+Chemical+chaperones+increase+the+cellular+activity+of+N370S+%CE%B2-glucosidase%3A+A+therapeutic+strategy+for+Gaucher+disease&doi=10.1073%2Fpnas.192582899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192582899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192582899%26sid%3Dliteratum%253Aachs%26aulast%3DSawkar%26aufirst%3DA.%2BR.%26aulast%3DCheng%26aufirst%3DW.-C.%26aulast%3DBeutler%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DNonlinear%2520partial%2520differential%2520equations%2520and%2520applications%253A%2520Chemical%2520chaperones%2520increase%2520the%2520cellular%2520activity%2520of%2520N370S%2520%25CE%25B2-glucosidase%253A%2520A%2520therapeutic%2520strategy%2520for%2520Gaucher%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D15428%26epage%3D15433%26doi%3D10.1073%2Fpnas.192582899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, G. A.</span></span> <span> </span><span class="NLM_article-title">Phenotype, diagnosis, and treatment of Gaucher’s disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">1263</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(08)61522-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fs0140-6736%2808%2961522-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=19094956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2ku7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=1263-1271&author=G.+A.+Grabowski&title=Phenotype%2C+diagnosis%2C+and+treatment+of+Gaucher%E2%80%99s+disease&doi=10.1016%2Fs0140-6736%2808%2961522-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotype, diagnosis, and treatment of Gaucher's disease</span></div><div class="casAuthors">Grabowski, Gregory A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9645</span>),
    <span class="NLM_cas:pages">1263-1271</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Gaucher's disease continues to be a model for applications of mol. medicine to clin. delineation, diagnosis, and treatment.  Analyses of several thousand affected individuals have broadened the range of the pan-ethnic disease variants, provided initial genotype and phenotype correlations, and established the effectiveness of enzyme therapy.  Large nos. of affected individuals worldwide have provided insight into the effect of disease variation related to ethnic origin, prognosis, and outcome.  The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacol. chaperone strategies.  Such innovations could provide interventions that are effective for neuronopathic variants and, potentially, could be more cost effective than other treatments.  These developments are novel, clin. important, advancements for patients with other lysosomal storage diseases and genetic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UO6xuFQQO7Vg90H21EOLACvtfcHk0lgM9gmeYQ3e9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2ku7nP&md5=78f8052baf74c448ecff494b66b4d06d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2808%2961522-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252808%252961522-6%26sid%3Dliteratum%253Aachs%26aulast%3DGrabowski%26aufirst%3DG.%2BA.%26atitle%3DPhenotype%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520Gaucher%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D1263%26epage%3D1271%26doi%3D10.1016%2Fs0140-6736%2808%2961522-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, D.</span></span> <span> </span><span class="NLM_article-title">Gaucher disease and its treatment options</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1177/1060028013500469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1177%2F1060028013500469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2013&pages=1182-1193&author=L.+L.+Bennettauthor=D.+Mohan&title=Gaucher+disease+and+its+treatment+options&doi=10.1177%2F1060028013500469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1177%2F1060028013500469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028013500469%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DL.%2BL.%26aulast%3DMohan%26aufirst%3DD.%26atitle%3DGaucher%2520disease%2520and%2520its%2520treatment%2520options%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2013%26volume%3D47%26spage%3D1182%26epage%3D1193%26doi%3D10.1177%2F1060028013500469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.cell.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=21700325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=37-52&author=J.+R.+Mazzulliauthor=Y.-H.+Xuauthor=Y.+Sunauthor=A.+L.+Knightauthor=P.+J.+McLeanauthor=G.+A.+Caldwellauthor=E.+Sidranskyauthor=G.+A.+Grabowskiauthor=D.+Krainc&title=Gaucher+disease+glucocerebrosidase+and+%CE%B1-synuclein+form+a+bidirectional+pathogenic+loop+in+synucleinopathies&doi=10.1016%2Fj.cell.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies</span></div><div class="casAuthors">Mazzulli, Joseph R.; Xu, You-Hai; Sun, Ying; Knight, Adam L.; McLean, Pamela J.; Caldwell, Guy A.; Sidransky, Ellen; Grabowski, Gregory A.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Parkinson's disease (PD), an adult neurodegenerative disorder, has been clin. linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known.  Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degrdn., causes accumulation of α-synuclein (α-syn), and results in neurotoxicity through aggregation-dependent mechanisms.  Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified α-syn by stabilizing sol. oligomeric intermediates.  We further demonstrate that α-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies.  These findings suggest that the bidirectional effect of α-syn and GCase forms a pos. feedback loop that may lead to a self-propagating disease.  Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2Uua6ozAKLVg90H21EOLACvtfcHk0lgM9gmeYQ3e9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslCksrk%253D&md5=03172d302518c8ca4f788a6207a37291</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DXu%26aufirst%3DY.-H.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DKnight%26aufirst%3DA.%2BL.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DGrabowski%26aufirst%3DG.%2BA.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DGaucher%2520disease%2520glucocerebrosidase%2520and%2520%25CE%25B1-synuclein%2520form%2520a%2520bidirectional%2520pathogenic%2520loop%2520in%2520synucleinopathies%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.cell.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sardi, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamsett, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treleaven, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shihabuddin, L. S.</span></span> <span> </span><span class="NLM_article-title">Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3537</span>– <span class="NLM_lpage">3542</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220464110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.1220464110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=23297226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3537-3542&author=S.+P.+Sardiauthor=J.+Clarkeauthor=C.+Vielauthor=M.+Chanauthor=T.+J.+Tamsettauthor=C.+M.+Treleavenauthor=J.+Buauthor=L.+Sweetauthor=M.+A.+Passiniauthor=J.+C.+Dodgeauthor=W.+H.+Yuauthor=R.+L.+Sidmanauthor=S.+H.+Chengauthor=L.+S.+Shihabuddin&title=Augmenting+CNS+glucocerebrosidase+activity+as+a+therapeutic+strategy+for+parkinsonism+and+other+Gaucher-related+synucleinopathies&doi=10.1073%2Fpnas.1220464110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies</span></div><div class="casAuthors">Sardi, S. Pablo; Clarke, Jennifer; Viel, Catherine; Chan, Monyrath; Tamsett, Thomas J.; Treleaven, Christopher M.; Bu, Jie; Sweet, Lindsay; Passini, Marco A.; Dodge, James C.; Yu, W. Haung; Sidman, Richard L.; Cheng, Seng H.; Shihabuddin, Lamya S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3537-3542, S3537/1-S3537/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations of GBA1, the gene encoding glucocerebrosidase, represent a common genetic risk factor for developing the synucleinopathies Parkinson disease (PD) and dementia with Lewy bodies.  PD patients with or without GBA1 mutations also exhibit lower enzymic levels of glucocerebrosidase in the central nervous system (CNS), suggesting a possible link between the enzyme and the development of the disease.  Previously, we have shown that early treatment with glucocerebrosidase can modulate α-synuclein aggregation in a presymptomatic mouse model of Gaucher-related synucleinopathy (Gba1D409V/D409V) and ameliorate the assocd. cognitive deficit.  To probe this link further, we have now evaluated the efficacy of augmenting glucocerebrosidase activity in the CNS of symptomatic Gba1D409V/D409V mice and in a transgenic mouse model overexpressing A53T α-synuclein.  Adeno-assocd. virus-mediated expression of glucocerebrosidase in the CNS of symptomatic Gba1D409V/D409V mice completely cor. the aberrant accumulation of the toxic lipid glucosylsphingosine and reduced the levels of ubiquitin, tau, and proteinase K-resistant α-synuclein aggregates.  Importantly, hippocampal expression of glucocerebrosidase in Gba1D409V/D409V mice (starting at 4 or 12 mo of age) also reversed their cognitive impairment when examd. using a novel object recognition test.  Correspondingly, overexpression of glucocerebrosidase in the CNS of A53T α-synuclein mice reduced the levels of sol. α-synuclein, suggesting that increasing the glycosidase activity can modulate α-synuclein processing and may modulate the progression of α-synucleinopathies.  Hence, increasing glucocerebrosidase activity in the CNS represents a potential therapeutic strategy for GBA1-related and non-GBA1-assocd. synucleinopathies, including PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3A7pMjY6NM7Vg90H21EOLACvtfcHk0lgM9gmeYQ3e9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyntrc%253D&md5=5735e718c200156d42b53319fbc95121</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220464110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220464110%26sid%3Dliteratum%253Aachs%26aulast%3DSardi%26aufirst%3DS.%2BP.%26aulast%3DClarke%26aufirst%3DJ.%26aulast%3DViel%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DM.%26aulast%3DTamsett%26aufirst%3DT.%2BJ.%26aulast%3DTreleaven%26aufirst%3DC.%2BM.%26aulast%3DBu%26aufirst%3DJ.%26aulast%3DSweet%26aufirst%3DL.%26aulast%3DPassini%26aufirst%3DM.%2BA.%26aulast%3DDodge%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DSidman%26aufirst%3DR.%2BL.%26aulast%3DCheng%26aufirst%3DS.%2BH.%26aulast%3DShihabuddin%26aufirst%3DL.%2BS.%26atitle%3DAugmenting%2520CNS%2520glucocerebrosidase%2520activity%2520as%2520a%2520therapeutic%2520strategy%2520for%2520parkinsonism%2520and%2520other%2520Gaucher-related%2520synucleinopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D3537%26epage%3D3542%26doi%3D10.1073%2Fpnas.1220464110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sybertz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Development of targeted therapies for Parkinson’s disease and related synucleinopathies</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1996</span>– <span class="NLM_lpage">2003</span>, <span class="refDoi"> DOI: 10.1194/jlr.r047381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1194%2Fjlr.r047381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1996-2003&author=E.+Sybertzauthor=D.+Krainc&title=Development+of+targeted+therapies+for+Parkinson%E2%80%99s+disease+and+related+synucleinopathies&doi=10.1194%2Fjlr.r047381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1194%2Fjlr.r047381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.r047381%26sid%3Dliteratum%253Aachs%26aulast%3DSybertz%26aufirst%3DE.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520targeted%2520therapies%2520for%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520related%2520synucleinopathies%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1996%26epage%3D2003%26doi%3D10.1194%2Fjlr.r047381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goker-Alpan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarca, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span> <span> </span><span class="NLM_article-title">Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">13192</span>– <span class="NLM_lpage">13197</span>, <span class="refDoi"> DOI: 10.1073/pnas.0705637104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.0705637104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=17670938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13192-13197&author=W.+Zhengauthor=J.+Padiaauthor=D.+J.+Urbanauthor=A.+Jadhavauthor=O.+Goker-Alpanauthor=A.+Simeonovauthor=E.+Goldinauthor=D.+Auldauthor=M.+E.+LaMarcaauthor=J.+Ingleseauthor=C.+P.+Austinauthor=E.+Sidransky&title=Three+classes+of+glucocerebrosidase+inhibitors+identified+by+quantitative+high-throughput+screening+are+chaperone+leads+for+Gaucher+disease&doi=10.1073%2Fpnas.0705637104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease</span></div><div class="casAuthors">Zheng, Wei; Padia, Janak; Urban, Daniel J.; Jadhav, Ajit; Goker-Alpan, Ozlem; Simeonov, Anton; Goldin, Ehud; Auld, Douglas; LaMarca, Mary E.; Inglese, James; Austin, Christopher P.; Sidransky, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13192-13197, S13192/1-S13192/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gaucher disease is an autosomal recessive lysosomal storage disorder caused by mutations in the glucocerebrosidase gene.  Missense mutations result in reduced enzyme activity that may be due to misfolding, raising the possibility of small-mol. chaperone correction of the defect.  Screening large compd. libraries by quant. high-throughput screening (qHTS) provides comprehensive information on the potency, efficacy, and structure-activity relationships (SAR) of active compds. directly from the primary screen, facilitating identification of leads for medicinal chem. optimization.  We used qHTS to rapidly identify three structural series of potent, selective, nonsugar glucocerebrosidase inhibitors.  The three structural classes had excellent potencies and efficacies and, importantly, high selectivity against closely related hydrolases.  Preliminary SAR data were used to select compds. with high activity in both enzyme and cell-based assays.  Compds. from two of these structural series increased N370S mutant glucocerebrosidase activity by 40 - 90% in patient cell lines and enhanced lysosomal colocalization, indicating chaperone activity.  These small mols. have potential as leads for chaperone therapy for Gaucher disease, and this paradigm promises to accelerate the development of leads for other rare genetic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQME0eO7kg7Vg90H21EOLACvtfcHk0ljl_ZU9Hp8ebQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Gmsr0%253D&md5=78aa269b58404b3324a1099f8efd3628</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705637104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705637104%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DGoker-Alpan%26aufirst%3DO.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DAuld%26aufirst%3DD.%26aulast%3DLaMarca%26aufirst%3DM.%2BE.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DSidransky%26aufirst%3DE.%26atitle%3DThree%2520classes%2520of%2520glucocerebrosidase%2520inhibitors%2520identified%2520by%2520quantitative%2520high-throughput%2520screening%2520are%2520chaperone%2520leads%2520for%2520Gaucher%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D13192%26epage%3D13197%26doi%3D10.1073%2Fpnas.0705637104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubblefield, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aungst, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1058</span>, <span class="refDoi"> DOI: 10.1021/jm1008902</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1008902" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1033-1058&author=J.+J.+Maruganauthor=W.+Zhengauthor=O.+Motabarauthor=N.+Southallauthor=E.+Goldinauthor=W.+Westbroekauthor=B.+K.+Stubblefieldauthor=E.+Sidranskyauthor=R.+A.+Aungstauthor=W.+A.+Leaauthor=A.+Simeonovauthor=W.+Leisterauthor=C.+P.+Austin&title=Evaluation+of+quinazoline+analogues+as+glucocerebrosidase+inhibitors+with+chaperone+activity&doi=10.1021%2Fjm1008902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm1008902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008902%26sid%3Dliteratum%253Aachs%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DStubblefield%26aufirst%3DB.%2BK.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DAungst%26aufirst%3DR.%2BA.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26atitle%3DEvaluation%2520of%2520quinazoline%2520analogues%2520as%2520glucocerebrosidase%2520inhibitors%2520with%2520chaperone%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1033%26epage%3D1058%26doi%3D10.1021%2Fjm1008902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBernardi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span> <span> </span><span class="NLM_article-title">Non-iminosugar glucocerebrosidase small molecule chaperones</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1039/c1md00200g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1039%2Fc1md00200g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=56-60&author=J.+J.+Maruganauthor=W.+Huangauthor=O.+Motabarauthor=W.+Zhengauthor=J.+Xiaoauthor=S.+Patnaikauthor=N.+Southallauthor=W.+Westbroekauthor=W.+A.+Leaauthor=A.+Simeonovauthor=E.+Goldinauthor=M.+A.+DeBernardiauthor=E.+Sidransky&title=Non-iminosugar+glucocerebrosidase+small+molecule+chaperones&doi=10.1039%2Fc1md00200g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc1md00200g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00200g%26sid%3Dliteratum%253Aachs%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DDeBernardi%26aufirst%3DM.%2BA.%26aulast%3DSidransky%26aufirst%3DE.%26atitle%3DNon-iminosugar%2520glucocerebrosidase%2520small%2520molecule%2520chaperones%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D56%26epage%3D60%26doi%3D10.1039%2Fc1md00200g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tropak, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhaber, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuske, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahuran, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on β-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2662</span>, <span class="refDoi"> DOI: 10.1002/cbic.200800304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1002%2Fcbic.200800304" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2650-2662&author=M.+B.+Tropakauthor=G.+J.+Kornhaberauthor=B.+A.+Rigatauthor=G.+H.+Maegawaauthor=J.+D.+Buttnerauthor=J.+E.+Blanchardauthor=C.+Murphyauthor=S.+J.+Tuskeauthor=S.+J.+Coalesauthor=Y.+Hamuroauthor=E.+D.+Brownauthor=D.+J.+Mahuran&title=Identification+of+pharmacological+chaperones+for+Gaucher+disease+and+characterization+of+their+effects+on+%CE%B2-glucocerebrosidase+by+hydrogen%2Fdeuterium+exchange+mass+spectrometry&doi=10.1002%2Fcbic.200800304"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800304%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DBlanchard%26aufirst%3DJ.%2BE.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DTuske%26aufirst%3DS.%2BJ.%26aulast%3DCoales%26aufirst%3DS.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520pharmacological%2520chaperones%2520for%2520Gaucher%2520disease%2520and%2520characterization%2520of%2520their%2520effects%2520on%2520%25CE%25B2-glucocerebrosidase%2520by%2520hydrogen%252Fdeuterium%2520exchange%2520mass%2520spectrometry%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2650%26epage%3D2662%26doi%3D10.1002%2Fcbic.200800304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5783</span>– <span class="NLM_lpage">5789</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.08.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.bmcl.2007.08.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=17827006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSit7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5783-5789&author=W.+Huangauthor=W.+Zhengauthor=D.+J.+Urbanauthor=J.+Ingleseauthor=E.+Sidranskyauthor=C.+P.+Austinauthor=C.+J.+Thomas&title=N4-phenyl+modifications+of+N2-%282-hydroxyl%29ethyl-6-%28pyrrolidin-1-yl%29-1%2C3%2C5-triazine-2%2C4-diamines+enhance+glucocerebrosidase+inhibition+by+small+molecules+with+potential+as+chemical+chaperones+for+Gaucher+disease&doi=10.1016%2Fj.bmcl.2007.08.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease</span></div><div class="casAuthors">Huang, Wenwei; Zheng, Wei; Urban, Daniel J.; Inglese, James; Sidransky, Ellen; Austin, Christopher P.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5783-5789</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 1,3,5-triazine-2,4,6-triamines were prepd. and analyzed as inhibitors of glucocerebrosidase.  Synthesis, structure activity relationships and the selectivity of chosen analogs against related sugar hydrolases enzymes are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5lbmm0Aa1arVg90H21EOLACvtfcHk0lj2injbED6GaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSit7rF&md5=d1d66009fdbc3ab7d79ace982c81ff7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.08.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DUrban%26aufirst%3DD.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DN4-phenyl%2520modifications%2520of%2520N2-%25282-hydroxyl%2529ethyl-6-%2528pyrrolidin-1-yl%2529-1%252C3%252C5-triazine-2%252C4-diamines%2520enhance%2520glucocerebrosidase%2520inhibition%2520by%2520small%2520molecules%2520with%2520potential%2520as%2520chemical%2520chaperones%2520for%2520Gaucher%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5783%26epage%3D5789%26doi%3D10.1016%2Fj.bmcl.2007.08.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motabar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbroek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velayati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5734</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1021/jm300063b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300063b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5734-5748&author=S.+Patnaikauthor=W.+Zhengauthor=J.+H.+Choiauthor=O.+Motabarauthor=N.+Southallauthor=W.+Westbroekauthor=W.+A.+Leaauthor=A.+Velayatiauthor=E.+Goldinauthor=E.+Sidranskyauthor=W.+Leisterauthor=J.+J.+Marugan&title=Discovery%2C+structure-activity+relationship%2C+and+biological+evaluation+of+noninhibitory+small+molecule+chaperones+of+glucocerebrosidase&doi=10.1021%2Fjm300063b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300063b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300063b%26sid%3Dliteratum%253Aachs%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DMotabar%26aufirst%3DO.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DWestbroek%26aufirst%3DW.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DVelayati%26aufirst%3DA.%26aulast%3DGoldin%26aufirst%3DE.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520biological%2520evaluation%2520of%2520noninhibitory%2520small%2520molecule%2520chaperones%2520of%2520glucocerebrosidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5734%26epage%3D5748%26doi%3D10.1021%2Fjm300063b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbulla, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sue, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Activation of β-glucocerebrosidase reduces pathological α-synuclein and restores lysosomal function in Parkinson's patient midbrain neurons</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7693</span>– <span class="NLM_lpage">7706</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.0628-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1523%2Fjneurosci.0628-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=27445146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=7693-7706&author=J.+R.+Mazzulliauthor=F.+Zunkeauthor=T.+Tsunemiauthor=N.+J.+Tokerauthor=S.+Jeonauthor=L.+F.+Burbullaauthor=S.+Patnaikauthor=E.+Sidranskyauthor=J.+J.+Maruganauthor=C.+M.+Sueauthor=D.+Krainc&title=Activation+of+%CE%B2-glucocerebrosidase+reduces+pathological+%CE%B1-synuclein+and+restores+lysosomal+function+in+Parkinson%27s+patient+midbrain+neurons&doi=10.1523%2Fjneurosci.0628-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of β-glucocerebrosidase reduces pathological α-synuclein and restores lysosomal function in parkinson's patient midbrain neurons</span></div><div class="casAuthors">Mazzulli, Joseph R.; Zunke, Friederike; Tsunemi, Taiji; Toker, Nicholas J.; Jeon, Sohee; Burbulla, Lena F.; Patnaik, Samarjit; Sidransky, Ellen; Marugan, Juan J.; Sue, Carolyn M.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7693-7706</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by the accumulation of α-synuclein (α-syn) within Lewy body inclusions in the nervous system.  There are currently no disease-modifying therapies capable of reducing α-syn inclusions in PD.  Recent data has indicated that loss-of-function mutations in the GBA1 gene that encodes lysosomal β-glucocerebrosidase (GCase) represent an important risk factor for PD, and can lead to α-syn accumulation.  Here we use a small-mol. modulator of GCase to det. whether GCase activation within lysosomes can reduce α-syn levels and ameliorate downstream toxicity.  Using induced pluripotent stem cell (iPSC)-derived human midbrain dopamine (DA) neurons from synucleinopathy patients with different PD-linked mutations, we find that a non-inhibitory small mol. modulator of GCase specifically enhanced activity within lysosomal compartments.  This resulted in redn. of GCase substrates and clearance of pathol. α-syn, regardless of the disease causing mutations.  Importantly, the redn. of α-syn was sufficient to reverse downstream cellular pathologies induced by α-syn, including perturbations in hydrolase maturation and lysosomal dysfunction.  These results indicate that enhancement of a single lysosomal hydrolase, GCase, can effectively reduce α-syn and provide therapeutic benefit in human midbrain neurons.  This suggests that GCase activators may prove beneficial as treatments for PD and related synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpohFsjVOGt-7Vg90H21EOLACvtfcHk0ljSOUMp0DJrSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWks7%252FM&md5=a69d50297698c71db413c0af99d07003</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.0628-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.0628-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DZunke%26aufirst%3DF.%26aulast%3DTsunemi%26aufirst%3DT.%26aulast%3DToker%26aufirst%3DN.%2BJ.%26aulast%3DJeon%26aufirst%3DS.%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSidransky%26aufirst%3DE.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DSue%26aufirst%3DC.%2BM.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DActivation%2520of%2520%25CE%25B2-glucocerebrosidase%2520reduces%2520pathological%2520%25CE%25B1-synuclein%2520and%2520restores%2520lysosomal%2520function%2520in%2520Parkinson%2527s%2520patient%2520midbrain%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26spage%3D7693%26epage%3D7706%26doi%3D10.1523%2Fjneurosci.0628-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent quinazolines as selective β-glucocerebrosidase modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8508</span>– <span class="NLM_lpage">8520</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGjtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8508-8520&author=J.+Zhengauthor=L.+Chenauthor=M.+Schwakeauthor=R.+B.+Silvermanauthor=D.+Krainc&title=Design+and+synthesis+of+potent+quinazolines+as+selective+%CE%B2-glucocerebrosidase+modulators&doi=10.1021%2Facs.jmedchem.6b00930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators</span></div><div class="casAuthors">Zheng, Jianbin; Chen, Long; Schwake, Michael; Silverman, Richard B.; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8508-8520</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gaucher's disease is a common genetic disease caused by mutations in the β-glucocerebrosidase (GBA1) gene that have been also linked to increased risk of Parkinson's disease and Lewy body dementia.  Stabilization of misfolded mutant β-glucocerebrosidase (GCase) represents an important therapeutic strategy in synucleinopathies.  Here we report a novel class of GCase quinazoline inhibitors, obtained in a high throughput screening, with moderate potency against wild-type GCase.  Rational design and a SAR study of this class of compds. led to a new series of quinazoline derivs. with single-digit nanomolar potency.  These compds. were shown to selectively stabilize GCase when compared to other lysosomal enzymes and to increase N370S mutant GCase protein concn. and activity in cell assays.  To the best of our knowledge, these mols. are the most potent noniminosugar GCase modulators to date that may prove useful for future mechanistic studies and therapeutic approaches in Gaucher's and Parkinson's diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3P9w1W1rwPbVg90H21EOLACvtfcHk0ljSOUMp0DJrSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGjtrbM&md5=007e764b27dc604eac179ae85cc33311</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00930%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSchwake%26aufirst%3DM.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520quinazolines%2520as%2520selective%2520%25CE%25B2-glucocerebrosidase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8508%26epage%3D8520%26doi%3D10.1021%2Facs.jmedchem.6b00930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Storz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoagland, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisardi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollywood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, G.</span></span> <span> </span><span class="NLM_article-title">Convenient and practical one-pot synthesis of 4-chloropyrimidines via a novel chloroimidate annulation</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/op1002352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op1002352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=918-924&author=T.+Storzauthor=R.+Heidauthor=J.+Zeldisauthor=S.+M.+Hoaglandauthor=V.+Rapisardiauthor=S.+Hollywoodauthor=G.+Morton&title=Convenient+and+practical+one-pot+synthesis+of+4-chloropyrimidines+via+a+novel+chloroimidate+annulation&doi=10.1021%2Fop1002352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fop1002352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1002352%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DT.%26aulast%3DHeid%26aufirst%3DR.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DHoagland%26aufirst%3DS.%2BM.%26aulast%3DRapisardi%26aufirst%3DV.%26aulast%3DHollywood%26aufirst%3DS.%26aulast%3DMorton%26aufirst%3DG.%26atitle%3DConvenient%2520and%2520practical%2520one-pot%2520synthesis%2520of%25204-chloropyrimidines%2520via%2520a%2520novel%2520chloroimidate%2520annulation%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D918%26epage%3D924%26doi%3D10.1021%2Fop1002352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ysselstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansbury, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerlj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrosek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heunisch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">β-Glucocerebrosidase modulators promote dimerization of β-glucocerebrosidase and reveal an allosteric binding site</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">5914</span>– <span class="NLM_lpage">5924</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b13003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b13003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=5914-5924&author=J.+Zhengauthor=L.+Chenauthor=O.+S.+Skinnerauthor=D.+Ysselsteinauthor=J.+Remisauthor=P.+Lansburyauthor=R.+Skerljauthor=M.+Mrosekauthor=U.+Heunischauthor=S.+Krappauthor=J.+Charrowauthor=M.+Schwakeauthor=N.+L.+Kelleherauthor=R.+B.+Silvermanauthor=D.+Krainc&title=%CE%B2-Glucocerebrosidase+modulators+promote+dimerization+of+%CE%B2-glucocerebrosidase+and+reveal+an+allosteric+binding+site&doi=10.1021%2Fjacs.7b13003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b13003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b13003%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSkinner%26aufirst%3DO.%2BS.%26aulast%3DYsselstein%26aufirst%3DD.%26aulast%3DRemis%26aufirst%3DJ.%26aulast%3DLansbury%26aufirst%3DP.%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DMrosek%26aufirst%3DM.%26aulast%3DHeunisch%26aufirst%3DU.%26aulast%3DKrapp%26aufirst%3DS.%26aulast%3DCharrow%26aufirst%3DJ.%26aulast%3DSchwake%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DN.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3D%25CE%25B2-Glucocerebrosidase%2520modulators%2520promote%2520dimerization%2520of%2520%25CE%25B2-glucocerebrosidase%2520and%2520reveal%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D5914%26epage%3D5924%26doi%3D10.1021%2Fjacs.7b13003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zunke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothaug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwake, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3791</span>– <span class="NLM_lpage">3796</span>, <span class="refDoi"> DOI: 10.1073/pnas.1514005113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1073%2Fpnas.1514005113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=3791-3796&author=F.+Zunkeauthor=L.+Andresenauthor=S.+Wesselerauthor=J.+Grothauthor=P.+Arnoldauthor=M.+Rothaugauthor=J.+R.+Mazzulliauthor=D.+Kraincauthor=J.+Blanzauthor=P.+Saftigauthor=M.+Schwake&title=Characterization+of+the+complex+formed+by+%CE%B2-glucocerebrosidase+and+the+lysosomal+integral+membrane+protein+type-2&doi=10.1073%2Fpnas.1514005113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1514005113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1514005113%26sid%3Dliteratum%253Aachs%26aulast%3DZunke%26aufirst%3DF.%26aulast%3DAndresen%26aufirst%3DL.%26aulast%3DWesseler%26aufirst%3DS.%26aulast%3DGroth%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DP.%26aulast%3DRothaug%26aufirst%3DM.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSchwake%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520complex%2520formed%2520by%2520%25CE%25B2-glucocerebrosidase%2520and%2520the%2520lysosomal%2520integral%2520membrane%2520protein%2520type-2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3D3791%26epage%3D3796%26doi%3D10.1073%2Fpnas.1514005113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0lgLhHeSWs8Rqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seibler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziotto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simunovic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">5970</span>– <span class="NLM_lpage">5976</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4441-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1523%2Fjneurosci.4441-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=21508222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5970-5976&author=P.+Seiblerauthor=J.+Graziottoauthor=H.+Jeongauthor=F.+Simunovicauthor=C.+Kleinauthor=D.+Krainc&title=Mitochondrial+Parkin+recruitment+is+impaired+in+neurons+derived+from+mutant+PINK1+induced+pluripotent+stem+cells&doi=10.1523%2Fjneurosci.4441-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</span></div><div class="casAuthors">Seibler, Philip; Graziotto, John; Jeong, Hyun; Simunovic, Filip; Klein, Christine; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5970-5976</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Genetic Parkinson disease (PD) has been assocd. with mutations in PINK1, a gene encoding a mitochondrial kinase implicated in the regulation of mitochondrial degrdn.  While the studies so far examd. PINK1 function in non-neuronal systems or through PINK1 knockdown approaches, there is an imperative to examine the role of endogenous PINK1 in appropriate human-derived and biol. relevant cell models.  Here we report the generation of induced pluripotent stem (iPS) cells from skin fibroblasts taken from three PD patients with nonsense (c.1366C>T; p.Q456X) or missense (c.509T>G; p.V170G) mutations in the PINK1 gene.  These cells were differentiated into dopaminergic neurons that upon mitochondrial depolarization showed impaired recruitment of lentivirally expressed Parkin to mitochondria, increased mitochondrial copy no., and upregulation of PGC-1α, an important regulator of mitochondrial biogenesis.  Importantly, these alterations were cor. by lentiviral expression of wild-type PINK1 in mutant iPS cell-derived PINK1 neurons.  In conclusion, our studies suggest that fibroblasts from genetic PD can be reprogrammed and differentiated into neurons.  These neurons exhibit distinct phenotypes that should be amenable to further mechanistic studies in this relevant biol. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOdV6u6gwXKLVg90H21EOLACvtfcHk0lgLhHeSWs8Rqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSqs7Y%253D&md5=1d653ce94d4fff88dd9f6f16c0ab4382</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.4441-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.4441-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSeibler%26aufirst%3DP.%26aulast%3DGraziotto%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DSimunovic%26aufirst%3DF.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DMitochondrial%2520Parkin%2520recruitment%2520is%2520impaired%2520in%2520neurons%2520derived%2520from%2520mutant%2520PINK1%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5970%26epage%3D5976%26doi%3D10.1523%2Fjneurosci.4441-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kriks, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganat, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo-Reid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auyeung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonacci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surmeier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordower, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, L.</span></span> <span> </span><span class="NLM_article-title">Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>480</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature10648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1038%2Fnature10648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=22056989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=547-551&author=S.+Kriksauthor=J.-W.+Shimauthor=J.+Piaoauthor=Y.+M.+Ganatauthor=D.+R.+Wakemanauthor=Z.+Xieauthor=L.+Carrillo-Reidauthor=G.+Auyeungauthor=C.+Antonacciauthor=A.+Buchauthor=L.+Yangauthor=M.+F.+Bealauthor=D.+J.+Surmeierauthor=J.+H.+Kordowerauthor=V.+Tabarauthor=L.+Studer&title=Dopamine+neurons+derived+from+human+ES+cells+efficiently+engraft+in+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1038%2Fnature10648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease</span></div><div class="casAuthors">Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Wakeman, Dustin R.; Xie, Zhong; Carrillo-Reid, Luis; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Yang, Lichuan; Beal, M. Flint; Surmeier, D. James; Kordower, Jeffrey H.; Tabar, Viviane; Studer, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">480</span>
        (<span class="NLM_cas:issue">7378</span>),
    <span class="NLM_cas:pages">547-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new strategy for derivation of human midbrain dopamine neurons from pluripotent cells was developed; transplantation of the neurons in mice, rats and parkinsonian monkeys show they are a promising source of cells for applications in regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowqLdlQBwForVg90H21EOLACvtfcHk0lgLhHeSWs8Rqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfP&md5=99bc76fc18a87a84078260bf0bae23ad</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature10648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10648%26sid%3Dliteratum%253Aachs%26aulast%3DKriks%26aufirst%3DS.%26aulast%3DShim%26aufirst%3DJ.-W.%26aulast%3DPiao%26aufirst%3DJ.%26aulast%3DGanat%26aufirst%3DY.%2BM.%26aulast%3DWakeman%26aufirst%3DD.%2BR.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DCarrillo-Reid%26aufirst%3DL.%26aulast%3DAuyeung%26aufirst%3DG.%26aulast%3DAntonacci%26aufirst%3DC.%26aulast%3DBuch%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DKordower%26aufirst%3DJ.%2BH.%26aulast%3DTabar%26aufirst%3DV.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DDopamine%2520neurons%2520derived%2520from%2520human%2520ES%2520cells%2520efficiently%2520engraft%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D547%26epage%3D551%26doi%3D10.1038%2Fnature10648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burbulla, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzulli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampese, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermaier, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strojny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiskinis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surmeier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1126/science.aam9080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=10.1126%2Fscience.aam9080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=28882997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=1255-1261&author=L.+F.+Burbullaauthor=P.+Songauthor=J.+R.+Mazzulliauthor=E.+Zampeseauthor=Y.+C.+Wongauthor=S.+Jeonauthor=D.+P.+Santosauthor=J.+Blanzauthor=C.+D.+Obermaierauthor=C.+Strojnyauthor=J.+N.+Savasauthor=E.+Kiskinisauthor=X.+Zhuangauthor=R.+Kr%C3%BCgerauthor=D.+J.+Surmeierauthor=D.+Krainc&title=Dopamine+oxidation+mediates+mitochondrial+and+lysosomal+dysfunction+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.aam9080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease</span></div><div class="casAuthors">Burbulla, Lena F.; Song, Pingping; Mazzulli, Joseph R.; Zampese, Enrico; Wong, Yvette C.; Jeon, Sohee; Santos, David P.; Blanz, Judith; Obermaier, Carolin D.; Strojny, Chelsee; Savas, Jeffrey N.; Kiskinis, Evangelos; Zhuang, Xiaoxi; Krueger, Rejko; Surmeier, D. James; Krainc, Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6357</span>),
    <span class="NLM_cas:pages">1255-1261</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurodegeneration in Parkinson's disease (PD), but how these pathways are linked in human neurons remains unclear.  Here we studied dopaminergic neurons derived from patients with idiopathic and familial PD.  We identified a time-dependent pathol. cascade beginning with mitochondrial oxidant stress leading to oxidized dopamine accumulation and ultimately resulting in reduced glucocerebrosidase enzymic activity, lysosomal dysfunction, and α-synuclein accumulation.  This toxic cascade was obsd. in human, but not in mouse, PD neurons at least in part because of species-specific differences in dopamine metab.  Increasing dopamine synthesis or α-synuclein amts. in mouse midbrain neurons recapitulated pathol. phenotypes obsd. in human neurons.  Thus, dopamine oxidn. represents an important link between mitochondrial and lysosomal dysfunction in PD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNrpNz9CE9s7Vg90H21EOLACvtfcHk0lgw-15f8524gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWhurfK&md5=1425c696c8a838b8f0d697f6b055fe2d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aam9080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aam9080%26sid%3Dliteratum%253Aachs%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DZampese%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DJeon%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DD.%2BP.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DObermaier%26aufirst%3DC.%2BD.%26aulast%3DStrojny%26aufirst%3DC.%26aulast%3DSavas%26aufirst%3DJ.%2BN.%26aulast%3DKiskinis%26aufirst%3DE.%26aulast%3DZhuang%26aufirst%3DX.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DDopamine%2520oxidation%2520mediates%2520mitochondrial%2520and%2520lysosomal%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D1255%26epage%3D1261%26doi%3D10.1126%2Fscience.aam9080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01294">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35560"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01294">10.1021/acs.jmedchem.8b01294</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Characterization of iPSC lines and differentiated dopaminergic neurons. <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>6a</b>, <b>8a</b>, <b>9l</b>, <b>9o</b>, <b>9q</b>, <b>9s</b>, <b>11a</b>, and <b>11b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_001.pdf">jm8b01294_si_001.pdf (1.85 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01294/suppl_file/jm8b01294_si_002.csv">jm8b01294_si_002.csv (4.63 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01294&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01294%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01294" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679994acbc693cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
